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ABSTRACT 
 
The thymus is organised into distinct microenvironments, and trafficking through 
these regions enables thymocytes to receive essential signals for the generation of a diverse 
and self-tolerant T-cell repertoire. Thymic epithelial cells (TEC) represent a key stromal cell 
type during defined stages in T cell development, yet the mechanisms regulating their 
development are only partly understood.  
 An ontogenetic approach was employed to study stages of cortical thymic epithelial 
cell (cTEC) development. This study identifies a previously unreported population of cTEC 
progenitors expressing CD205 and β5T and has defined distinct checkpoints in the 
development of the cTEC lineage. Furthermore, the importance of thymic crosstalk during 
specific stages of cTEC development and also the requirement for RANK-RANKL signalling 
for the development of various medullary thymic epithelial cell (mTEC) subsets has also been 
defined.  Additionally, the importance of chemokine-mediated signalling for the 
establishment and compartmentalisation of the thymus has been highlighted by employing 
laser capture microdissection and studying thymus microenvironments in mice deficient for 
particular chemokine related signalling pathways. 
 Overall this study has provided novel insight into the development of the thymic 
cortex and will help to understand how these cells become specialised in their ability to 
support positive selection of developing T cells. 
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GENERAL INTRODUCTION 
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1.1 Overview of the Immune System. 
1.1.1 The Role of the Immune System. 
The immune system has evolved to protect organisms from disease by recognising and 
destroying foreign pathogens and tumour cells.  The immune system is made up of a complex 
and organised network of cells and molecules that are specialised in their role of defending 
the body against infection whilst maintaining tolerance to self-tissues (Delves and Roitt, 
2000). There are two systems that function together to eliminate pathogens and provide an 
effective defence system.  The evolutionary ancient innate or ‘natural’ immune system 
initiates a rapid, non-specific response to foreign pathogens and lacks immunological 
memory.  By contrast, the adaptive or ‘acquired’ immune system is characterised by the 
clonal expansion of T and B lymphocytes, which express antigen specific receptors and 
confers lifelong immunity to re-infection with the same antigen. 
The innate immune system includes mechanical, chemical and cellular elements, 
which act in concert as the first line of defence (Basset et al., 2003).  The mechanical element 
comprises the physical barrier of the epithelia preventing access to tissues and organs of the 
body.  Epithelial cells are held together by tight junctions and comprise the skin and line the 
body’s respiratory, gastrointestinal and urogenital tracts.  These epithelial cells form an 
effective barrier against the external environment by secreting anti-microbial enzymes (such 
as lysozyme and pepsin) and mucus that can inhibit attachment of the microbe.  Should these 
microbes evade the outer defences, other innate immune mechanisms are in place to detect 
and eliminate the invaders. 
The chemical element of innate immunity is in the form of hydrolytic proteins or 
peptides and inflammatory cytokines such as TNF-α and IL-6, which induce fever and 
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enhance epithelial responses to pathogens (Basset et al., 2003).  The key cellular components 
of innate immunity include the macrophages, dendritic cells (DCs), mast cells, neutrophils 
and the natural killer (NK) cells, which can become activated during an inflammatory 
response against an infection (Janeway and Medzhitov, 2002).  The basis of this activation is 
the recognition of pathogen associated molecular patterns (PAMPs) such as LPS, by pattern 
recognition receptors (PRRs) (Basset et al., 2003; Medzhitov and Janeway, 1997).  
Additionally, cells of the innate immune system such as the macrophages have receptors for 
antibodies and complement that enhance the process of phagocytosis when such cells 
encounter microbes coated in antibody or components of the complement pathway.  Although 
the innate immune response can be effective in eliminating or preventing the spread of an 
infection, in some circumstances these defences can be breached and hence an adaptive 
immune response will follow. 
 
1.1.2 The Adaptive Immune Response. 
The adaptive immune response is distinguishable from innate immunity based on the 
specific recognition of foreign antigens by specialised classes of lymphocytes and the 
differentiation of pathogen specific effector cells (Janeway and Medzhitov, 2002).  Following 
elimination of antigen during the primary immune response, a small number of effector cells 
persist and these are known as memory cells.  This defines the secondary immune response 
and ensures a more rapid and effective response on subsequent exposure, thereby providing 
lasting immunological memory. 
Adaptive immunity is comprised of a variety of cell types including B cells, NK T 
cells, γδ T cells, αβ CD4 helper T cells and αβ CD8 cytotoxic T cells.  All these cells derive 
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from pluripotent haematopoietic stem cells (HSCs) in the bone marrow.  Adaptive immunity 
has evolved to generate a large repertoire of T and B lymphocytes, which in contrast to the 
cells of the innate immune system have the capability of targeting a multitude of pathogens 
via the diverse expression of unique antigen specific receptors (Turner et al., 2006).  
Adaptive immune responses are initiated by DCs, which develop in the bone marrow 
and lie at the interface between the innate and adaptive immune system (Basset et al., 2003).  
Immature DCs reside in the peripheral tissues where they are continuously sampling their 
environment by a process of endocytosis until they receive a danger signal.  Such signals are 
either endogenous, consisting of molecules such as heat shock proteins produced from cells 
undergoing stress or abnormal cell death, or exogenous such as LPS on foreign microbes 
(Gallucci and Matzinger, 2001). Upon receiving a danger signal, the immature DCs undergo a 
programme of maturation, which transforms them into highly efficient antigen presenting 
cells (APCs) and potent activators of naïve T cells (Guermonprez et al., 2002).    The 
maturation of DCs is typified by the increase in surface expression of co-stimulatory markers 
such as CD40, CD80 and CD86, greater antigen processing efficiency and increased MHC 
molecule expression (Banchereau et al., 2000).  The maturation of DCs coincides with their 
migration to the secondary lymphoid organs (such as the spleen and lymph nodes) where they 
prime naïve antigen specific T cells and consequently activate the adaptive immune response.  
The organisation of these secondary lymphoid organs provide specialised microenvironments 
integral in providing optimal cellular interactions between B and T lymphocytes and DCs (Fu 
and Chaplin, 1999).  
Another important cell that plays a vital role in the adaptive immune response is the B 
lymphocyte.  B cells develop in the bone marrow and express a B cell receptor (BCR) that is 
the membrane bound form of the antibody that is secreted following B cell activation and 
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differentiation into a plasma cell.  Antibodies or immunoglobulins bind specifically to 
pathogens with the function to neutralise them or prepare them for uptake by phagocytes.  The 
activation of B cells and their differentiation into antibody secreting plasma cells and 
thereafter memory cells is triggered by antigens and usually requires assistance from T 
lymphocytes (MacLennan et al., 2003).  
 
1.1.3 T Lymphocytes. 
T lymphocytes play a central role in adaptive immunity by orchestrating the immune 
response to infection.  T cells derive from precursors in the bone marrow and in contrast to B 
cells continue their development in the thymus (see section 1.2).  T cells express a T cell 
receptor (TCR) and unlike B cells that can recognise antigen in its native form, T cells can 
only recognise processed antigen peptides presented by APCs in the context of Major 
Histocompatibility Complex (MHC) molecules.  There are two major classes of T cells 
defined by the surface expression of the co-receptors CD4 and CD8.  Following antigen 
recognition and the initiation of T cell signalling (see section 1.1.6) naïve CD4+ and CD8+ T 
cells differentiate into effector T cells, which have differing effector functions. 
 
1.1.3.1 CD8+ cytotoxic T cells. 
CD8+ cytotoxic T cells are selected in the thymus to recognise and respond to foreign 
peptides in the context of MHC class I (Bevan, 2004).  Naïve CD8+ T cells exit the thymus 
and differentiate into potent cytotoxic CD8+ T lymphocytes (CTLs) following the recognition 
of antigen.  CTLs kill virally infected or abnormal cells by inserting perforins into the cell 
membrane of target cells, producing pores that provide a route for proteolytic enzymes that 
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induce apoptosis in the target cell.  Additionally, CTL also activate apoptosis via the 
engagement of their Fas ligand with the Fas molecule on target cells.  The destruction of 
virally infected cells prevents viral replication and the release of cytokines (such as IFN-γ) 
induces an antiviral state in neighbouring cells that renders them resistant to infection (Delves 
and Roitt, 2000; Yewdell and Haeryfar, 2005).  
 
1.1.3.2 CD4+ helper T cells. 
CD4+ T cells are selected in the thymus to recognise and respond to foreign peptides 
in the context of MHC class II.  CD4+ T cells play an integral role in the immune response 
through their ability to stimulate antibody production in B cells and to recruit neutrophils, 
eosinophils and basophils to sites of infection and inflammation (Zhu and Paul, 2008).  
Following activation by antigen, naïve CD4+ T cells differentiate into either T helper 1 (Th1) 
or T helper 2 (Th2) effector cells (Mosmann and Coffman, 1989).  Th1 cells secrete cytokines 
including IFN-γ and IL-2 and are involved in targeting intracellular pathogens and are thought 
to be responsible for the induction of autoimmune disease (Zhu and Paul, 2008).  Th2 cells 
target extracellular pathogens including helminths and secrete cytokines including IL-4, IL-5 
and IL-10 and help B cells make antibody (Zhu and Paul, 2008).  CD4+ T cells can also 
differentiate into Th17 cells and regulatory T cells (Tregs).  Th17 cells secrete cytokines 
including IL-21 and IL-17 and play a role in the induction of autoimmune tissue injury.  
(Bettelli et al., 2006).  Tregs express CD4, CD25 and the transcription factor FoxP3.  Tregs 
are made in the thymus and are essential for maintaining peripheral tolerance and preventing 
autoimmune disease by suppressing T cell responses (Vignali et al., 2008). 
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1.1.4 Antigen Processing and Presentation to T cells. 
 The recognition of antigens in the peptide-binding groove of surface expressed MHC 
molecules by the TCR is at the forefront of the T cell immune response.  To activate T cells, 
MHC proteins must first be loaded with and present peptide antigens.  There are two subtypes 
of MHC involved in TCR recognition; class I and class II (Vyas et al., 2008).  A third subtype 
also exists and is important for the complement activation pathway of the humoral immune 
response (Yung Yu et al., 2000). 
MHC class I molecules are expressed on the surface of almost all nucleated cells and 
initiate an immune response to virally infected cells, intracellular bacterial infections or 
malignant cells by presenting endogenously derived peptides to CD8+ cytotoxic T cells 
(Flutter and Gao, 2004). Endogenous proteins to be loaded onto MHC class I molecules are 
degraded by proteasomes in the cytosol for MHC class I presentation (Trombetta and 
Mellman, 2005).  Peptide transporters transfer the resulting peptides to the endoplasmic 
reticulum (ER) and are loaded onto new MHC class I molecules.  Following association with 
peptide, MHC class I molecules are rapidly transferred via the Golgi apparatus to the cell 
surface membrane (Guermonprez et al., 2002). 
 In contrast to MHC class I molecules, expression of MHC class II molecules are 
mostly restricted to professional APCs such as DCs, B cells, macrophages and also epithelial 
cells in the thymus.  MHC class II molecules associate with peptides derived from exogenous 
antigens, which have been internalised into vesicles via the endocytic pathway (Guermonprez 
et al., 2002).  Assembly of the MHC II molecule occurs in the ER where the presence of the 
invariant chain (Ii) in the peptide binding groove, targets the complex to the endosomal 
pathway (Watts, 2004).  Within the endosomes or lysosomes the Ii chain is degraded by 
cysteine proteases of the cathepsin family.  The accessory molecule HLA-DM (or H-2M in 
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mice) catalyses the dissociation of the CLIP (class II associated invariant chain peptide) from 
the peptide binding groove of the MHC class II molecule for antigenic peptide loading 
(Bryant and Ploegh, 2004).  Following CLIP removal and peptide loading, peptide-MHC 
class II complexes are delivered to the plasma membrane for presentation to CD4+ helper T 
cells. 
 The process of antigen presentation in the context of MHC class I and class II 
molecules is also imperative for the intra-thymic positive selection of T cells expressing 
diverse, self-MHC restricted T cell receptors capable of recognising a multitude of peptides 
(see section 1.2.5). 
 
1.1.5 Structure of the T Cell Receptor. 
 One of the most important interactions during an immune response is that of the TCR 
with peptide-MHC complexes.  In addition to delivering essential signals at distinct stages of 
T cell development in the thymus, the TCR is vital for the activation and differentiation of 
mature T cells into effector and memory cells in the periphery (Call and Wucherpfennig, 
2005).  The TCR is associated with the CD3 complex as described in section 1.1.6 and 
illustrated in figure 1.1.  The majority of T cells express the αβTCR, which engages with 
processed antigen peptides in the context of MHC molecules expressed on APCs (van der 
Merwe and Davis, 2003).  There are T cells that also express the γδTCR and these cells 
constitute only 1-5% of the circulating peripheral lymphocytes (Carding and Egan, 2002).  
The γδ T cells are mostly found within epithelial tissues such as the skin and unlike αβ T cells 
they recognise unprocessed antigen in a non- MHC restricted manner (Hayday, 2000; Hayday 
and Pennington, 2007).  Data and discussion of T cells in this study will refer to αβ-T cells 
unless otherwise stated. 
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Figure 1.1 Structure of the T cell Receptor and CD3 Complex.  
The T cell receptor is composed of an α- and β-chain joined together by a disulphide 
bond.  Each chain is comprised of a variable (V) region and a constant (C) region. The Vα 
and Vβ domains encode regions of hypervariability known as complementarity-determining 
regions (CDRs) and these form the peptide-MHC binding site.  The TCR is associated with 
the CD3 complex, which is comprised of CD3γ, CD3δ, two molecules of CD3ε and the 
additional CD3ζ subunit, which exists primarily as a disulphide-linked homodimer.  Each 
CD3 subunit contains cytoplasmic domains with conserved immunoreceptor tyrosine based 
activation motifs (ITAMs).  
Image adapted from Janeway et al (2005).   
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  The αβTCR is composed of an α-chain and a β-chain, linked together by disulphide 
bonds to form a heterodimer.  Each chain is comprised of a variable (V) domain and a 
constant (C) domain (Saito et al., 1984), which are spliced together during T cell development 
in the thymus.  The V domain of the β-chain is encoded by variable (V), diversity (D) and 
junctional (J) gene segments, whereas only the V and J gene segments encode the V region of 
the α-chain (Turner et al., 2006).  The Vα and Vβ domains encode regions of hypervariability 
known as complementarity-determining regions (CDRs) and this forms the peptide-MHC 
binding site (Chothia et al., 1988; Davis et al., 1998).   
The immune system has the remarkable capacity to generate a vastly diverse repertoire 
of antigen receptors specific for the multitude of pathogens we may encounter in a lifetime.  
Such diversity is achieved through a complex and highly regulated site-specific genomic 
process called V(D)J recombination (Alt et al., 1992).  A combinatorial rearrangement of the 
V, D and J segments generates diversity in the variable region of each TCR chain and further 
receptor structure diversity is achieved by the addition or removal of nucleotides at joining 
sites by the enzyme terminal deoxynucleotidyl transferase (TdT) (Fugmann et al., 2000; 
Komori et al., 1993).  V(D)J recombination in both T and B cells is regulated by the proteins 
encoded by the recombination activating genes RAG-1 and RAG-2, which are expressed in 
developing lymphocytes undergoing antigen receptor assembly.  Defects in either of these 
genes result in severe immunodeficiency due to a defect in the production of functional 
lymphocytes bearing antigen receptors (Mombaerts et al., 1992; Schwarz et al., 1996). 
Engagement of the TCR with APCs presenting antigen peptides in the context of 
MHC class I or class II is imperative for T cell activation and requires association with a 
multi-component signalling complex. 
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1.1.6 TCR and CD3 Signalling.  
The sustained engagement of TCR with peptide-MHC on the cell surface of APCs 
leads to the cross-linking of the TCR, which initiates a complex intracellular signalling 
cascade culminating in the activation of T cell effector functions (Ehrlich et al., 2002) (figure 
1.2).  The specialised contact area between T cells and APCs has been termed the 
‘immunological synapse’ and is defined by the ‘bull’s eye’ distribution of the TCR with other 
cell surface signalling and adhesion molecules associated with the propagation of a signal 
from the T cell surface to the nucleus (Grakoui et al., 1999; Kane et al., 2000).  The centre of 
the bull’s eye is enriched for the TCR and peptide-MHC complex, whereas the ring contains 
the integrin LFA-1 and its major counter receptor ICAM-1 (Bromley et al., 2001a).  
Due to a short cytoplasmic domain, the αβTCR is incapable of signalling to the cells 
alone and hence associates with a group of invariant molecules that are non-covalently 
associated with the αβ heterodimer and are collectively termed the CD3 complex.  This 
complex, which is also important for surface expression of the αβTCR, consists of CD3γ, 
CD3δ and two molecules of CD3ε, which are encoded by genes on mouse chromosome 9 and 
are structurally related to the immunoglobulin family (Call and Wucherpfennig, 2005; Chan 
et al., 1994).  The additional subunit CD3ζ has a large cytoplasmic domain and exists 
primarily as a disulphide-linked homodimer with a small percentage of TCRs containing 
heterodimers of ζ and η (a splice variant of ζ) (Call and Wucherpfennig, 2005; Clayton et al., 
1992).  Each CD3 subunit contains cytoplasmic domains with conserved immunoreceptor 
tyrosine based activation motifs (ITAMs), which are important in mediating intracellular 
signal transduction following TCR recognition of antigen (Clevers et al., 1988; Kane et al., 
2000).  Upon TCR engagement by antigen presented by MHC molecules, T cell  
 
 22 
 
 
 
 
 
 
Figure 1.2 Overview of the Immunological Synapse. 
Overview showing the key signalling pathways initiated following TCR engagement 
with peptide loaded MHC molecules on antigen presenting cells (APCs).  Signalling 
pathways culminate in the activation of transcription factors involved in T cell effector 
functions.  
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signalling is initiated following binding of the co-receptors CD4 (on helper T cells) or CD8 
(on cytotoxic T cells) to the constant regions of MHC class II and MHC class I molecules 
respectively. 
The recruitment and activation of co-receptor associated p56lck (tyrosine kinase 
belonging to the Src family) and receptor associated p59fyn (also belonging to the Src family) 
initiates Lck and Fyn mediated phosphorylation of ITAMs in the cytoplasmic tails of the CD3 
complex (Lin and Weiss, 2001; Straus and Weiss, 1992; Turner et al., 1990).  The 
consequence of phosphorylated ITAMs is the recruitment and activation of another tyrosine 
kinase belonging to the Syk family called ZAP-70.  ZAP-70 associates with the CD3ζ chain 
and is important for the propagation of the signal by acting as a scaffold for the binding of 
additional adapter proteins such as LAT and SLP-76 (Deindl et al., 2007; Samelson, 2002).  
Events occurring downstream of LAT and SLP-76 phosphorylation include calcium 
mobilisation via the generation of inositol phospholipids and cytoskeletal reorganisation via 
Vav-dependent activation of Rac, which is integral for the formation of the immunological 
synapse (Ardouin et al., 2003; Turner and Billadeau, 2002).  The culmination of these 
signalling pathways is the activation of transcription factors such as nuclear factor κB (NF-
κB), nuclear factor of activated T cells (NFAT) and activator protein 1 (AP-1), which initiate 
transcription of genes involved in differentiation, proliferation and effector actions of T cells.     
Signalling by the TCR/CD3 complex only, in the absence of co-stimulatory signals 
fails to activate T cells and instead induces apoptosis.  Signals delivered to the TCR by co-
stimulatory cell surface molecules on APCs are important for optimal activation of T cells and 
the induction of tolerance by the provision of inhibitory signals (Sharpe and Freeman, 2002).  
One of the most understood co-stimulatory pathways is B7-CD28.  B7 members include B7.1 
(CD80) and B7.2 (CD86) expressed on APCs, which augment and sustain T cell responses by 
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interacting with CD28 on T cells (Bromley et al., 2001b).  CTLA-4 is expressed on activated 
T cells and binds to B7.1 and B7.2 to deliver an inhibitory signal to the T cell (Linsley et al., 
1991).  Other members of the B7 family include PD-L1 (CD274) and PD-L2 (CD273), which 
bind to PD-1 on T cells and this pathway is thought to be involved in the induction of T cell 
tolerance. (Liang et al., 2003).  
The generation of T lymphocytes that are specific for a wide spectrum of antigens 
occurs in the thymus.  The establishment of this self-tolerant and diverse T cell repertoire is 
dependent on the unique structure of the thymus and this is of considerable interest.  Further 
discussion and data within this thesis relates to this subject. 
 
1.2 T Cell Development.  
1.2.1 Structure and Function of the Thymus. 
 The thymus is an encapsulated primary lymphoid organ situated in the upper anterior 
thorax above the heart and whose emergence during evolution occurred in parallel with the 
appearance of V(D)J recombination (Boehm, 2008).  The thymus plays a fundamental role in 
establishing a fully functional immune system by supporting the development of T cells that 
are highly specialised in their ability to mount a reactive immune response against specific 
antigens. The importance of the thymus in T cell development was first demonstrated in 1961 
when thymectomised neonatal mice developed severe immunodeficiency (Miller, 2002).  
After birth, the thymus starts to undergo a gradual process of involution or atrophy, where the 
thymus shrinks in size and is replaced by fat and the production of new T cells is decreased.    
 The thymus consists of numerous lobules separated by mesenchymal septae, with each 
lobe comprising a unique three-dimensional complex network of non-lymphoid stromal cells, 
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which provides a supporting framework to mediate T cell development.  (Anderson and 
Jenkinson, 2001). The two main regions of the stroma comprise of the peripheral cortex and 
the central medulla, each containing several distinct types of thymic epithelial cells (TECs) 
(Boyd et al., 1993).  These distinct regions generate highly specialised intra-thymic 
microenvironments, which direct the maturation of immature T cell precursors into a diverse 
repertoire of self-tolerant and antigen-specific T cells.  To achieve this, T cells must undergo 
a series of checkpoints including, commitment to the T cell lineage, TCR gene 
rearrangements, selection of the αβ T cell repertoire, CD4 and CD8 lineage commitment and 
post-selection maturation.  This highly orchestrated development of thymocytes is defined by 
their migration through the different microenvironments of the thymus allowing them to 
receive essential signals from the thymic stroma.  However, prior to intra-thymic T cell 
development, haematopoietic precursors must first colonise the thymus. 
 
1.2.3 Colonisation of the Thymus by Thymocyte Progenitors. 
T cells develop from migrant progenitors that originate in different haematopoietic 
sites depending on the stage of development (Anderson et al., 2006).  The liver and yolk sac 
are the primary sites of haematopoiesis in the fetus, whereas progenitors colonising the 
thymus in the adult are derived from the bone marrow.  The very early thymic progenitors or 
HSCs have self-renewal capacity and can give rise to all lymphocyte populations and other 
blood cell types.  In mice, multipotent HSCs lack lineage markers (Lin-) indicative of 
differentiated cells but do express stem cell antigen 1 (Sca-1) and CD117 (c-Kit) and are 
termed LSK cells (Ikuta and Weissman, 1992).  LSK cells represent the most immature HSCs 
in the bone marrow.  
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 T cell development is dependent on the colonisation of the thymus by HSC-derived T 
cell progenitors. Progenitors in the thymus have an extremely limited capacity to self-renew 
and so continuous replenishment of the thymic pool is necessary.  This seeding of the thymus 
from progenitors migrating through the bloodstream requires a continuous input of 
progenitors to maintain T cell development and this is thought to occur in periodic waves 
(Foss et al., 2001).  Before vascularisation is established, precursors colonise the fetal thymus 
at day 12 of gestation (E12) by exiting nearby blood vessels and entering the perithymic 
mesenchyme surrounding the thymus before migrating across the epithelial basement 
membrane (Itoi et al., 2001; Suniara et al., 2000).  However, in the postnatal thymus 
circulating progenitors enter the thymus via blood vessels in a region of the thymus called the 
cortico-medullary junction (CMJ) (Lind et al., 2001). 
There is still considerable debate as to the precise phenotypic identity of precursors 
seeding the thymus and if these cells represent cells with multiple lymphoid lineage potential 
or cells committed to the T cell lineage (Jenkinson et al., 2006).  Studies have implicated the 
role of Notch signalling in T cell commitment.  Notch genes encode a family of 
transmembrane receptors, which have a role in cellular differentiation and cell fate decisions 
(Maillard et al., 2005).  Four mammalian Notch homologues exist (Notch 1-4) and their 
ligands include Jagged 1, Jagged 2, Delta-like 1 (DL1) and Delta-like 4 (DL4), which are 
expressed on thymic epithelial cells.  The essential role of Notch signalling in T cell 
development is evidenced by the absence of T cells and the presence instead of B cells in the 
thymus of mice with perturbed Notch signalling (Wilson et al., 2001).  Initially it was argued 
that intrathymic Notch signalling determines lineage choice of progenitors entering the 
thymus, which have T cell and B cell potential (Pui et al., 1999).  However, a study has 
shown that T and B lineage choice occurs prior to precursor recruitment to the thymus and so 
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argues against a role for intrathymic Notch signalling in determining T/B lineage choice 
during initial fetal thymus colonisation (Harman et al., 2005).  These studies may suggest that 
intrathymic Notch signalling may in fact be required for continued T cell differentiation and 
for revealing T cell fate in already committed progenitors entering the thymus.  Notch 
signalling pathway is also thought to have a role in subsequent T cell development including, 
regulation of TCRβ rearrangements, αβ versus γδ and CD4 versus CD8 lineage commitment 
(Anderson et al., 2006). 
   The precise mechanisms that mediate recruitment of thymic progenitors from the 
bone marrow are yet to be fully defined.  However, such recruitment of progenitors is known 
to differ in the fetal and post-natal thymus.  Thymic colonisation in the fetal thymus is 
regulated by a chemotactic mechanism.  In the fetal thymus it has been shown that 
CCL21/CCR7 and CCL25/CCR9 mediated chemokine signals are essential for early thymus 
colonisation prior to vascularisation but are not required post-vascularisation (Liu et al., 
2006).  A study analysing chemokine expression on the first wave of progenitors entering the 
E12 thymus, identified heterogeneity within these early thymic migrants as defined by the 
expression of multiple chemokine receptors including, CCR7, CCR9 and CXCR4 (Jenkinson 
et al., 2007a).  A population of cells lacking this expression pattern was also observed 
suggesting that other chemokine independent mechanisms are important or other as yet 
unidentified chemokines play a role in progenitor colonisation.  
In the post-natal thymus, recruitment of thymic progenitors in the adult is regulated by 
a family of carbohydrate binding proteins called selectins, which have an important role 
during inflammatory responses by recruiting effector cells to sites of infection (Rossi et al., 
2005).  P-selectin was found to be expressed extensively throughout the thymus vasculature 
and is a key mediator of the homing and recruitment of circulating cells.  The cognate ligand 
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for P-selectin is P-selectin glycoprotein ligand 1 (PSGL-1).  PSGL-1 is expressed on LSK 
cells in the bone marrow and early progenitors in the thymus and hence implicates the role of 
selectins in facilitating progenitor recruitment to the thymus.  A recent study has shown that 
the periodic thymic expression of P-selectin and the CCR9 ligand CCL25, which is also 
important for thymic progenitor immigration, is likely to contribute to thymic gating (Gossens 
et al., 2009).  This study also demonstrated a role for sphingosine-1-phosphate (S1P) in the 
expression of P-selectin.    
Once T cell progenitors enter the thymus they subsequently undergo a tightly 
regulated process of T cell development. 
 
1.2.4 Early Intra-thymic T Cell Development. 
 Following thymic colonisation, thymocytes differentiate through various 
phenotypically distinct stages as defined by expression of cell surface markers including the 
co-receptors CD4 and CD8 (Figure 1.3).  Thymic progenitors interact closely with thymic 
stromal cells throughout the various stages of T cell development allowing them to receive 
important signals for their differentiation.  This development correlates with an orchestrated 
migration of thymocytes through different thymic microenvironments (see section 1.2.7).  
Following progenitor colonisation in the fetal thymus, thymocyte development proceeds in an 
organised manner with sequential developmental stages occurring at different stages of 
ontogeny.  However, T cell development in the adult represents a dynamic equilibrium 
between colonising progenitors and newly arising mature T cells with all stages of 
development present (Zuniga-Pflucker and Lenardo, 1996). 
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Figure 1.3 Stages of Intrathymic T Cell Development. 
Stages of T cell development in the thymus as defined by phenotypic changes in the 
expression of cell surface markers including the co-receptors CD4 and CD8.  Thymocytes 
differentiate from double negative (DN) to double positive (DP) and finally to single positive 
(SP) cells.  Alternative lineage potentials are indicted in the boxes and red arrows show the 
essential checkpoints during T cell development. 
 31 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 32 
The earliest described progenitors that first enter the thymus at the CMJ are described 
as lineage double negative (DN) cells because they lack expression of CD4 and CD8. During 
the DN stage each precursor entering the thymus gives rise to approximately 1 million 
daughter cells and hence is the most proliferative stage of T cell development (Lind et al., 
2001).  The DN stage is further sub-divided into four separate stages based on the differential 
expression of CD44 (phagocytic glycoprotein 1), CD25 (IL-2 receptor α), CD117 and CD127 
(IL-7 receptor α chain) (Godfrey et al., 1993; Zuniga-Pflucker and Lenardo, 1996).  As these 
early thymocytes differentiate through the DN substages, they undergo a progressive loss in 
multi-lineage potential and start to acquire a phenotype characteristic of T cells.  Cells at the 
double negative 1 stage (DN1) are defined as CD25- CD44hi CD117+ CD127-.  This subset is 
the most immature cell type in the thymus and is thought to contain subsets of common 
lymphoid progenitors with multi-lineage potential, including T and B cells, DCs and NK T 
cells but not myeloid cells.  However, this definition of DN1 cells is very much simplified 
and heterogeneity has been identified within this stage as defined by the expression of other 
haemato-lymphoid lineage markers such as CD24 (Porritt et al., 2004) and Flt3 (Sambandam 
et al., 2005).  These various DN1 progenitor subsets all home to the thymus but have different 
proliferative capacities and lineage potentials.    
DN1 cells acquire CD25 and CD127 and transition to the double negative 2 (DN2) 
stage of development (defined as CD25+ CD44hi CD117+ CD127+) and these cells are found 
predominantly in the mid-cortical region of the thymus.  DN2 cells are thought to have lost B 
cell potential and have limited NK T cell potential but can still give rise to αβ and γδ T cells 
and DCs (Schmitt et al., 2004).  At this stage of development, expression of the RAG genes 
are upregulated (Wilson et al., 1994) and rearrangement of the TCRγ and δ loci occurs, which 
precede rearrangement at the TCRβ locus (Livak et al., 1999). TCRβ rearrangement is 
 33 
completed upon transition to the double negative 3 (DN3) stage of development, which is 
defined as CD25+ CD44lo CD117lo CD127lo.  IL-7 signalling has been shown to be important 
at this early stage of T cell development.  IL-7 is produced by thymic epithelial cells and 
binds to IL-7Rα, (CD127), which is complexed with the common cytokine receptor γ chain 
(γc) (Zamisch et al., 2005).  A study using OP9-DL1 cells, a stromal cell line known to 
support T cell development in vitro (Schmitt and Zuniga-Pflucker, 2002), demonstrated that 
proliferation and differentiation of DN1 and DN2 cells required the presence of IL-7, whilst 
differentiation beyond the DN3 stage was IL-7 independent (Balciunaite et al., 2005). 
DN3 cells are localised in a region of the thymus adjacent to the capsule, called the 
subcapsular zone (SCZ).  Cells at this stage of development have absolutely committed to the 
T cell lineage and can give rise to αβ and γδ T cells. The complete loss of non-T lineage 
potential, coinciding with the large-scale gene rearrangement of TCR chains, marks the 
irreversible commitment to the T cell lineage.  The exact branch point of αβ and γδ lineages 
and the molecular mechanisms determining this lineage decision have not yet been fully 
characterised.  However, a study has reported a differential role for Notch signalling during 
αβ and γδ T lineage diversification (Ciofani et al., 2006).  In the context of αβ T cell 
development, rearranged TCRβ chain pairs with an invariant pre-Tα and CD3 components on 
the cell surface forming the pre-TCR complex initiating further differentiation of the 
thymocyte (Baldwin et al., 2005). The pre-TCR complex consists of the TCRβ chain 
disulphide linked to the pre-TCRα, which is homologous to the TCRα chain but contains a 
single extracellular immunoglobulin-like structural domain (Groettrup et al., 1993; von 
Boehmer et al., 1999; Zuniga-Pflucker and Lenardo, 1996).  Only cells with a functional pre-
TCR are selected for expansion and further maturation and this process is called β-selection 
and defines the first checkpoint of T cell development. The failure to express a functional pre-
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TCR prevents further thymocyte differentiation and leads to apoptosis.  β-selection ensures 
that only thymocytes that have successfully generated functional in frame TCRβ progress to 
the next stage of T cell development.  This occurs through pre-TCR signalling, which requires 
association with the CD3 complex and activation of the protein tyrosine kinases lck and fyn 
(as described in section 1.1.5) (von Boehmer et al., 1999). 
The pre-TCR/CD3 complex prevents further DNA recombination at the TCRβ locus 
by a process of allelic exclusion, which ensures that developing T cells express only one 
TCRβ chain (Aifantis et al., 1997; Petrie et al., 1993).  Signalling through the pre-TCR 
complex terminates β-selection and drives the proliferation and differentiation of DN cells to 
the next stage of T cell development (Ardouin et al., 1998). 
Thymocytes emerging from β-selection at the DN3 stage undergo a dramatic increase 
in proliferation and down-regulate CD25 and CD44 to make the transition to what is known 
as the double negative 4 stage (DN4) of T cell development.  However, these cells do not 
represent true DN cells as they are in the process of up-regulating CD4 and CD8 expression to 
become double positive (DP) thymocytes (Petrie and Zuniga-Pflucker, 2007).  DP cells 
constitute the entire region of the cortex.  This phase of T cell development is marked by the 
rearrangement of the TCRα gene locus, which displaces the pre-Tα and pairs with the already 
expressed β chain.  This is then followed by surface expression of low levels of αβTCR 
assembled with the CD3 complex.  Following upregulation of the co-receptors, a large 
population of DP cells are generated and these constitute approximately 90% of thymus 
cellularity (Germain, 2002).  This transition of DN cells to DP cells occurs via a subset of 
thymocytes called immature single positive (ISP) cells, which can be defined as either CD4+ 
CD8- CD3- or CD4- CD8+ CD3- (Hugo et al., 1990; Tatsumi et al., 1990). Such CD4+ or CD8+ 
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ISP cells represent a rapidly cycling intermediate precursor for CD4+ CD8+ cells.  Notch 
signalling has been implicated in this transition of DN cells to DP cells (Huang et al., 2003). 
The successful rearrangement of the TCRα and β chains prepares the DP thymocyte 
for T cell repertoire selection, which defines the next checkpoint of T cell development 
(Zuniga-Pflucker and Lenardo, 1996). 
 
1.2.5 Thymic Selection of the αβTCR Repertoire. 
 Immature CD4+ CD8+ CD3lo double positive (DP) thymocytes expressing low levels 
of αβTCR are subjected to stringent positive and negative selection events in the cortical 
region of the thymus.  Interactions between developing thymocytes and self-MHC molecules 
expressed on the thymic stroma define this stage of development and represent a vital 
checkpoint in the development of T cells.  
   DP cells have a relatively short life span of approximately 3-5 days (Egerton et al., 
1990) during which the RAG genes continue to be expressed and there is further 
rearrangement at the TCRα locus.  Approximately 90% of DP cells are thought to die by 
neglect unless there is an appropriate interaction between the TCR with self-peptide/MHC 
complexes, presented by cortical epithelial cells, ensuring their survival and differentiation 
into single positive (SP) cells.  Survival of pre-selection DP cells has been reported to be 
regulated by the expression of the anti-apoptotic factor Bcl-2 as well as initiation of the Wnt 
signalling pathway via the transcription factors TCF-1 and LEF-1 (Ioannidis et al., 2001; 
Pongracz et al., 2003).  Wnt proteins belong to a family of secreted glycoproteins and are 
expressed by the thymic epithelium.  Wnts bind to frizzled receptors on developing T cells, 
which initiates distinct signalling pathways resulting in the stabilisation of β-catenin 
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(Anderson et al., 2006).  Stabilised β-catenin translocates to the nucleus where it binds to 
TCF-1 and LEF-1 resulting in expression of Wnt target genes.   
Successful engagement of the TCR on DP cells with self-peptide/MHC on the stroma 
prevents further TCRα rearrangement and leads to various developmental fates depending on 
the strength and the nature of the interaction between the TCR and peptide-MHC (Ober et al., 
2000).  DP cells that can bind to self-peptide presented on MHC I with low affinity will 
differentiate into CD4- CD8+ (SP8) T cells, whereas DP cells that bind to self-peptides 
presented on MHC II will differentiate into CD4+ CD8- (SP4) T cells.  This process ensures 
that only thymocytes expressing receptors with the potential to recognise foreign peptides in 
the context of self-MHC are selected to mature into single positive T cells (Anderson and 
Jenkinson, 2001).  DP cells that interact with self-MHC with too high an affinity are 
potentially autoreactive and will die by apoptosis in a process called negative selection 
(Anderson et al., 2006).  Only a small fraction of thymocytes (approximately 3-5%) will 
survive this checkpoint in T cell development (Goldrath and Bevan, 1999).  
Early studies have shown that radioresistant stromal cells are responsible for imposing 
MHC-restricted antigen recognition by developing T cells (Bevan, 1977; Zinkernagel et al., 
1978).  It become increasingly clear that the cortical thymic epithelial cells (cTECs) have a 
unique ability to mediate and support positive selection of thymocytes from the DP to SP 
stage (see section 1.3.6).  Experiments using reaggregate thymic organ cultures (RTOCs), 
where thymocytes were cultured with thymic stroma expressing MHC II, have established the 
importance of MHC II+ cTECs in supporting positive selection of DP thymocytes (Anderson 
et al., 1994a; Anderson et al., 1994b).  Sustained interactions of DP cells with MHC are 
important for further maturation into functional SP4 and SP8 cells and this is evidenced by 
the upregulation of the early activation marker CD69.  Experiments involving the 
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reaggregation of CD4+ CD8+ CD69- (preselection) thymocytes with MHC II deficient stroma 
failed to generate SP4 thymocytes with no evidence of CD69 expression, thereby further 
confirming the importance of MHC interactions to initiate positive selection (Hare et al., 
1999).  However, in the same study CD4+ CD8+ CD69+ thymocytes did not require MHC 
expression on stroma for differentiation to the SP stage of development.  Therefore, CD69 
expression discriminates between MHC-dependent and MHC-independent stages of 
thymocyte development, where the initial stages of positive selection require sustained TCR-
MHC interactions.  However, further functional and phenotypic differentiation to SP4 and 
SP8 cells does not require continuous signalling through the TCR, although still requires 
interaction with the thymic epithelium.  Other phenotypic changes at this stage include, the 
upregulation of another activation/selection marker CD5 and down-regulation of RAG 1 and 
2 (Merkenschlager et al., 1997). Further maturation into SP thymocytes is also dependent on 
the upregulation of particular cytokine receptors, most notably the IL-7 receptor α chain 
(CD127) and the common γ chain (CD132), which is an important component of IL-2, IL-4, 
IL-7, IL-9 and IL-15 cytokine receptors (Hare et al., 2000).  
  In addition to these changes, the levels of CD4 and CD8 expression decreases during 
selection giving rise to a CD4low CD8low TCRint population (Lucas and Germain, 1996).  
These cells are thought to differentiate into either SP4 or SP8 thymocytes via a transitional 
population of cells defined as CD4+ CD8low (Singer et al., 2008).  The precise cellular and 
molecular mechanisms that underlie CD4/CD8 lineage decisions are still subject to debate.  
However, a study showed that constitutively activated Notch1 promotes the development of 
SP8 cells over SP4 cells, thereby implicating a role for Notch signalling in CD4 and CD8 
lineage fate (Robey et al., 1996). 
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 Following TCR mediated repertoire selection positively selected thymocytes migrate 
to the medulla where they are subject to post-selection maturation. 
 
1.2.6 Post-Selection Maturation and Export to the Periphery. 
 Positively selected thymocytes induced to differentiate into SP4 and SP8 cells 
expressing high levels of TCR are rapidly relocated to the medulla where they are thought to 
spend approximately 14 days awaiting export to the periphery (Egerton et al., 1990).  During 
this stay in the medulla, thymocytes undergo a process of receptor tuning and maturation, 
which is accompanied by further deletion of potentially auto-reactive thymocytes that have 
escaped negative selection in the cortex by exposure to tissue restricted antigens (TRAs) 
(Takahama, 2006).  This process of negative selection is supported by the medullary thymic 
epithelial cells (mTEC) and in particular a subset expressing the autoimmune regulator AIRE 
is vital for regulating central tolerance (see section 1.3.7.1). 
In the medulla SP4 and SP8 cells undergo waves of expansion with at least 6 rounds 
of cell division and this is developmentally regulated as post-selection expansion was greater 
in neonatal thymocytes compared to adult thymocytes (Hare et al., 1998).  Although this 
expansive phase is independent of TCR/MHC interactions, it is dependent on continuous 
signals from thymic epithelial cells.  Notably IL-7 signalling, which plays an important role in 
the early stages of T cell development, mediates intra-thymic expansion of positively selected 
thymocytes and supports the establishment of a peripheral T cell pool in the neonate (Hare et 
al., 2000).  IL-7 produced by MHC II+ thymic epithelium signals to SP cells following their 
upregulation of IL-7Rα and γ chains. 
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Recently selected SP thymocytes residing in the medulla undergo further sequential 
changes in the expression of particular cell surface markers to become recent thymic 
emigrants (RTEs).  Such phenotypic changes include the down-regulation of CD69 and heat 
stable antigen (HSA) and the upregulation of CD62L, Qa-2 and CD45RB and this 
differentiation occurs simultaneously with the acquisition of functional maturity (Gabor et al., 
1997a; Jin et al., 2008).  
Following this differentiation process, mature thymocytes are thought to migrate 
towards the post-capillary venules at the CMJ and are exported at a rate of 1-2% of total 
thymocytes per day (Gill et al., 2003).  Export of cells from the thymus occurs synchronously 
and is a heterogeneous mix of cells including αβ CD4+ T cells, αβ CD8+ T cells, γδ T cells, 
NK T cells and Tregs (McCaughtry et al., 2007).  The export of T cells is not regulated by the 
size of the peripheral T cell pool but rather intrinsically regulated within the thymus (Gabor et 
al., 1997b). 
Thymic emigration occurs in a poorly defined chemokine dependant mechanism via 
blood vessels at the CMJ and in the medulla, where naïve T cells enter the blood and 
lymphatic system to take up residence in the secondary lymphoid organs, including the spleen 
and lymph nodes, where they await stimulation by antigen. 
 
1.2.7 Directed Migration of Thymocytes and the Role of Chemokines. 
During their development, thymocytes migrate through the various regions of the 
thymus continuously interacting with the thymic stroma (figure 1.4).  The stratified 
organisation of thymocytes forms specialised microenvironments in the post-natal thymus 
providing important signals for each stage of T cell development (Anderson et al., 2006).  The 
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signals that mediate thymocyte trafficking are yet to be fully elucidated.  However, there is 
increasing evidence to suggest an important role for chemokines and their receptors during 
this process (Takahama, 2006). 
Chemokines are a family of chemotactic cytokines that were thought to primarily 
regulate leukocyte traffic and recruitment of leukocytes during infection and inflammation.  
However, they are also known to play a role in lymphoid trafficking in the absence of 
inflammation and also the development of lymphoid organs.  Chemokines stimulate cell 
migration via G-protein-coupled seven-transmembrane receptors (Rossi and Zlotnik, 2000). 
Many studies have identified the production of chemokines by distinct thymic stromal cells 
and the expression of their corresponding receptors on different thymocyte subsets. This 
differential expression pattern suggests the essential role that chemokines play in regulating 
the complex trafficking of thymocytes within the post-natal thymus (Ladi et al., 2006). It is 
important to note that the requirement for chemokine receptor mediated migration of 
thymocytes is likely to differ in the fetal thymus, which is neither vascularised or structured 
during progenitor colonisation. Studies in mice with mutations in genes encoding for 
chemokines or their receptors have identified several groups important in post-natal 
thymocyte migration.   
Progenitors enter the thymus via large postcapillary venules at the CMJ and their 
differentiation through the DN1 to DN4 substages corresponds with their directed migration 
through the cortex towards the subcapsular zone (SCZ).  DN1 progenitors, which are largely 
absent from the outer cortex, are abundant at the CMJ and typically spend approximately 9-10 
days confined to this area (Porritt et al., 2003).  Migration out of this area into the mid- 
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Figure 1.4 Organisation of the Thymic Microenvironment. 
During T cell development, thymocytes undergo directed migration through the 
different thymic microenvironments where they receive essential signals from specialised 
stromal cells.   
Arrows indicate direction of migration.  DN, double negative, DP, double positive, 
SP4, single positive CD4 T cell, SP8, single positive CD8 T cell, CMJ, corticomedullary 
junction, cMES, cortical mesenchyme, cTEC, cortical thymic epithelial cell, mTEC, 
medullary epithelial cell.     
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cortex corresponds with the differentiation to the DN2 stage of development, which lasts 
approximately 2 days.  Commitment to the T cell lineage and β-selection defines 
differentiation to the DN3 stage and correlates with polarised migration towards the SCZ 
where DN3 cells begin to accumulate (Lind et al., 2001; Porritt et al., 2003).  The lifespan of 
DN3 cells is approximately 4 days.  The SCZ provides a microenvironment that supports the 
final stages of DN proliferation and transition to the DP stage.  The acquisition of CD4 and 
CD8 during the transition from DN to DP correlates with a reversion of the migration polarity 
guiding the DP thymocytes back inwards across the cortex towards the medulla (Misslitz et 
al., 2004) 
The polarised migration of DN cells towards the SCZ, against the flow of DP cells 
moving inwards, implicates delivery of a chemotactic signal from thymic stromal cells in the 
outer cortex and/or SCZ.  Signalling through CXCL12 (stromal derived factor 1, SDF-1) and 
its receptor CXCR4 has been identified as an absolute requirement for the proper localisation 
of DN progenitors in the cortex (Plotkin et al., 2003).  CXCR4 is expressed by all DN subsets 
with the highest expression in DN2 and DN3 cells.  The ligand, CXCL12 is expressed on 
cortical epithelial cells but not in the medulla.  Cells lacking CXCR4 fail to differentiate past 
the DN1 stage and this clearly indicates the importance of CMJ to cortex migration for 
normal T cell development (Plotkin et al., 2003).  Another chemokine important for the 
polarised migration of DN cells towards the SCZ is CCL25 (thymus expressed chemokine, 
TECK), which is found on epithelial cells in the cortex and medulla.  Its receptor CCR9, 
although expressed at low levels on DN2 and DN3 cells, is predominantly on DP cells and is 
down-regulated following transition to the SP stage.  Premature over expression of CCR9 
leads to an accumulation of DN3 cells in the cortex (Uehara et al., 2006), whereas CCR9 
deficiency results in the failure of DN3 cells to localise to the SCZ suggesting an important 
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role for CCR9 in SCZ homing (Benz et al., 2004).  Surprisingly, thymocytes failing to 
migrate to the SCZ in CCR9-/- mice are still able to undergo normal T cell development, 
thereby suggesting that homing to this area is not an absolute requirement for T cell 
development (Benz et al., 2004).  Signalling through the chemokine receptor CCR7 was also 
found to be important for the normal differentiation of DN cells (Misslitz et al., 2004).  A 
transitional population of DN cells called DN1-2 (CD25int CD44high) express CCR7 before its 
expression on SP4 and SP8 cells.  CCR7-/- mice have an accumulation of DN cells at the DN1 
and DN1-2 stage, whereas the proportion of DN2, DN3 and DN4 cells are severely reduced 
suggesting a partial block or delay in the transition of DN1 cells to the DN2 stage.  The DN1-
2 cells are aberrantly located at the CMJ suggesting that signalling through CCR7 is essential 
for the efficient migration of DN1-2 cells to the mid-cortex allowing for their differentiation 
to the next stage of development.  Together the studies by Plotkin et al (2003), Benz et al 
(2004) and Misslitz et al (2004) demonstrate the vital role of CXCR4, CCR9 and CCR7 
signalling for successful migration of early progenitors in the postnatal thymus.  Arrest of 
thymocytes at different stages of development correlates with abnormal thymic architecture 
indicating the importance of cross-talk between developing thymocytes and thymic epithelial 
cells. 
Differentiation of DP thymocytes to mature SP4 and SP8 cells correlates with their 
relocation to the medulla.  It has been identified that CCR7 signalling is essential for cortex to 
medulla migration of developing thymocytes (Ueno et al., 2004).  TCR engagement of 
immature cortical DP cells upregulates CCR7 expression.  The ligands for CCR7, CCL19 and 
CCL21 are predominantly produced in the medulla.  In a normal steady state thymus, DP 
thymocytes produced in the cortex undergoing positive selection following TCR/peptide-
MHC interactions, undergo a series of maturation stages (as described in section 1.2.5) 
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including upregulation of CCR7.  This is subsequently followed by migration to the medulla 
in response to CCL19 and CCL21 production where they become mature SP4 and SP8 cells. 
CCL19 but not CCL21 is known to be important for attracting newly generated T cells out of 
the thymic medulla to the circulation in newborn mice (Ueno et al., 2002). In mice deficient 
for CCR7 or CCR7 ligands (plt/plt mice) positively selected thymocytes that are 
differentiating into SP cells are arrested in the cortex and fail to localise to the medulla and 
these cells showed no defects in maturation and selection (Ueno et al., 2004).  These mice 
also exhibited normal export of T cells.  This suggests that the medulla may not be required 
for the maturation and export of T cells.  However, T cells produced in the absence of CCR7 
mediated cortex-medulla migration were incapable of acquiring tolerance to organ-specific 
antigens, thereby suggesting that cortex to medulla migration is essential for the establishment 
of central tolerance rather than for supporting maturation or export of T cells (Kurobe et al., 
2006). 
As summarised in this section, the development of a diverse and self-tolerant T cell 
repertoire is a tightly regulated process and is clearly dependent on the thymic epithelial cells, 
which constitute the major stromal cell type of the different thymic microenvironments.  
However, developing thymocytes are also important in regulating the establishment of 
organised cortical and medullary compartments through a process of crosstalk.  Thus, 
research aimed at elucidating the developmental origins of thymic epithelial cells will reveal 
how such cells become specialised in their ability to support T cell development.  
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1.3 The Thymic Stroma. 
1.3.1 Composition of Thymic Stroma. 
The composition and cellular compartmentalisation of the thymic stroma provides 
optimal microenvironments to support the different stages of T cell development as described 
above.  The stroma, defined as the non-haematopoietic component of the thymus, is extremely 
heterogeneous and is comprised of many cell types with specialised functions.  The stroma 
can be characterised by the expression of keratin (K) with keratin+ cells representing thymic 
epithelial cells and keratin- cells representing a mixture of mesenchymal cells, fibroblasts and 
endothelial cells.  Keratin+ epithelial cells are further subdivided into cortical epithelial cells 
(cTECs) and medullary epithelial cells (mTECs), which display further heterogeneity. 
 
1.3.1.1 Cortical epithelium. 
The cortex is characterised by a meshwork of reticular, MHC I and II positive cortical 
epithelial cells (cTECs) that can be identified by the expression of specific cell markers 
including MTS44, keratin 8 and Ly51 (Gray et al., 2006).  By histology cTECs are typically 
identified as K8+ K5-, whereas by flow cytometry, cTECs are identified as epithelial cell 
adhesion molecule 1+ (EpCAM-1+) Ly51+.  Although not a commonly used marker, CD205 
(also known as DEC205) is known to be specifically expressed on cTECs in the adult thymus 
and is also expressed on DCs (Jiang et al., 1995).  The non-epithelial component of the cortex 
includes EpCAM-1- Ly51+ cortical mesenchyme cells (cMES) (Muller et al., 2005).  
However, there are very few markers specific for the thymic cortex that enables their isolation 
and study.  
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1.3.1.2 Medullary epithelium.  
The cellular composition of the medulla is extremely heterogeneous and consists of 
bone marrow derived DCs and macrophages as well as epithelial cells, which display further 
heterogeneity.  mTECs have a globular morphology and express an array of co-stimulatory 
markers such as CD40 (Dunn et al., 1997) and CD80 (B7.1) (Nelson et al., 1993), which are 
implicated in T cell activation.  By histology mTECs are typically identified on the basis of a 
K5+ K8- phenotype and by flow cytometry on the basis of an EpCAM-1+ Ly51- phenotype 
(Anderson et al., 2007).  Cells of this lineage also bind the lectin Ulex Europaeus Agglutinin 
1 (UEA-1) (Gray et al., 2002). Subsets of mTECs also express the autoimmune regulator 
AIRE.  By comparison to cTECs, mTECs also express MHC I and II molecules. However, in 
contrast to cTECs, mTECs express varying levels of MHC II with the presence of an MHC 
IIlow and high population.  The non-epithelial components of the medulla include extracellular 
matrix proteins (such as ER-TR7 and perlecan), podoplanin and DCs and macrophages, which 
also form an integral element of the stroma.  
 
1.3.2 Thymus Organogenesis. 
Thymus organogenesis occurs in several consecutive stages and is dependent on 
interactions between cells of all three embryonic germ layer origins including, endoderm-
derived epithelium, ectoderm-derived neural crest mesenchyme and mesoderm-derived 
haematopoietic cells and endothelial cells (Manley, 2000). 
Development of the thymus is initiated at around day 9 of embryonic gestation (E9) in 
the mouse, with the first morphological signs of the thymus becoming apparent at 
approximately E10.5 (Manley, 2000).  The early stages of thymus organogenesis is closely 
tied to that of the parathyroid gland with both organs developing from bilateral organ 
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primordia arising from an embryonic region called the 3rd pharyngeal pouch.  Pharyngeal 
pouches, which initially constitutes a double-layered membrane composed of an ectodermal 
and endodermal cell sheet, represent specialised pockets of the foregut endodermal tube and 
contain primordia for organs and tissues that are later found in the chest, neck and head 
regions including the thymus and the parathyroid gland (Rodewald, 2007).  The common 
primordium begins to develop at E11.5 via budding and outgrowth from the 3rd pharyngeal 
pouch endoderm with each endodermal primordium containing precursors for one thymus 
lobe and one parathyroid gland.  However, as early as day 10 of gestation, parathyroid and 
thymus specific domains can already be identified before separation into distinct organs by 
the complementary expression of the transcription factors Gcm2 and FoxN1, respectively 
(Gordon et al., 2001).  Gcm2 is first expressed in a specific region of the 3rd pharyngeal pouch 
at E9.  By contrast, FoxN1 expression does not appear until after the formation of the 
common primordium (E11.5).  
A mesenchymal capsule of neural crest (NC) origin surrounds each primordium and is 
thought to be important in supporting the growth and development of the primordium as well 
as its importance in regulating the differentiation of thymic epithelial cells (TECs).  
Interactions between epithelial and mesenchymal cells prior to thymocyte colonisation define 
these early events in thymus organogenesis.  The NC mesenchyme surrounds the thymic 
primordium until eventually invaginating the epithelial primordium to contribute to the septae 
and a network of fibroblast cells.  
At around E12 (when the thymic rudiment is undergoing the first wave of progenitor 
colonisation) the common primordium separates from the pharynx and begins to migrate 
towards the anterior chest cavity so that by E13.5 the thymus and parathyroid have separated 
into distinct organs (Blackburn and Manley, 2004).  During this stage of organogenesis the 
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thymus reaches its normal anatomical position at the midline above the heart to form a 
bilobed organ, with the parathyroid located adjacent to the thyroid gland in the neck.  Studies 
have also reported the presence of a cervical thymus, which develops after birth and has a 
normal cortex and medulla organisation with the ability to support T cell development 
(Dooley et al., 2006; Terszowski et al., 2006). 
At this stage of organogenesis, which occurs in the absence of thymocytes, TECs are 
homogenous as they lack cortical and medullary compartmentalisation and are yet to reach 
functional maturity.  The patterning and differentiation of the thymic rudiment, which is 
required to establish normal organisation and function of cortical and medullary regions, 
defines the later stages of thymus development (approximately E15.5-birth) (Manley, 2000; 
Rodewald, 2007).  The rapid accumulation of thymocytes leads to the formation of a 
functional thymic microenvironment capable of supporting full T cell development.  This 
patterning and differentiation of the thymus requires stage specific interactions between TECs 
and thymocytes via a process of thymic crosstalk.   
 
1.3.3 Molecular Regulation of Thymus Organogenesis: A Role for FoxN1. 
Many genes have been implicated in early development of the thymic anlage including 
Hoxa3, Pax1 and Tbx1 and mutations in these genes can lead to thymic aplasia, hypoplasia, or 
failure of the lobes to migrate towards the chest (Hollander et al., 2006; Rodewald, 2007).  
However, in the context of this study the transcription factor FoxN1 (formerly known as whn) 
is the most important.  FoxN1, which is encoded by the gene mutated in the nude mouse, 
belongs to a family of forkhead box transcription factors, which also includes Foxp3 
important for determining the development and function of Tregs (Coffer and Burgering, 
2004).  FoxN1 is expressed in hair follicles and all TEC subsets.  The FoxN1 protein contains 
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a winged-helix DNA binding domain and a transcriptional activation domain (Schuddekopf et 
al., 1996).  Mice and humans with a mutation in the Foxn1 gene, resulting in an absence of 
the Foxn1 protein display the nude phenotype characterised by loss of hair and congenital 
athymia. 
The expression of Foxn1 is first detectable at E11.5 following the budding and 
outgrowth of the thymic anlagen from the 3rd pharyngeal pouch (Gordon et al., 2001; Nehls et 
al., 1996).  Hence, FoxN1 is not required for the initiation of thymus organogenesis, as nude 
mice display normal formation of the thymus primordium and normal migration of the anlage 
to its correct anatomical location (Hollander et al., 2006).  Aberrant thymus development in 
the nude mouse is first detected at approximately E12, where the thymic anlage does not 
further develop and there is a failure of the epithelial cells to form the characteristic 3D 
meshwork that is typical of a normal thymus.  Hence FoxN1 is thought to be essential for cell 
autonomous regulation of TEC differentiation, where it acts to regulate the growth and 
differentiation of the epithelial cells (Blackburn et al., 1996).  Moreover, the thymic epithelial 
rudiment in the nude mouse fails to induce haematopoietic cell colonisation and persists in the 
adult as a rudimentary thymus with a cystic epithelial structure.  Hence, nude mice have 
severe immunodeficiency due to the failure of the thymus to support T cell development.  The 
precise role of FoxN1 in the development of TECs is unclear.  However, it has been reported 
that epithelial cells in the nude anlagen have a respiratory like phenotype with regard to their 
organisation and appearance, suggesting that FoxN1 may be important in directing the 
epithelial cells towards a thymic fate (Dooley et al., 2005).   
The molecular mechanisms that regulate FoxN1 expression and function are not 
completely understood.  A study has demonstrated a role for the canonical Wnt pathway, 
 51 
where overexpression of certain Wnt proteins (detected in 3rd pharyngeal pouch at E10.5) 
increased FoxN1 transcription in TECs (Balciunaite et al., 2002). 
It is clear that there are many key issues relating to thymus organogenesis that are of 
importance.  However, in the context of this study the identification of progenitors or stem 
cells with TEC forming potential and the molecular regulators of their development through 
ontogeny are of particular interest.  
 
1.3.4 Identification of Bipotent Thymic Epithelial Progenitors.  
  The embryonic origins of the cortical and medullary regions is of great interest and 
previously it had been controversial as to whether the thymic epithelium is of a dual germ 
layer origin with contribution from the endoderm and ectoderm.  The ‘dual germ layer origin’ 
model originally suggested that the cortex develops from the ectodermal derived epithelium 
and the medulla develops from endodermal derived epithelium (Cordier and Heremans, 
1975).  Such a model would imply that for TEC differentiation to precede then contributions 
from both endoderm and ectoderm are required.  However, the prevailing view from chick-
quail studies supports the ‘single origin’ model where the thymic epithelium is solely derived 
from progenitors or stem cells of endoderm origin, which are committed to the TEC lineage 
(Le Douarin and Jotereau, 1975).  A further study in mice also argued against the ‘dual origin’ 
model and provided evidence to support the ‘single origin’ model (Gordon et al., 2004).  
Ectopic transplantation of isolated pharyngeal endoderm generated a functional thymus with 
organised cortex and medullary areas, indicating that contribution from the ectoderm is not 
required.  However, despite this confirmation of a single germ layer origin, it was still unclear 
 52 
whether cTECs and mTECs arise from a distinct progenitor pool or a common progenitor 
population. 
The existence of bipotent progenitors that can develop into both cortical and 
medullary lineages were first demonstrated in studies identifying TEC populations in the early 
thymus expressing both cTEC and mTEC markers, which are typically rare in an adult 
thymus (Ropke et al., 1995).  Such ‘double positive’ TECs are thought to be predominant in 
patients with thymic epithelial tumours (e.g. myasthenia gravis) (Ritter and Boyd, 1993).  
Early organogenesis of the thymus is defined by a lack of anatomical compartmentalisation 
and TECs are homogenous lacking phenotypic markers indicative of a mature cortical or 
medullary phenotype, such as expression of MHC II (Jenkinson et al., 1981).  Heterogeneity 
in adult cTECs and mTECs are can be distinguished by their keratin expression profiles, 
which are K5-K8+ and K5+K8- respectively (Rodewald, 2007).  However, all immature TECs 
in the embryo co-express K5 and K8 and these cells are infrequently scattered throughout the 
cortex and predominate mostly at the CMJ in the adult (Klug et al., 1998).  Such cells are 
present at a higher frequency in both CD3εtg26 and RAG1-/- mice displaying blocks in 
thymocyte development, highlighting the possible role of lymphostromal interactions in TEC 
development.  This co-expression of keratins precedes the appearance of mature K5-K8+ 
cTECs and K5+K8- mTECs, thereby suggesting that these ‘double positive’ TECs may arise 
from a common progenitor pool (Anderson et al., 2007).  However, these studies do not show 
direct evidence that the ‘double positive’ TECs represent bipotent progenitors. 
In 2006 two seminal studies provided definitive proof for the existence of a bipotent 
TEC (bTEC) progenitor.  In a clonal assay by Rossi et al (2006), a single TEC was isolated 
from an E12 yellow fluorescent protein (eYFP) transgenic mouse.  This single cell (identified 
on the basis of expression of a pan-epithelial marker EpCAM-1) was microinjected into a 
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non-fluorescent host thymus and then grafted under the kidney capsule of a recipient mouse.  
Immunohistological analysis of the transplanted thymus revealed that the single YFP+ cell 
gave rise to cells in the cortex and medulla.  Contributions to a single TEC lineage were 
strikingly absent.  Not only did this study demonstrate that all TEC progenitor activity is 
already present at E12, this study elegantly demonstrated that a bipotent pool of progenitors 
are present in the early thymus and that they can develop into cells of the cTEC and mTEC 
lineage.  
A genetic approach by Bleul et al (2006) provided further evidence for the existence 
of bTECs. Using in vivo cell lineage analysis, eYFP expression was randomly switched on in 
TECs by Cre recombinase under the control of the human Keratin 14 promoter (K14Cre) (the 
K14 promoter is active in epithelial progenitor cells).  In newborn mice, labelled TECs gave 
rise to either mTEC clusters only, cTEC clusters only or both mTEC and cTEC progeny.  In 
this experiment K14Cre randomly marked common and committed TEC progenitors and their 
progeny and so provided evidence for the presence of bi and unipotent progenitors for the 
cortex and medulla (Bleul et al., 2006).  To address whether single TEC progenitors can form 
functional thymus units, Bleul et al (2006) created a conditional mutant allele of FoxN1, 
which was reverted to wild-type function in single TECs in vivo.  Neonatal mice showed 
organised cortex and medulla, with expression of AIRE, and elevated numbers of T cells.  
This study clearly showed that the block in TEC development in the nude mouse does not 
result in a loss of TEC progenitors but rather suggests that bTEC progenitors may lie dormant 
in the nude mouse and can be induced to differentiate into functional TECs following a 
genetic reversion to wild-type (Rodewald, 2007). 
Despite the significant breakthroughs in the identification of bipotent progenitors that 
can development to TECs of both cortical and medullary lineage, such common progenitors 
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have yet to be phenotypically characterised and isolated.  Initial studies identified MTS24+ 
TECs in the embryo as a putative TEC progenitor (Bennett et al., 2002; Gill et al., 2002).  
Heterogeneity in MTS24 expression was observed as early as E12, a stage in which bipotent 
epithelial cells predominate, with equal proportions of MTS24- and MTS24+ populations.  It 
was found that MTS24+ TECs were able to give rise to functional thymic tissue containing 
both cortex and medulla when ectopically transferred, whereas MTS24- TECs were unable to 
establish a thymus.  However, reassessment of TEC progenitor potential using MTS24, found 
that MTS24 expression does not discriminate between progenitor and non-progenitor 
populations as both MTS24- and MTS24+ cells could give rise to a functional thymus (Rossi et 
al., 2007a).  Furthermore, the potential of MTS24+ TECs to give rise to a functional thymus 
diminished by E18 suggesting that at this stage of development MTS24+ TECs are likely to 
represent quiescent, mature cells rather than thymus forming progenitor cells.   
 Studies have also yet to resolve the issue of self-renewal capacity of TEC progenitors.  
It is yet to be addressed whether there is self-renewing pool of bipotent progenitors remaining 
throughout life or if a fixed number of bipotent progenitors exists with self-renewal capacity 
restricted to downstream lineage committed progenitors (Anderson et al., 2007).  Another 
important unresolved issue is whether bipotent progenitors persist in the adult.  Indeed studies 
suggest their existence as K5+ K8+ cells expand significantly during thymic atrophy, prior to 
thymic regeneration (Popa et al., 2007), with another study showing reversal of thymic 
atrophy with restored thymic architecture and thymic output (Gray et al., 2006).  These 
studies demonstrate plasticity in TEC microenvironments and provide evidence that TEC 
progenitors persist and can be induced to proliferate and differentiate in the post-natal thymus 
(Anderson et al., 2007).  
 55 
  To summarise, despite the identification at a functional level that cTECs and mTECs 
arise from a common progenitor pool, the lack of specific markers means that the quest to 
identify and characterise the thymic epithelial stem cell remains elusive.  (Figure 1.5 shows a 
simplified overall scheme of TEC development).   
 
1.3.5 Regulation of Bipotent TEC Development: The Role of the Mesenchyme. 
Although thymocytes are required for later stages of TEC development, the 
development and differentiation of bipotent progenitors into cTEC and mTEC lineages occurs 
independently of thymic crosstalk.  This suggests that signals for TEC differentiation may be 
cell autonomous or derived from additional cells. Studies have demonstrated a role for the 
mesenchyme in regulating TEC development.   
As described in section 1.3.1, epithelial-mesenchymal interactions between the 3rd pharyngeal 
pouch endoderm and the surrounding neural crest-derived mesenchyme during embryogenesis 
are vital for the formation and development of thymic primordium.  The mesenchyme is 
comprised of a heterogeneous population of cells that changes throughout thymus 
development.  In the fetal mouse, neural crest derived mesenchyme cells contribute to thymic 
capsule, interlobular septae and the stromal cell network, such as fibroblasts (Yamazaki et al., 
2005).  Mesenchymal cells in the adult make up the thymic capsule and septae and also 
constitute a small proportion of cortical stromal cells defined as EpCAM- Ly51+ and these 
have been assigned as cortical mesenchymal cells (cMES) (Muller et al., 2005).  A population 
of mesenchymal fibroblasts expressing MTS15 have also been identified and these cells were 
found to express a number of chemokines and growth factors important for both thymocyte 
and epithelial cell development (Gray et al., 2007b).      
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Figure 1.5 Development of Thymic Epithelial Cells. 
Development of mature cortical and medullary thymic epithelial cells from an 
endoderm derived bipotent thymic epithelial cell. 
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The mesenchyme is thought to have a role in T cell development by acting directly on 
DN2 cells through the provision of extracellular matrix (ECM) molecules and they are located 
in the cortex in association with non-epithelial stromal cells (Anderson et al., 1997; Anderson 
et al., 1993).  The mesenchyme also has a role in the regulation of thymic epithelial cell 
proliferation. At E12, an age that comprises mostly of TEC progenitors at the bipotent stage, 
there is high proliferation of TECs, which declines throughout thymus ontogeny. The removal 
of mesenchyme from E12 fetal thymic lobes demonstrated its importance in the expansion of 
epithelial cells (Jenkinson et al., 2003). Mesenchymal cells regulate this expansion through 
the provision of fibroblast growth factors (FGFs), namely FGF7 and 10.  The receptor for 
FGF7 and 10 is FGFR2-IIIb and the deletion of this receptor was found to be required for the 
proliferation of TECs after E12, further demonstrating the importance of the mesenchyme 
(Revest et al., 2001). However, TEC differentiation beyond E12 is independent of ongoing 
mesenchyme derived signals (Jenkinson et al., 2003).  A majority of the mesenchyme 
expresses platelet derived growth factor receptor α (PDGFRα) and these cells were found to 
be important for the expansion of epithelial cells to provide sufficient intrathymic niches to 
support normal numbers of developing thymocytes.  (Jenkinson et al., 2007b).  It has also 
recently been demonstrated that the epithelial progenitor pool in the thymus has a limited 
capacity for proliferation and a restriction of the size of this pool affects the number of mature 
TECs (Jenkinson et al., 2008). 
 Events occurring downstream of bipotent progenitors and the mechanisms that 
regulate commitment and differentiation leading to the development of cortex and medulla are 
not clear (Anderson et al., 2007). However, some advances have already been made regarding 
development and function of TEC lineages and in particular mTEC development.  
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1.3.6 Development of cTECs and their Specialised Role During Positive Selection. 
 Due to a paucity of cTEC markers, very little is known about cTEC development and 
regulation and how distinct lineages may reflect functional specialisation (Anderson et al., 
2007). In contrast to our understanding of mTEC development (discussed in section 1.3.7), 
cTEC progenitors downstream of bTECs have yet to be identified.  Furthermore, whilst many 
abnormalities in mTEC development as a result of genetic deficiencies have been reported, 
reports of abnormalities in cTEC development have been scarce.     
cTECs express both MHC I and II molecules have been identified as efficient and 
unique mediators of positive selection (Anderson et al., 1994b).  However, whilst some have 
argued against a role for cTECs in central tolerance, there is speculation that cTECs can 
induce central tolerance by supporting negative selection of potentially autoreactive 
thymocytes (Goldman et al., 2005).  A recent study (McCaughtry et al., 2008) demonstrated 
unequivocally that the clonal deletion of thymocytes can occur in the cortex and requires no 
involvement of the medulla and can occur in the absence of cortex-medulla migration, as 
previously thought (Kurobe et al., 2006).  The elimination of these autoreactive T cells by 
apoptosis is induced by rare CD11c+ cortical DCs (McCaughtry et al., 2008) and this 
tolerising mechanism helps to eliminate TCRs reactive to ubiquitous self antigens.  
The unique ability of cTECs to support positive selection is based on poorly defined 
antigen-processing and antigen-presenting capabilities.  Cortical epithelium is likely to 
express unique cell surface molecules providing signals that promote positive selection rather 
than negative selection.  These molecules are likely to be distinct from mTECs and DCs and 
are unlikely to be the same as those required for activation of mature T cells (Anderson and 
Jenkinson, 2001). 
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In the context of CD8+ T cell selection, the generation of peptides for MHC I 
presentation requires proteasomes.  A catalytic proteasome subunit called β5T was recently 
identified as being exclusively expressed by cTECs and is essential for generating MHC I-
restricted CD8+ T cells during thymic selection (Murata et al., 2007).  β5T deficiency in mice 
was associated with a significant reduction in SP8 thymocytes, with no apparent affect on 
numbers of SP4 thymocytes.  It is thought that in contrast to constitutive proteasomes, which 
produce high affinity ligands, thymoproteasomes such as β5T produce low affinity MHC I 
ligands in cTECs, thereby supporting positive selection (Murata et al., 2007). 
MHC II-restricted selection of CD4+ T cells by cTECs involves lysosomal 
endoproteinases called cathepsins.  More specifically cathepsin L was identified as essential 
for degradation of class II invariant chain peptides (CLIP) in cTECs but not in bone marrow 
derived APCs, which require cathepsin S (Beers et al., 2005; Nakagawa et al., 1998).  A 
recent study has also highlighted the role of thymus-specific serine protease (TSSP), which is 
expressed in the endosomal compartment of cTECs only, in the positive selection of a subset 
of CD4+ T cells (Gommeaux et al., 2009).  TSSP is thought to be involved in the processing 
of self-peptides for MHC II presentation.   
The studies of Murata et al (2007) and Gommeaux et al (2009) highlight the adaptive 
phenotype of cTECs in regulating the functional specialisation of cTECs for positive selection 
(Boehm, 2009).    
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1.3.7 Specialisation of the Medulla. 
1.3.7.1 The role of mTECs in central tolerance.  
Central tolerance is established via a combination of distinct mechanisms that include 
clonal deletion of thymocytes that bear TCRs with high affinity for peptide/self-MHC 
complexes and the positive selection of FoxP3+ CD4+ CD25+ regulatory T cells (Tregs) 
(Anderson et al., 2007).   
mTECs express a wide spectrum of tissue restricted antigens (TRAs) previously 
thought to be expressed only by specialised tissues in the periphery and this has been termed 
promiscuous gene expression (Derbinski et al., 2001). The self-antigens presented by mTECs 
represent all the organ-specific antigens, mirroring the peripheral self and thereby allowing 
the pre-emptive encounter of potentially destructive T cells with peripheral self-antigens 
(Kyewski and Klein, 2006). The regulation of this unusual gene expression pattern is poorly 
understood.  However, a subset of mTECs expressing AIRE is known to be involved.  AIRE 
encodes a 545 amino acid protein that is localised in the nucleus and acts as transcription 
factor for promiscuous gene expression of TRAs (Anderson et al., 2007).  AIRE is defective 
in human autoimmune condition autoimmune polyendocrinopathy-candidiasis-ectodermal 
dystrophy (APECED), which is characterised by the presence of autoimmune antibodies 
specific for multiple self-antigens.  Mice with defects in AIRE also show similar signs of 
autoimmunity with multi-organ lymphocytic infiltration and presence of autoantibodies 
(Peterson et al., 2008).  Interestingly, a recent study claims that whilst AIRE expression in the 
perinatal period is sufficient to induce self-tolerance, AIRE mediated tolerance in the adult is 
largely dispensable because a previously generated tolerised T cell pool can control newly 
emerging autoreactive T cells (Guerau-de-Arellano et al., 2009). 
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 AIRE clearly has a role in regulating central tolerance through TRA expression.  
However, a recent study has shown that AIRE+ mTECs may also have a role in the selection 
of FoxP3+ Tregs (Aschenbrenner et al., 2007).  The absence of MHC II+ mTECs was found to 
be associated with a decrease in Tregs and that mTECs specifically generated antigen specific 
Tregs suggesting that AIRE+ mTECs shapes the Treg repertoire and so provides a 
microenvironment for their selection.  
 
1.3.7.2 Identification and development of medullary epithelial progenitors.  
In contrast to cTEC development, many advances in the development of the mTEC 
lineage has been made and most significantly, mTEC specific progenitors that develop 
downstream of bipotent progenitors have been identified.   
A study by Rodewald et al (2001) showed that the medulla develops from clonal islets 
arising from single progenitors.  Using chimaeric mice that were generated by injecting 
embryonic stem (ES) cells into MHC mismatched blastocysts, they found that individual 
medullary islets arose from either ES cell or blastocyst origin but not both.  Furthermore this 
study also demonstrated the formation of medullary islets from disaggregated cell suspensions 
of TECs obtained from E16 thymus.  Reaggregate thymus organ cultures (RTOC) were made 
from TEC suspensions from MHC mismatched donors.  RTOCs were grafted into MHC II 
knockout mice and the resulting graft showed evidence of clonal islets of IAb or IAd origin but 
not both.  This study suggests that the medulla develops as isolated medullary islets from 
single progenitors as opposed to developing from an epithelial cell layer and such individual 
islets are likely to coalesce during thymus ontogeny to form confluent regions of medulla.  
Most significantly this study identifies the existence of an mTEC progenitor cell, and such a 
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cell is still present at day 16 of gestation.  This study also demonstrates the remarkable 
capacity of isolated epithelial cells to self-reorganise into an organised and functionally 
competent microenvironment supporting T cell development in vivo (Rodewald et al., 2001). 
Following the identification of the existence of mTEC progenitors many studies have 
sought to further phenotypically characterise the development of such progenitors.  The 
medullary epithelium is extremely heterogeneous.  Two distinct mTEC subsets include the 
CD80- mTECs expressing a limited array of TRAs and the CD80+ mTECs, which express 
AIRE and a wide array of TRAs (Derbinski et al., 2005; Derbinski et al., 2008).  Until 
recently it was uncertain if this heterogeneity reflects functionally distinct lineages or 
different developmental stages in a single mTEC lineage.  A recent study identified a 
precursor-product relationship where a subset of RANK expressing Ly51- EpCAM+ CD80- 
AIRE- mTECs were precursors for a mature subset of Ly51- EpCAM+ CD80+AIRE+ mTECs 
(Rossi et al., 2007b).  This study also found that RANKL signals from thymic CD4+ CD3- 
lymphoid tissue inducer cells (LTi) promote the maturation of these immature mTECs into 
mature mTECs via RANK-RANKL signalling. Another study provided evidence that AIRE+ 
mTECs develop from mTEC progenitors expressing the tight junction proteins claudin 3 and 
claudin 4 and UEA-1 (Cld3, 4+ UEA-1+) and that these cells were present as early as E13.5 
(Hamazaki et al., 2007).  They also found that grafting these Cld3, 4+ TECs into nude mice 
exclusively generated mTEC clusters.  
Furthermore, mTEC proliferation has been identified in the adult thymus suggesting a 
developmental pathway where differentiation and replacement of mTECs arises from an 
mTEC progenitor pool undergoing cellular turnover (Gray et al., 2006).  A further study 
identified a large pool of non-cycling cells within the immature mTEC subset suggesting that 
these cells provide a ‘reservoir’ of mTEC committed progenitors that maintain the continuous 
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renewal of mTECs in the adult thymus (Gabler et al., 2007).  Such studies support a terminal 
differentiation model where AIRE+ mTECs represent end-stage cells expressing the 
differentiation marker involucrin, which are subsequently replaced by a pool of immature 
mTEC subsets (Yano et al., 2008) and TRAs become more diverse as the mTECs mature. 
The identification of precursor-product relationships has been helpful in elucidating 
some of the stages of mTEC development and has aided the identification of various 
molecular regulators of these stages (figure 1.6).   
 
 
1.3.7.3 Regulation of mTEC development. 
Mechanisms and signalling pathways that underlie mTEC development are poorly 
understood.  However, many studies have implicated a number of tumour necrosis factor 
receptor superfamily (TNFRSF) members such as lymphotoxin β receptor (LTβR), receptor 
activator of NF-κB (RANK) and CD40.   
Lymphotoxin is expressed by lymphocytes and signals through LTβR, which is 
expressed on stromal cells and is vital for inducing cytokines, chemokines and other 
molecules that organise and maintain the specialised microenvironments of lymphoid tissues. 
The precise role of LTβR in the formation of the medulla is still a matter of dispute with 
initial studies suggesting a role in the induction of AIRE+ mTECs and control of 
autoimmunity (Boehm et al., 2003; Chin et al., 2003), whereas subsequent studies find that 
LTβR is not essential for expression of AIRE (Martins et al., 2008; Rossi et al., 2007b; 
Venanzi et al., 2007). 
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Figure 1.6 Development of AIRE+ Medullary Thymic Epithelial Cells. 
The terminal differentiation model of medullary thymic epithelial cell (mTEC) 
development states that immature AIRE- CD80- mTEC progenitors expressing RANK interact 
with lymphoid tissue inducer (LTi) cells to induce AIRE and CD80 expression to become 
mature AIRE+ CD80+ mTECs.  This developmental step is accompanied by an increase in 
expression of tissue-restricted antigens (TRAs).  
Image adapted from Anderson et al (2007). 
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The most well understood mediator of mTEC development is RANK-RANKL signalling.  As 
described in the previous section, RANK signals from LTi cells are important in regulating 
the development of CD80+ mTECs, which are known to also express AIRE (Rossi et al., 
2007b).  RANKL is expressed on both thymic and splenic LTi cells, which were previously 
known to be important for secondary lymphoid organ development and organisation.  RANK-
/- mice were found to have marked absence of AIRE+ mTECs by histology and nude mice 
receiving RANK-/- thymus lobes via kidney capsule transfer were found to develop severe 
symptoms of autoimmunity (Rossi et al., 2007b).  This study highlighted the importance of 
LTi derived RANKL signals in the development of AIRE+ mTECs and as a key regulator of 
central tolerance.   
Subsequent studies have shown a possible role for CD40-CD40L signalling in mTEC 
development (Akiyama et al., 2008; Hikosaka et al., 2008).  CD40 is expressed on all TECs 
whereas the ligand is expressed on CD4+ thymocytes.  CD40-/- has been associated with a 
reduction of AIRE+ mTECs but not a complete ablation (White et al., 2008).  These studies 
suggest that whilst RANKL provide initial signals for AIRE+ mTEC differentiation, CD4+ 
thymocytes provide additional signals for maintenance.  The identification of these molecular 
mediators has highlighted the importance of thymic crosstalk where lymphocyte derived 
signals play a vital role in the development of TECs.   
 
1.4 General Aims of Study. 
As discussed in this chapter, the steps of T cell development have been well described.  
However, stages and mechanisms regulating the development of thymic stromal cells and 
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establishment of various thymic microenvironments are yet to be fully elucidated.  Hence, the 
aims and objectives of this thesis are as follows; 
• To investigate TEC development downstream of bTEC progenitors. 
o Characterise stages of cTEC development. 
o Phenotypically assess heterogeneity within the mTEC lineage and 
elucidate signals involved in their development.  
• To study the establishment of thymic microenvironments with particular 
regard to the role of chemokine-induced signals for the establishment of the 
SCZ. 
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CHAPTER 2 
GENERAL MATERIALS AND METHODS 
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2.1 Mice. 
 The use of inbred mouse models in the context of thymus development is vital to fully 
understand the sequence of events occurring during organogenesis and so provides a source of 
accurately timed embryonic, neonatal and adult material.  Wildtype mice were used to 
characterise the normal development of thymocytes and thymic stromal cells.   Knockout and 
transgenic mice were used to attribute particular genes and mechanisms to key stages in 
thymus development. 
 
2.1.1 Mouse Husbandry and Breeding. 
 All mice used in this study were housed and maintained in the Biomedical Sciences 
Unit (BMSU), University of Birmingham, in accordance to home office regulations. Mice 
were obtained from either commercial suppliers, other research groups or from the BMSU in-
house stock.  Timed matings were obtained by placing a male mouse into a cage with two or 
three female mice overnight.  Successful matings were identified by the presence of a vaginal 
plug (VP), the day of which was designated as day zero of gestation (E0).  The gestation of 
mice can take between 18-21 days, with the day of birth designated postnatal day 0 (P0).  This 
makes it possible to obtain fetal and neonatal material of specified developmental stages. 
Details of all wildtype and genetically modified mouse strains used in this study are outlined 
in Table 2.1.    
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Table 2.1 WildType and Genetically Modified Mouse Strains Used In This Study. 
Mouse Strain 
 
MHC 
haplotype 
 
CD45 
Isotype 
Phenotype Source 
Balb/c 
 
H-2d CD45.2 Wild type BMSU 
C57/BL6 
 
H-2b CD45.2 Wild type BMSU 
Balb/c nude 
(nu/nu) 
 
H-2d CD45.2 Deficiency in the FoxN1 gene.  
Abnormal thymic epithelial cell 
development.  Thymus rudiment 
is not populated by lymphoid 
precursors and consequently nude 
mice do not have T cells. 
 
BMSU 
CD3 epsilon 
transgenic  
(CD3ε26Tg) 
 
H-2b CD45.2 Over expression of the human 
CD3 ε transgene.  Lack of T cells 
due to a block at the earliest stage 
of T cell development (CD4- 8- 
25- 44+, double negative 1 stage) 
(Wang et al., 1995). 
 
Jackson Lab 
Rag1-/- 
(C57/BL6) 
 
H-2b CD45.2 RAG1 deficiency leads to a 
defect in the production of 
functional lymphocytes bearing 
antigen receptors.  Block at the 
CD4- 8- 25+ 44- (double negative 
3) stage of T cell development 
(Mombaerts et al., 1992). 
 
Jackson Lab 
DOCK2-/- 
(C57/BL6) 
 
H-2b CD45.2 Deficiency in DOCK2 (a 
downstream mediator of 
chemokine signalling) leads to 
disruption of chemokine induced 
lymphocyte migration.  Failure to 
respond to CXCL12, CCL19 and 
CCL21.  
 
Y. Fukui, Kyushu 
University, Japan 
CCR9-/- 
(C57/BL6) 
 
H-2b CD45.2 Deficiency in CCR9 leads to 
failure of T cells to respond to 
CCL25 signalling. 
W. Agace, 
University of 
Lund, Sweden 
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2.2 Medium and Tissue Culture Reagents. 
2.2.1 Medium. 
 All media and additives were obtained from Sigma, Poole, UK, unless otherwise 
stated.  Isolation of tissues and general handling of cells was carried out in RPMI-1640 Hepes 
(RF10-H) supplemented with 10% heat inactivated fetal calf serum (FCS) (Table 2.2).  The 
long term culture of cells and tissues was carried out in Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 10% FCS and other additives as indicated in Table 2.3 and 2.4.  
Aliquots of media were prepared in advance and stored at 4°C. 
 
2.2.2 Additives.  
 To eliminate all lymphoid and dendritic cells from fetal thymic organ cultures, 2-
deoxyguanosine (2-dGuo) (Sigma) was added to culture media (Jenkinson et al., 1982).  Stock 
solutions of 9mM 2-dGuo were stored at -20°C prior to addition to culture medium to give a 
final concentration of 1.35mM.  To prepare stromal cell suspensions, 2.5% stock of trypsin in 
Hank’s balanced salt solution (HBSS, Sigma) was diluted 10-fold in 0.02% EDTA in Ca++ 
Mg++ free phosphate buffered saline (PBS), to give a working concentration of 0.25% trypsin.   
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Table 2.2 Preparation of RPMI-1640 Hepes (RF10-H).  
Medium and additives 
 
Volume Final concentration 
RPMI-1640 + 20mM Hepes, with  
L-glutamine, without bicarbonate 
 
10ml  - 
200nM L-glutamine  
 
100µl 2mM 
5000 IU/ml Penicillin and 
Streptomycin  
 
200µl 100 IU/ml 
Heat-inactivated fetal calf serum 
(FCS) 
 
1ml  10% 
 
Table 2.3 Preparation of Dulbecco’s Modified Eagle’s Medium (DMEM). 
Medium and additives 
 
Volume Final concentration 
Dulbecco’s Medium with 3.7g/I 
bicarbonate, without glutamine 
 
10ml - 
100x non-essential amino acids  
 
100µl - 
1M Hepes – final conc. 100µl 
 
10mM 
5x103 M2-Mercaptoethanol 100µl 
 
- 
200mM L-glutamine – final conc. 
 
200µl 4mM 
5000 IU/ml penicillin and 
streptomycin 
 
200µl 100IU/ml 
Heat-inactivated FCS 10% 
 
1ml 10% 
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Table 2.4 Constituents of 100x Non-Essential Amino Acids. 
Constituents 
 
Concentration (mg/ml) 
L-alanine  
 
8.9 
L-asparagine  15.0 
 
L-aspartic Acid 
 
13.0 
Glycine 
 
7.5 
L-glutamic Acid 
 
14.2 
L-proline  11.5 
 
L-serine  10.5 
 
 
 
2.3 Isolation of Mouse Tissue. 
 All handling of murine adult, embryonic and neonatal tissue was performed in a 
laminar flow hood to provide a sterile environment, using sterile surgical instruments and 
sterile solutions.   
All adult mice used in this study were culled by cervical dislocation of the neck and 
the thymus was dissected out and placed in RF10-H.  For embryonic work, pregnant mice 
were culled and the uterus was removed whole.  Embryos in their amniotic sacs were 
removed from the uterus and washed in PBS.  Placentas and sacs were then removed and the 
embryos were washed in 1:1 PBS:RF10.  Thymic lobes were dissected out from the thoracic 
tree (encompassing the heart, lungs, thymus and trachea) and transferred into RF10-H before 
either explantation into organ culture or processing for FACs analysis or immunohistology. 
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2.4 Fetal Thymus Organ Culture (FTOC). 
Fetal thymus organ culture (FTOC) is a well established system that supports a 
complete programme of T cell development in vitro, whilst maintaining the integrity of the 
3D architecture of the thymic stromal cells (Jenkinson and Anderson, 1994).  This system 
promotes efficient interactions between developing T cells and stromal cells, thus emulating 
the specialised microenvironment that is typical of a mature thymus in vivo (figure 2.1 
illustrates this technique). 
Thymic lobes were removed from mouse embryos at the required stage of gestation 
(usually E15 for FTOC). Using a finely drawn mouth-controlled glass pipette, lobes were 
placed on 0.8µm sterile nucleopore filters (Millipore) on sterile artiwrap sponges 
(approximately 1cm2 in size) (Medipost Ltd) in DMEM.  The nucleopore filters maintain 
organ cultures at the liquid-air interface, for optimal exchange with both the medium and gas 
phase vital for optimal growth (Jenkinson et al., 1982). 
For normal organ culture, lobes were set up in 90mm, single vent sterile Petri dishes 
(Sterilin) containing 4mls DMEM. When required, 2-dGuo was added to the DMEM to give a 
final concentration of 1.35mM.  A maximum of six lobes were cultured on a single sponge 
and filter, with two sponges and filters per dish.  Petri dishes were then placed in humidified 
chambers.  Cultures were gassed with 10% CO2 to get the desired pH (7.2-7.4) for 
approximately 10 minutes before being sealed and transferred to a 37°C incubator for a 
minimum of 7 days.  For optimal lymphoid and dendritic cell depletions by 2-dGuo, fetal 
lobes were cultured for 5-7 days. 
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Figure 2.1 Fetal Thymus Organ Culture. 
 Mouse embryos at day 15 of gestation were used as a source of thymus lobes (A).  
Thoracic cavity was exposed and thymus lobes can be visualised lying above the heart (red 
box) (B).  Lobes were isolated (C) and explanted in organ culture (D). 
 Images A-C courtesy of F. Kinsella, University of Birmingham.  
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2.5 Isolation of Cell Types. 
 To study development and phenotype of thymic stromal cells, methods for enrichment 
of specific thymic epithelial cells was employed.  Two approaches for this are highlighted 
below and include high-speed cell sorting and immunomagnetic bead separation. 
 
2.5.1 Isolation of Thymocytes. 
 To obtain cell suspensions of thymocytes for flow cytometry adult thymic lobes or 
embryonic lobes were gently teased apart in RF10-H medium with fine forceps to release the 
cells.  Cells were counted in a haemocytometer and centrifuged. 
 
2.5.2 Isolation of Thymic Stromal Cells. 
 In order to obtain single cell suspensions of thymic stromal cells, freshly dissected 
embryonic thymic lobes or embryonic lobes that have been in organ culture for 7 days were 
washed three times in Ca++ Mg++ free PBS (Sigma) to remove all traces of serum that can 
inactivate trypsin.  Washed lobes were then suspended in 600µl 0.25% trypsin (Sigma) 
diluted in 0.02% EDTA (Sigma) and then incubated at 37°C for approximately 15-20 minutes 
(precise timing depends on the stage of thymus development and days in organ culture).  
After this, dissaggregation of the lobes was aided by gentle pipetting, until a stromal cell 
suspension had formed.  The activity of the trypsin was blocked by adding an equal volume of 
RF10-H.  Cells were centrifuged for 10 minutes at 1000rpm and the supernatant removed.  
The cell pellet was resuspended in 1ml RF10-H and the cells were counted in a 
haemocytometer.  
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2.5.3 Bead Coating and Immunomagnetic Separation Techniques. 
For further enrichment and selection of thymic epithelial cells, an immunomagnetic 
separation technique was employed using Dynabeads (Dynal, Wirral, UK).  Beads were 
prepared the day before use by washing in RF10 three times to remove sodium azide and then 
incubated at 4°C overnight in the presence of the appropriate antibody, which was diluted to 
the required concentration in PBS.  Details of antibodies used to coat Dynabeads are outlined 
in table 2.5.  Tissue culture derived CD45 supernatant was coated onto anti-rat IgG 
Dynabeads, whilst anti-CD205 and anti-CD40 biotin were coated onto streptavidin 
Dynabeads.  Following incubation, beads were washed three times in RF10 to remove all 
excess antibody and resuspended in 100µl of RF10.  Beads were then added to cell 
suspensions in 200µl of RF10 at an approximate ratio of 10:1.  Cells and beads were 
centrifuged for 10 minutes at 1000 rpm, at 4°C in round bottomed sterile cryogenic vials 
(Cryovial, Quebec, Canada) to ensure a large surface area for optimal cell to bead 
interactions.  This was repeated a second time after gentle pippetting of the cells and beads.  
Such interactions result in the formation of ‘rosettes’, clusters of cells bound to beads, which 
were visualised by light microscopy throughout the process.  Once positive binding was 
detected, cells rosetted to beads were isolated from unbound cells using an Eppendorf (1.5ml) 
Dynal Magnetic Particle Concentrator (Dynal).  Supernatant containing the unbound 
populations was removed and rosettes were washed gently to eliminate any none specifically 
binding cells.     
 To obtain cells of defined epithelial populations for RT-PCR, cell suspensions 
depleted of CD45 were treated with biotin conjugated CD205 and CD40 streptavidin beads as 
described above.  Rather than discarding, the CD205 and CD40 rosettes were snap frozen for 
RT-PCR. 
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Table 2.5 Details of Antibodies Used to Coat Dynabeads for Immunomagnetic Separation. 
Bead type 
 
Coating antibody 
and dilution 
 
Use 
Anti-rat IgG Anti-mouse CD45 
tissue culture 
supernatant used 
neat (ATCC) 
 
Depletion of CD45+ 
haematopoietic 
cells from freshly 
dissected 
embryonic or organ 
cultured thymus 
lobes. 
 
Streptavidin  Anti-mouse CD205 
biotin used 1:20 
 
Selection of 
CD205+ thymic 
epithelial cells from 
freshly dissected 
embryonic thymus 
lobes. 
 
Streptavidin Anti-mouse CD40 
biotin used 1:50 
 
Selection of CD40+ 
thymic epithelial 
cells from freshly 
dissected 
embryonic thymus 
lobes. 
 
 
2.5.4 Preparation of Cells for High Speed Sorting. 
 Suspensions of thymocytes or stromal cells were immunolabelled for flow cytometric 
high speed sorting in a similar manner to cell suspensions prepared for flow cytometry, which 
is described in section 2.6.   
 Following completion of immunolabelling, cells were washed and resuspended.  
Single colour controls, of approximately 100,000 cells, were resuspended in 200µl RF10-H.  
Experimental samples of no less than 1x106 were resuspended in 1ml RF10-H.  Suspensions 
were filtered to remove any adherent cell clumps through a 30µm mesh-membrane filter unit 
(Miltenyi Biotech) and then transferred to polypropylene FACs tubes (Becton Dickinson) 
before sorting.  Sorting was performed on a MoFlo high speed sorter (Dako Cytomations).  
Sorted cells were collected into FACs tubes containing 500µl RF10-H and then centrifuged 
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and counted.  A small sample was kept to reanalyse to determine purity of the sorted 
population of cells.  Sorted cells were snap-frozen for cDNA extraction (as described in 
section 2.8).  
  
2.6 Immunolabelling and Flow Cytometry. 
2.6.1 Antibodies and Immunoconjugates. 
 Table 2.6 outlines all primary antibodies used for flow cytometry.  Secondary 
antibodies, used when the primary was not conjugated to a fluorochrome, are listed in table 
2.7.  All antibodies were titrated to optimise working concentrations prior to use. 
 
2.6.2 Immunolabelling of Cell Suspensions for Flow Cytometric Analysis. 
Cell suspensions of thymocytes or stromal cells were prepared as described in section 
2.5.  Cells were counted and samples of less than 1 x 106 were aliquoted into 1.5ml eppendorf 
tubes and centrifuged.  All suspensions were made up in RF10-H.  
 After removal of the supernatants, cell pellets were resuspended in 50µl of the 
relevant primary and secondary antibody.  Samples were then incubated for 30 minutes on 
ice.  Appropriate single colour controls were also set up.  Where primary antibodies were not 
directly conjugated to a fluorochrome, a control sample was needed to set the negative peak 
of florescence and measure non-specific binding of the antibody.  To achieve this, the primary 
antibody was omitted from the protocol and replaced with 50µl PBS.  Once the 
immunolabelling was complete, cells were washed in 1ml PBS and centrifuged.  When 
required, the relevant secondary antibodies were added to cells and incubated for 30 minutes  
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Table 2.6 Details of Primary Antibodies for Flow Cytometric Immunolabelling.  
Specificity (clone) 
 
Species/Isotype Source Working dilution 
Anti-mouse CD45.2 
FITC (clone 104) 
 
Mouse IgG2a eBioscience 1:200 
Anti-mouse CD205 
(DEC205) biotin (clone 
NLDC145) 
 
Rat IgG2a AbCAM 1:50 
Purified anti-mouse 
EpCAM-1 (clone G8.8) 
conjugated to Alexa 647 
by A. White, University 
of Birmingham 
 
Rat Purified EpCAM-1 a gift 
from A. Farr, University 
of Washington, USA 
1:800 
Anti-mouse CD40 PE 
(clone 3/23) 
 
Rat IgG2a Serotec 1:20 
Anti-mouse Ly51 (6C3) 
PE (clone BP-1)  
 
Mouse IgG2a eBioscience  
 
1:500 
Anti-mouse CD80 biotin 
(B7.1) (clone 16-10A1) 
 
Armenian hamster IgG eBioscience 1:400 
Anti-mouse PD-L2 
(B7.DC) biotin (clone 
TY25) 
 
Rat IgG2a eBioscience 1:100 
Anti-mouse PD-L1 (B7-
H1) biotin (clone MIH5) 
 
Rat IgG2a eBioscience 1:100 
Anti-mouse CD4 PE 
(clone GK1.5) 
 
Rat IgG2b eBioscience 1:1200 
Anti-mouse CD8α FITC 
(clone 53-6.7) 
 
Rat IgG2a eBioscience 1:200 
Anti-mouse CD25 (IL-
2Rα) APC (clone 
PC61.5) 
 
Rat IgG1 eBioscience 1:200 
Anti-mouse/human CD44 
(clone IM7) 
 
Rat IgG2b eBioscience 1:400 
Anti-mouse TCRβ biotin 
(clone H57-597) 
 
Armenian hamster IgG2 BD 1:200 
Anti-mouse IAd (MHC 
II) FITC (clone AMS-
32.1) 
 
Mouse IgG2b BD 1:600 
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Continued. 
Anti-mouse IAb (MHC 
II) FITC (clone AF6-
120.1) 
 
Mouse IgG2a BD 1:600 
Anti-BrdU FITC 
 
- BD 1:50 
Anti-mouse lineage 
markers biotin (including 
CD11b (Mac-1), Ly-6G 
(erythroid cells), CD3 ε 
chain, CD45R/B220 
 
Rat IgG2b BD 1:200 
Anti-mouse CD4 biotin 
(GK1.5) 
 
Rat IgG2b eBioscience  1:100 
Anti-mouse CD8 biotin 
(clone CT-CD8b) 
 
Rat IgG2b eBioscience  1:100 
Anti-mouse IAd PE 
(clone AMS-32.1) 
 
Mouse IgG2b BD 1:200 
Anti-mouse Ly51 biotin 
(clone 6C3) 
 
Rat IgG2a eBioscience  1:200 
Anti-mouse AIRE 
conjugated to Alexa 488 
by A. White, University 
of Birmingham 
 
Rat Purified AIRE a gift from 
H. Scott, University of 
Melbourne, Australia 
1:200 
Anti-mouse PD-1 PE 
(clone J43) 
 
Armenian hamster IgG1 eBioscience 1:100 
Anti-mouse CD69 biotin 
(clone H1.2F3) 
 
Armenian Hamster IgG1 BD 1:100 
gp38 supernatant (clone 
8.1.1) 
 
Hamster Grown from a hybridoma 
cell line, gift from A. 
Farr, University of 
Washington, USA 
 
1:2 
Anti-mouse VCAM-1 
(clone 429) 
 
Rat IgG2a eBioscience 1:100 
Anti-mouse ICAM-1 
(clone 3E2) 
 
Rat BD 1:100 
Anti-mouse PDGFRα 
(clone APA5) 
 
 
Rat IgG2a eBioscience 1:200 
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Table 2.7 Details of Secondary Antibodies for Flow Cytometric Immunolabelling.  
 
on ice.  After washing, cells were then resuspended in 200µl of PBS. Samples were then 
transferred to 12.5ml polystyrene FACS tubes (Becton Dickinson) for FACS analysis.  
 
2.6.3 Flow Cytometric Analysis.  
Acquisition was performed using a Becton Dickinson LSR flow cytometer and 
subsequent analysis was carried out using FloJo software. Prior to acquisition of experimental 
samples, any relevant negative control samples were examined in order to set negative peaks 
for populations not expressing the tested antibodies.  For experiments using more than two 
fluorochromes, single colour controls were used to set up the machine to set the positive 
peaks for populations expressing the tested antibodies, but also to adjust compensation levels 
required between the various fluorochrome detection channels. 
 Where possible at least 100,000 events were recorded per experimental sample, with 
forward and side scatter gates to exclude non-viable cells, while fluorochrome detection 
channel gates were set in accordance to negative and positive peaks generated from the 
control samples.   
 
Specificity (clone) 
 
Species/Isotype Source Working dilution 
Streptavidin PE Cy7 
 
- eBioscience  1:500 
Streptavidin APC 
 
- BD 1:400 
Streptavidin PE 
 
- eBioscience  1:1200 
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2.7 Immunohistology Techniques. 
2.7.1 Sectioning and Fixation of Tissues. 
To produce sections of embryonic and adult thymi, organs previously frozen in liquid 
nitrogen, were mounted onto a microtome in OCT compound (Tissue Tek) at a defined 
orientation.  5µM thick sections were cut and mounted onto 4 spot glass slides (Hendley-
Essex) for immunohistology.  All slides were dried at room temperature for an hour and then 
fixed for 20 minutes in acetone (Baker) at 4°C.  Slides were allowed to air dry for 10 minutes 
before storage in polythene grip seal bags at -20°C until further use.  
 
2.7.2 Immunolabelling of Frozen Tissue Sections. 
Slides were allowed to dry at room temperature within grip seal bags for 10 minutes.  
In order to examine slides by confocal microscopy, sections were stained with fluorochrome-
conjugated anti-mouse antibodies diluted in PBS containing 1% bovine serum albumin 
(BSA).  Slides were pre-blocked with 10% normal goat serum and secondary and tertiary step 
antibodies were pre-absorbed with 10% normal mouse serum.  For intracellular staining (such 
as AIRE), antibodies were made in PBS containing Tween (Sigma).  Details of all primary 
antibodies used in this study are outlined in table 2.8 and details of secondary and tertiary 
antibodies are detailed in table 2.9.  After staining the sections, slides were mounted in 
Vectashield with DAPI (VectorLabs).  DAPI is nuclear stain and allows for visualisation of 
the whole tissue section.   
 Confocal images were acquired using a Zeiss LSM510 laser scanning confocal head 
with a Zeiss Axio Imager Z1 microscope (Zeiss, Welwyn Garden City, UK).  Digital images 
were recorded in four separately scanned channels with no overlap in the detection of 
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emissions from the respective fluorochromes.  FITC or Alexa 488 conjugated antibodies were 
excited with a 488nm argon laser, TRITC and Alexa 555 and 594 conjugated antibodies were 
excited with a 561nm helium laser, Alexa 647 conjugated antibodies were excited with the 
633nm helium laser and finally DAPI was detected using the 405nm diode laser.  Confocal 
micrographs were stored as digital arrays of 2048x2048 pixels with 8 bit sensitivity.   
 
Table 2.8 Details of Primary Antibodies used for Immunohistology. 
Specificity (clone) 
 
Species/isotype Source Working dilution 
Anti-mouse CD205 
(DEC205) FITC (clone 
NLDC145) 
 
Rat IgG2a AbCAM 1:50 
Anti-mouse CD40 biotin 
(clone 3/23) 
 
Rat IgG2a BD 1:50 
Purified anti-mouse 
EpCAM-1 (G8.8) 
conjugated to Alexa 647 
by A.White, University 
of Birmingham 
 
Rat  Purified EpCAM-1 a gift 
from Andy Farr, 
University of 
Washington, USA 
1:150 
Anti-mouse CD25 FITC 
(clone 7D4)  
 
Rat IgM BD 1:150 
Purified anti-mouse CD4 
(clone GK1.5) 
conjugated to Alexa 647 
by D.Withers, University 
of Birmingham. 
 
Rat  Purified CD4 from 
eBioscience  
1:100 
Anti-mouse CD8β biotin 
(clone CT-CD8b) 
 
Rat IgG2b eBioscience  1:100 
Anti-mouse keratin 8 
(clone KS8.7) 
 
Mouse IgG1 Progene 1:10 
Anti-mouse pan-
cytokeratin FITC (clone 
C-11) 
 
Mouse IgG1 Sigma 1:600 
Anti-mouse keratin 5 
purified  
 
Rabbit Covance  1:1500 
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Continued. 
Anti-mouse CD31 biotin 
(clone ER-MP12) 
 
Rat IgG2a 
 
BMA Biomedicals 
 
1:100 
 Purified anti-mouse 
AIRE 
 
Rat  A gift from H. Scott, 
University of Melbourne, 
Australia 
 
1:200 
gp38 supernatant (clone 
8.1.1) 
Hamster 
 
Grown from a hybridoma 
cell line, gift from A. 
Farr. 
 
1:2 
Perlecan supernatant  
 
Rat 
 
A gift from Z. Lokmic, 
University of Muenster, 
Germany 
 
1:2 
ER-TR7 supernatant 
 
Rat Grown from a hybridoma 
cell line, gift from W. 
van Ewijk, Leiden 
University, Netherlands 
 
1:2 
 
 
Table 2.9 Details of Secondary and Tertiary Antibodies Used for Immunohistology. 
Specificity (clone) 
 
Species/isotype Source Working dilution 
 Anti-FITC 
 
Rabbit Biosource  1:200 
Anti-rabbit FITC IgG 
(H+L) 
 
Goat  Southern Biotech 1:100 
Anti-biotin TRITC 
 
Mouse  Stratech Scientific 1:400 
Anti-hamster biotin IgG 
(H+L) 
 
Goat  Vector Laboratories   
Streptavidin Alexa  555 
 
Goat Invitrogen 1:1000 
Anti-rabbit Alexa 647 
IgG (H+L) 
 
 
Goat Invitrogen 1:400 
Anti-rat Alexa 595 IgG 
(H+L) 
 
Goat Invitrogen 1:400 
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2.8 Preparation of Samples for Gene Expression Analysis. 
 All gene expression analysis was carried in collaboration with S. Parnell, University of 
Birmingham. 
2.8.1 Snap Freezing of Cell Populations. 
 Cell populations obtained following MoFlo sorting or immunomagnetic bead 
separations were transferred into 1.5ml RNase-free eppendorf tubes (Camlab) and centrifuged 
at 1000rpm for 10 minutes.  Supernatants were removed to leave a dry pellet. Closed 
eppendorfs were immersed in liquid nitrogen before storage at -80°C until further use. 
 
2.8.2 mRNA extraction. 
  mRNA was extracted from sections obtained by either laser capture microdissection 
(described in section 4.2), MoFlo sorted cells or cells obtained after immunomagnetic 
separation, using a thermoMACSTM heating block and protocol (Miltenyi).  The whole 
procedure was carried out in a laminar flow cabinet.  Lysis/binding and wash buffers were 
allowed to equilibrate to room temperature prior to carrying out the protocol.  Frozen tissue 
sections or cells obtained from MoFlo cell sorting were suspended in 900µl of lysis/binding 
buffer and vigorously vortexed for 3 minutes to ensure total cell lysis.  For cells obtained 
from immunomagnetic bead separation, cells were separated from the beads by suspending 
rosettes in lysis/binding buffer and using a 21-gauge needle to lyse the cells.  The resulting 
mix was then centrifuged briefly at 13,000 rpm to separate the cells from the beads.  Beads 
were discarded.  
Cell lysates were then centrifuged at 13,000 rpm for 3 minutes in LysateClear 
columns.  50µl of oligo microbeads were added to each lysate and gently mixed to allow the 
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polyA tails of the mRNA present to hybridise to the oligo microbeads.  Lysates were then 
placed in µMACS columns previously primed with 100µl lysis/binding buffer.  As the sample 
passed through the column, the magnetically labelled mRNA remained bound to the column.  
Columns were rinsed twice with 200µl lysis/binding buffer to remove proteins and DNA, 
followed by a rinse with 100µl of wash buffer 4 times to remove ribosomal RNA and DNA.  
In order to continue with cDNA synthesis directly, the bound mRNA was not eluted from the 
column.  100µl of equilibration/wash buffer was added to the column twice and allowed to 
run through.  Meanwhile, the lyophilised enzyme mix was dissolved in 20µl of resuspension 
buffer and applied on top of the column followed by 1µl of sealing solution applied directly to 
the top of the column to prevent evaporation.  The thermoMACSTM was then turned on to 
42°C and left for 1 hour and 15 minutes for reverse transcription to take place.  Following the 
incubation period, the column was rinsed twice with 100µl equilibration/wash buffer.  To 
release the cDNA, 20µl release solution was added to the column and then left for 30 minutes 
at 42°C.  Following the incubation period, 50µl elution buffer was added to elute the cDNA, 
which was collected into an eppendorf.  cDNA was placed at -20°C until ready for use.  High 
yields and purity of cDNA was obtained with this procedure. 
 
2.8.3 Quantitative RT-PCR. 
 Quantitative PCR was performed on the RotorGene RG-3000 (Corbett Research) 
using SYBR green with primers specific for various genes of interest.  Details of all primers 
used in this study are outlined in Table 2.10.  β-actin was used as the housekeeping gene for 
sample normalisation, prior to amplifying the target genes of interest.  Primers were made by 
Sigma-Genosys and primer pairs were designed using the aid of PrimerBank software 
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(http://pga.mgh.harvard.edu/primerbank/index.html) to minimise the possibility of 
dimerisation that could lead to non-specific PCR amplification.  PCR reactions were carried 
out in triplicates or duplicates in 15µl volumes in reaction buffer containing 1X QPCR 
SYBER Green Mix (Quantace) and 200nM-300nM forward and reverse primers.  The 
amplification program comprised of an initial ‘hot start’ (95°C for 15 minutes), followed by 
cycling at 95°C for 15 seconds, 58 to 62°C (depending on primer pair) for 20 seconds and 
72°C for 5 seconds (39 cycles).  The fluorescent signal produced from the amplicon was 
acquired at the end of each polymerisation step and at the end amplification, a melt curve 
profile was obtained (72-99°C, hold 30 seconds on 1st step then 5 seconds on next steps) in 
order to check specificity of amplicon.  Reaction amplification efficiency and the Ct values 
were obtained from the Rotor Gene 6.0 software (Corbett Research, Sydney Australia) using 
standard curves primarily obtained from cDNA from FTOCs.  For calculation of the relative 
expression values for samples normalised to β-actin, the Pfaffl model that takes gene-
dependent differences in the amplification efficiency into account was employed.  Specific 
amplification of target genes was normally verified by post-amplification melt curve analysis 
and also by fractionation of PCR products on a 2.0% agarose gel, which were identified by 
their fragment size.     
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Table 2.10 Details of primers. 
Primer Forward 5’ end primer sequence Reverse 3’ end primer sequence Product 
size 
(base 
pairs) 
β-actin 
(NM_007393.2) 
CGTGAAAAGATGACCCAGATCA TGGTACGACCAGAGGCATACAG 100 
AIRE 
(NM_009646)  
TGCATAGCATCCTGGACGGCT CCTGGGCTGGAGACGCTCTTT 
 
187 
CCL19  
(NM_011888.2) 
GGGGTGCTAATGATGCGGAA CCTTAGTGTGGTGAACACAAC 137 
CCL21  
(NM_011335.2) 
GCTGCCTTAAGTACAGCCAGA CTTCCTCAGGGTTTGCACAT 150 
RANK 
(NM_009399.3) 
GCTGGCTACCACTGGAACTC GTGCAGTTGGTCCAAGGTTT 182 
Claudin 3 
(NM_009902.3) 
ACCAACTGCGTACAAGACGAG CAGAGCCGCCAACAGGAAA 78 
Claudin 4 
(NM_009903.2) 
GTCCTGGGAATCTCCTTGGC TCTGTGCCGTGACGATGTTG 112 
LTβR 
(NM_010736.3) 
GAGCAGAACCGGACACTAGC GAAGGTAGGGATGAGCACC 256 
Cathepsin L 
(NM_009984.3) 
ATCAAACCTTTAGTGCAGAGTG CTGTATTCCCCGTTGTGTAGC 136 
Cathepsin S 
(NM_021281.2) 
CCATTGGGATCTCTGGAAGAAAA TCATGCCCACTTGGTAGGTAT 
 
155 
β5T 
(NM_175204.4) 
ACTCCCGACACTCCCAGAC CCGTGACGAAAGCGAAAAGC 149 
DOCK2 
(NM_033374.2) 
TGTCACAGGGCATTTTCCCTA TCGTACATCATGGACTGCACT 208 
CCL25 
NM_009138.2 
CGGAAGTAGAATCTCACAGCA TTACCAGCACAGGATCAAATG 105 
CCR9 
NM_001166625.1 
AGGCCAAGAAGTCATCCAAGC CCTTCGGAATCTCTCGCCAA 251 
CXCL12  
(NM_021704.2) 
GCTCTGCATCAGTGACGGTA TGTCTGTTGTTGTTCTTCAGC 162 
CXCR4 
NM_009911.3 
GAAGTGGGGTCTGGAGACTAT TTGCCGACTATGCCAGTCAAG 125 
CCR7 
NM_007719.2 
TGTACGAGTCGGTGTGCTTC GGTAGGTATCCGTCATGGTCTT 162 
FGF-7 
NM_008008.3 
CTCTACAGGTCATGCTTCCACC ACAGAACAGTCTTCTCACCCT 174 
FGF-10 
NM_008002.3 
CAGCGGGACCAAGAATGAAG TGACGGCAACAACTCCGATTT 77 
FGFR2 
NM_010207.2 
TTCTCCTAGTTACCCCGACAC AGGCAGACAGGGTTCATAAGG 94 
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3.1 Introduction. 
The thymus is comprised of a unique three-dimensional network of stromal cells, 
which provide specialised microenvironments for the development of a diverse and self-
tolerant T cell repertoire.  Thymic microenvironments are anatomically compartmentalised 
into cortical and medullary regions, which house the key stages of T cell development.  
Thymic epithelial cells (TECs) constitute the major cell type of the cortex and medulla and 
are phenotypically and functionally heterogeneous.  Cortical thymic epithelial cells (cTECs) 
support the positive selection of thymocytes that recognise self-peptide/MHC II complexes 
with low affinity, whereas medullary thymic epithelial cells (mTECs) regulate self-tolerance 
via the deletion of potentially autoreactive T cells by a process of negative selection.   
TECs provide a number of signals to developing thymocytes including; peptide/MHC 
ligands for TCR repertoire selection (Cosgrove et al., 1992), soluble growth factors such as 
Wnts (Pongracz et al., 2003), IL-7 and stem cell factor (SCF) for survival and expansion 
(Rodewald et al., 1997) and Notch ligands for differentiation and lineage commitment 
(Jenkinson et al., 2006).  Indeed, the importance of TECs has been further demonstrated 
during thymic atrophy where a reduction in TEC frequency and function is associated with a 
reduction in T cell output (Chidgey et al., 2007).  Furthermore, the autoimmune deficiencies 
that arise as a result of abnormal TEC development highlight the importance of TECs for 
maintaining self-tolerance (Naquet et al., 1999). Thus, characterising stages and mechanisms 
of cTEC and mTEC development and the interactions between thymocytes and stromal cells 
is central to our understanding of intrathymic T cell development.  
The discovery of a bipotent TEC (bTEC) progenitor that can develop into both cortical 
and medullary lineages was a significant finding and provided novel insight into TEC 
development (Bleul et al., 2006; Rossi et al., 2006). In the context of mTEC development, 
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most notably the subset expressing AIRE, several molecular mediators have now been 
identified as important, including the cell surface receptors RANK, CD40 and LTβR 
(Akiyama et al., 2008; Boehm et al., 2003; Hikosaka et al., 2008; Irla et al., 2008; Rossi et al., 
2007b; White et al., 2008).  Furthermore, a precursor-product relationship has been identified 
within the mTEC lineage (Hamazaki et al., 2007; Rossi et al., 2007b) along with the finding 
that mTEC committed progenitors have self-renewal capacity (Gabler et al., 2007).  In 
addition, defects in thymocyte development have been associated with mTEC abnormalities, 
highlighting the importance of thymic crosstalk in the development of the medulla.  In 
contrast to our understanding of mTEC development, stages and mechanisms regulating 
cTEC development downstream of bTEC progenitors are poorly characterised and a cTEC 
progenitor has yet to be identified (figure 3.1).  Clearly, further studies that attempt to isolate 
cTEC progenitors and define important mechanisms that regulate cTEC development are vital 
for understanding how cTECs become specialised in their ability to mediate positive selection 
of developing thymocytes. 
In view of this, the objective of this chapter was to characterise cTEC development 
occurring downstream of bTEC progenitors using the endocytic receptor CD205 (also known 
as DEC205), which is expressed in the thymic cortex and DCs but not the medulla (Jiang et 
al., 1995) and the recently identified proteasome subunit β5T (Murata et al., 2007).   
 Thus, the aims and objectives of this chapter were to; 
• Identify stages in cTEC development. 
• Assess proliferative status of cTEC subsets.  
• Identify cellular and molecular regulators of cTEC development. 
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Figure 3.1 A Previous Model of Cortical Thymic Epithelial Cell Development. 
A common bipotent thymic epithelial cell (bTEC) progenitor develops into a mature 
cortical thymic epithelial cell (cTEC) via an unknown developmental pathway.  A cTEC 
progenitor downstream of the bipotent TEC progenitor has not been identified and the precise 
molecular and cellular regulators of this pathway have not been elucidated.  
bTEC, bipotent thymic epithelial cell, Mat, mature, cTEC, cortical thymic epithelial 
cell.  
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3.2 Specialised Materials and Methods. 
3.2.1 BrdU Assay to Measure Cellular Proliferation. 
 To assess proliferation of stromal cell subsets, a bromodeoxyuridine (BrdU) flow 
cytometry protocol was employed (BD Pharmingen).  BrdU (an analogue of the DNA 
precursor thymidine) is incorporated into newly synthesised DNA by cells entering and 
progressing through the S phase of the cell cycle.  Thus, this assay allows for the 
identification of actively cycling cells.  BrdU assays were carried out in collaboration with G. 
Desanti, University of Birmingham. 
Freshly isolated thymus lobes or lobes placed in fetal thymus organ culture (FTOC) 
for 7 days (as described in section 2.4) were placed in DMEM containing BrdU at a final 
concentration of 10µM for an overnight incubation (note: for the negative controls, lobes 
were cultured without BrdU).  Lobes were then removed from culture and enzymatically 
disaggregated to obtain suspensions of stromal cells.  To enrich for stromal cells, cells were 
depleted of CD45+ haematopoietic cells by an immunomagnetic bead separation technique (as 
described in section 2.5.3).  Purity of the CD45 negative fraction was checked by flow 
cytometry.  The purified stromal cell suspension was then surface stained for the relevant 
primary and secondary antibodies.  Upon completion of the cell surface stain, the BrdU 
protocol was carried out on all samples, including the negative controls, according to the 
manufacturers instructions.  Washed cells were incubated with cytofix/cytoperm buffer for 25 
minutes on ice in order to fix and permeabilise cells.  This was followed by washing the cells 
with perm/wash buffer and then incubating the cells for 10 minutes on ice with cytoperm plus 
buffer.  Cells were then washed again with perm/wash buffer and re-fixated with 
cytofix/cytoperm buffer for 5 minutes on ice.  After another wash with perm/wash buffer, 
cells were incubated with DNase for 1 hour at 37°C in order to expose incorporated BrdU.  
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Following the incubation period, cells were again washed with perm/wash buffer.  Cells were 
then stained with a fluorescent anti-BrdU antibody made up in perm/wash buffer for 20 
minutes on ice.  Finally, cells were washed with perm/wash buffer and then resuspended in 
PBS before acquisition on an LSR flow cytometer (BD Biosciences). 
 
3.3 Results 
3.3.1 Characterisation of Stromal Cells in a Wildtype Thymus. 
 To determine the basic stromal cell composition of an adult thymus, embryonic 
thymus lobes were dissected from wildtype (WT) embryos at day 15 of gestation (E15) and 
placed in FTOC for 7 days.  To avoid long phases of dissaggregation, this in vitro system was 
employed instead of using thymi from neonatal or adult mice.  This well established system 
supports a complete programme of T cell development in vitro and the thymic stromal cells 
retain their 3D architecture allowing for efficient interactions between developing T cells and 
stromal cells (Jenkinson and Anderson, 1994).  Thus, this system emulates the specialised 
thymic microenvironment that is typical of a mature thymus in vivo (equivalent in age to an 
approximately 3 or 4 day old neonate).  
FTOC lobes removed from culture were enzymatically disaggregated to obtain cell 
suspensions of thymic stromal cells.  Stromal cells were then stained for flow cytometry for 
CD45 (haematopoietic cell surface marker), EpCAM-1 (a cell surface marker expressed on 
both cTECs and mTECs) and Ly51 (a cTEC specific marker). The non-haematopoietic 
compartment of the thymus identified as CD45- (figure 2.2A), is comprised of a 
heterogeneous population of stromal cells (figure 2.2B).  
 99 
 
 
 
 
 
 
Figure 3.2 Characterisation of Stromal Cells in a Wildtype Thymus. 
Thymus lobes dissected at day 15 of gestation from WT mouse embryos were placed 
in fetal thymus organ culture (FTOC) for 7 days.  Following culture, lobes were 
enzymatically digested to obtain suspensions of thymic stromal cells.  Cells were stained for 
flow cytometry for CD45, EpCAM-1 and Ly51.  A CD45- non-haematopoietic thymic 
stromal cell compartment is shown (A).  Thymic stromal cells are further subdivided into 
different subsets based on their EpCAM-1 and Ly51 expression (B).  Table summarises the 
different thymic stromal cell subsets and their phenotype (C). 
Percentages of cells within gated areas are indicated.  Data representative of three 
experiments.   
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A population of cTECs was identified on the basis of a CD45- EpCAM1-1+ Ly51+/high 
phenotype.  mTECs were identified as CD45- EpCAM-1+ Ly51-.  A CD45- EpCAM-1- Ly51+ 
phenotype distinguishes a non-epithelial stromal cell type previously described as the cortical 
mesenchyme (cMES) (Muller et al., 2005).  A population of stromal cells identified as CD45- 
EpCAM-1- Ly51- was also observed and these cells are likely to represent a non-epithelial 
population of cells comprising of fibroblasts and endothelial cells.  The table in figure 2.2 
summarises the stromal cell populations in the thymus and their phenotype as described 
above.  
 
3.3.2 An Adult Wildtype Thymus has a Defined Stromal Architecture. 
To identify the basic organisation of stroma in an adult WT thymus, frozen thymus 
tissue sections from a 4-6 week old WT mouse were stained for confocal microscopy analysis 
for a panel of stromal cell markers (figure 3.3A-F).  Cortex and medulla are identified on the 
basis of the nuclear stain DAPI (not shown).  Cortical and medullary epithelial cells were 
identified by the differential expression of keratins (figure 3.3A-D), where the cortex typically 
expresses keratin 8 (K8) and a pan-cytokeratin marker (typically follows the same expression 
pattern as K8), whereas the medulla expresses keratin 5 (K5).  K8+ K5+ cells were observed at 
the corticomedullary junction (CMJ) and some cells were scattered through the cortex (figure 
3.3A).  The autoimmune regulator AIRE is expressed specifically by mTECs, which are 
predominantly K5+ (figure 3.3A and B) and has a punctate appearance as illustrated in figure 
3.3B.  To identify endothelial vessels in the thymus, sections were also stained for the surface 
marker CD31 (figure 3.3C and D).  Endothelial cells appear to predominate at the CMJ, 
which represents the site of entry for T cell progenitors. Another important stromal marker is  
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Figure 3.3 An Adult Wildtype Thymus has a Defined Stromal Architecture. 
 Frozen tissue sections of thymus dissected from 4-6 week old WT mice were stained 
for keratin 8, keratin 5 and AIRE (A and B), Pan-cytokeratin, keratin 5 and CD31 (C and D) 
and gp38 and the extracellular matrix protein perlecan (E and F).  High power magnifications 
of boxed areas are shown in the right hand panels.  
 Cortex and medulla are identified on the basis of DAPI staining (not shown).  The 
solid line denotes edge of tissue and dashed line denotes the corticomedullary junction.  Bar 
indicates a scale of 50µm.  
C, cortex, M, medulla. 
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transmembrane glycoprotein 38 (gp38, also called podoplanin), which is known to be 
expressed by stromal cells in T cell dependent areas of peripheral lymphoid tissue and has 
been implicated in the presentation of chemokines (Farr et al., 1992).  Extracellular matrix 
proteins (ECM), such as perlecan are important components of basement membranes.  
Staining of adult thymus sections with gp38 and perlecan revealed that gp38 is predominantly 
expressed in the medulla as a large network with some gp38+ cells scattered throughout the 
cortex (figure 3.3E and F).  Perlecan was also observed in the medulla on vessel like 
structures in close association with gp38 (figure 3.3E and F). 
 
3.3.3 CD205 Expression Defines Cortical Epithelial Cells but not Medullary Epithelial 
Cells. 
 Having established that a WT thymus is comprised of a heterogeneous population of 
stromal cells with defined cortical and medullary regions (sections 3.3.1 and 3.3.2), we then 
turned our focus on trying to characterise the development of these thymic 
microenvironments with a particular emphasis on the development of cTECs. 
 Due to paucity of cTEC associated markers, successful characterisation of cTEC 
development has previously been limited.  CD205 was chosen in our study to characterise 
development of the cortex due to its previously known specificity as a cTEC marker in an 
adult thymus (Jiang et al., 1995; Nonaka et al., 2007).  To confirm the specificity of CD205 in 
our study, a stromal cell suspension was obtained from 7 day FTOC lobes, which were 
stained for CD45, EpCAM-1 and Ly51 to determine CD205 expression in cTECs and mTECs 
(figure 3.4).  CD205 expression was largely restricted to a cTEC population, defined as 
CD45- EpCAM-1+ Ly51+/high (figure 3.4B), whereas expression of CD205 on mTECs, defined 
as CD45- EpCAM-1+ Ly51-, was minimal (figure 3.4C).  
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Figure 3.4 CD205 Expression Defines Cortical Epithelial Cells but not Medullary 
Epithelial Cells. 
Thymus lobes dissected at day 15 of gestation from WT mouse embryos were placed 
in fetal thymus organ culture (FTOC) for 7 days.  Following culture, lobes were 
enzymatically digested to obtain suspensions of thymic stromal cells.  Cells were stained for 
flow cytometry for CD45, EpCAM-1, Ly51 and CD205.  A typical EpCAM-1 and ly51 
profile gated on CD45- cells is shown (A).  Histograms show CD205 expression on gated 
cortical (defined as EpCAM-1+ Ly51+/high) and medullary cells (defined as EpCAM-1+ Ly51-) 
(B and C).  Stromal cells were also stained for CD45, EpCAM-1 and CD205 with CD40.  By 
gating on thymic epithelial cells (defined as CD45- EpCAM-1+) (D), CD205 and CD40 
expression was analysed (E).  Percentages of cells within gated areas are indicated.  Shaded 
grey areas on histograms represent the negative control. Data representative of three 
experiments. 
 Frozen tissues sections of a 4-6 week old thymus were stained for EpCAM-1, CD205 
and CD40 (F). The dashed line denotes the corticomedullary junction. Bar indicates scale of 
50µm.  
C, cortex, M, medulla. 
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Having confirmed CD205 as a cTEC specific marker, CD205 expression was analysed in 7 
day FTOCs together with the co-stimulatory marker CD40, which is expressed by all TECs in 
the adult and is important for the development of mTECs.  Expression of CD205 and CD40 
was analysed within a TEC specific population defined as CD45- EpCAM-1+ (figure 3.4D).  A 
large population of CD45- EpCAM-1+ CD40+ CD205+ cTECs was observed with a smaller 
population of CD45- EpCAM-1+ CD40+ CD205- mTECs present (figure 3.4E).   
Histological analysis of CD205, CD40 and EpCAM-1 in a 4-6 week old thymus 
further confirmed CD205 expression as cortical specific based on the expression pattern of 
the nuclear stain DAPI (DAPI staining not shown), which appears dense in the cortex (figure 
3.4F).  (Note: flow cytometry analysis indicates that all mature TECs are EpCAM-1+ and 
CD40+, whereas by histological analysis, EpCAM-1 and CD40 expression appears to be 
medullary restricted because expression levels in the cortex of these two markers are below 
detection point.) 
 
3.3.4 Ontogeny of Cortical Epithelial Cell Development in a Wildtype Thymus. 
 Having characterised CD205 as a cTEC marker (section 3.3.3), CD205 was then used 
to identify the appearance of a cortical lineage through ontogeny.  Embryos at E12 were 
chosen as the starting point as it has previously been shown that the dominant population of 
cells in the E12 thymus are EpCAM-1+ TECs capable of giving rise to both cTECs and 
mTECs (Rossi et al., 2006).  To investigate the precise timing of cTEC development during 
ontogeny, thymic lobes were dissected from various ages of mouse embryos (E12-E15).  To 
emulate a mature thymus E15 lobes were placed in FTOC for 7 days.  Stromal cell 
suspensions obtained from freshly dissected and cultured lobes were stained for CD45, 
EpCAM-1, CD205 and CD40.  By gating on CD45- EpCAM-1+ TECs, CD205 and CD40 
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Figure 3.5 Ontogeny of Cortical Thymic Epithelial Cell Development. 
 Freshly isolated WT thymus lobes of the indicated ages and E15 lobes placed in 
FTOC for 7 days were enzymatically digested to obtain cell suspensions of thymic stromal 
cells.  Cells were stained for flow cytometry for CD45, EpCAM-1, CD205 and CD45.  
CD205 and CD40 expression on CD45- EpCAM-1+ thymic epithelial cells are shown for each 
stage of development (A-E).  Percentages of cells within gated areas are indicated.  Data 
representative of at least three experiments. 
 Quantitative RT-PCR of the cortical specific marker β5T, normalised to the 
housekeeping gene β-actin, was carried out on purified EpCAM-1+ thymic epithelial cells 
isolated by MoFlo sorting from the indicated stages of gestation (F).  PCRs were carried out 
in triplicate and error bars indicate the standard error of the mean.  Data representative of at 
least two distinct sorting experiments.  
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expression was analysed at all indicated stages of gestation (figure 3.5A-E).  In contrast to the 
large population of CD205+ cTECs observed in 7 day FTOCs (figure 3.4E and 3.5E) a small 
but detectable population of CD205+ cTECs was observed at E12 (figure 3.5A).  This 
population increased in frequency throughout ontogeny.  In contrast to a mature thymus, 
TECs at both E12 and E13 initially emerged as CD40-.  However, at E14 and E15 an 
emergence of a small population of CD205- cells expressing high levels of CD40 was 
observed (figure 3.5C and D).  Most striking is at both E14 and E15 distinct populations of 
CD205- CD40+ and CD205+ CD40- cells were present.  At both these stages of ontogeny a 
gradual acquisition of CD40 expression by CD205+ cTECs was also observed.  By contrast, 
all mature TECs in 7 day FTOC lobes express CD40 (figure 3.5E).  Interestingly, by using 
quantitative RT-PCR on total TEC populations we observed that the appearance of the small 
CD205+ CD40- population at E12 was accompanied by expression of the cortical specific 
proteasome subunit β5T (figure 3.5F).  Expression of the β5T gene in total TECs increased at 
later developmental stages (E14 and E16).   
  Together, the above data suggests the appearance of a cortical lineage of TECs 
expressing CD205 and β5T during early embryonic thymus development, with a population 
of medullary TECs expressing high levels of CD40 appearing later in development. 
   
3.3.5 Requirement for FoxN1 During Cortical Thymic Epithelial Cell Development. 
 Nude mice have a deficiency in the FoxN1 gene, which is important for TEC 
development past the initial formation of the thymus.  The nude phenotype results in an arrest 
at the immature TEC progenitor stage preventing the differentiation to the cortical and 
medullary lineages.  Hence, nude mice lack T cells due to a non-functional thymus.  To 
determine if FoxN1 deficiency has an effect on the development of CD205+ cTECs during 
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ontogeny, thymi from nude mouse embryos were dissected at different stages of gestation 
(E12-E15) (Note: at embryonic ages 12-15 the nude thymus remains a small alymphoid 
rudiment) (figure 3.6).  Stromal cell suspensions obtained from embryonic nude thymi were 
stained for CD45, EpCAM-1, CD205 and CD40. After gating on CD45- EpCAM-1+ TECs, 
CD205 and CD40 expression was analysed and compared to age and background matched 
WT embryonic thymi (see figure 3.5A-E for representative examples of CD205 and CD40 
expression on TECs obtained from different ages of embryonic WT mice).  In contrast to a 
WT E12 thymus (figure 3.5A), CD205 expression was noticeably absent from E12 TECs 
deficient for FoxN1 (figure 3.6A) and these cells remained negative at later stages of 
development (figure 3.6B-D).  In addition, FoxN1 deficient TECs also lacked CD40 
expression.  Therefore, acquisition of CD205 and CD40 during TEC development occurs in a 
FoxN1 dependent manner. 
 Furthermore, β5T expression was measured by quantitative RT-PCR in total TECs 
from E12 nude mice and compared to total TECs from E12 WT mice (figure 3.6E).  Analysis 
showed the complete absence of β5T in the E12 nude thymus, further confirming the absence 
of a cTEC lineage in mice deficient for FoxN1.  
 
3.3.6 Genotypic Profile of Immature cTEC and mTEC Populations During Early 
Thymus Development. 
 Having identified distinct populations of CD205+ CD40- cTECs and CD205- CD40+ 
mTECs at E15, which are absent in nude mice where TEC development is perturbed, we then 
aimed to further characterise the genotype of these cells by analysing the expression of a 
panel of cTEC and mTEC associated genes by RT-PCR. Stromal cell suspensions were  
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Figure 3.6 Requirement for FoxN1 During Cortical Thymic Epithelial Cell 
Development. 
Freshly isolated nude (FoxN1 deficient) thymus lobes of the indicated ages were 
enzymatically digested to obtain cell suspensions of thymic stromal cells.  Cells were stained 
for flow cytometry for CD45, EpCAM-1, CD205 and CD45.  CD205 and CD40 expression 
on CD45- EpCAM-1+ thymic epithelial cells are shown for each stage of development (A-D).  
Percentages of cells within gated areas are indicated.  Data representative of at least three 
experiments. 
 Quantitative RT-PCR of β5T, normalised to the housekeeping gene β-actin, was 
carried out on purified EpCAM-1+ thymic epithelial cells isolated by MoFlo sorting from WT 
and nude mice at E12 of development (E).  PCRs were carried out in triplicate and error bars 
indicate the standard error of the mean.  Data representative of at least two distinct sorting 
experiments.  
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obtained from freshly dissected E15 thymus lobes.  Using immunomagnetic Dynal beads, cell 
suspensions were depleted of CD45+ haematopoietic cells to enrich for stromal cells.  Also 
using Dynal beads, populations of CD205+ and CD40+ cells were positively selected for.  
These cells were then processed for mRNA and quantitative RT-PCR was carried out for a 
variety of cTEC and mTEC specific genes (figure 3.7A-J).  Relative gene expression was 
calculated for samples normalised to the housekeeping gene β-actin. 
 The medullary specific autoimmune regulator gene AIRE was expressed only in the 
CD40+ mTEC population with minimal expression detected in the CD205+ cTEC population 
(figure 3.7A).  RANK is expressed by stromal cells and its ligand RANKL is expressed by 
both thymic and splenic lymphoid tissue inducer cells (LTi) but not thymocytes.  Signalling 
through RANK has been shown to be important for the development of AIRE+ mTECs.  In 
the present study RANK was highly expressed by CD40+ mTECs with almost undetectable 
expression in the CD205+ cTEC population (figure 3.7B).  The cTEC associated proteasome 
subunit β5T was detected in the CD205+ cTEC population but was markedly low in the 
CD40+ mTEC population (figure 3.7C).  Claudin 3 (Cld3) and 4 (Cld4) are tetraspannin 
adhesion molecules that are the main proteins that contribute to the architecture of tight 
junctions.  A recent study identified that AIRE+ mTECs are derived from a unique subset of 
progenitors that are Cld3+ and Cld4+ (Hamazaki et al., 2007).  In this study we found that both 
genes are expressed at high levels by CD40+ mTECs with minimal expression in the CD205+ 
cTEC population (figure 3.7D and E).  Cathepsins S and L are cysteine proteases that are 
differentially expressed on APCs and play key roles in MHC II presentation by aiding the 
degradation of invariant chains.  Whilst cathepsin S expression is typically found on bone 
marrow derived APCs, cathepsin L expression in the thymus is restricted to cTECs.  In this 
study we identified cathepsin S expression predominantly in the CD40+ mTECs (figure 3.7F), 
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Figure 3.7 Genotypic Profile of Immature cTEC and mTEC Populations During Early 
Thymus Development. 
 Quantitative RT-PCR was used to compare relative mRNA expression of a panel of 
thymic epithelial cell expressed genes associated with the cortical and medullary lineages (A-
J).  The relative mRNA levels, normalized to the housekeeping gene β-actin, was assessed 
from E15 CD45 depleted TECs subdivided into CD205+ cortical cells and CD205- CD40+ 
medullary cells obtained following immunomagnetic bead separation.  
 PCRs were carried out in triplicate and error bars indicate the standard error of the 
mean.  Data representative of at least two distinct sorting experiments.  
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whereas cathepsin L was most highly expressed in the CD205+ cTEC population (figure 
3.7G).  CCL19 and CCL21 are chemokines important in the later stages of T cell 
development and are chemoattractive for single positive thymocytes.  In this study both 
chemokines were highly expressed in CD40+ mTECs with almost undetectable levels in the 
CD205+ cTEC population (3.7H and I).   
Lymphotoxin β receptor (LTβR) is expressed by stromal cells and is involved in 
lymphotoxin signalling, which is important for activating cytokines and chemokines and other 
growth factors that are important in maintaining the various lymphoid microenvironments.  
Interestingly, in this study LTβR was most highly expressed by CD205+ cTECs with high 
expression also detected in the CD40+ mTECs (figure 3.7J). 
To summarise, our genotypic data suggest that the CD205+ population at E15 express 
cTEC associated genes, whereas the CD40+ population express a panel of mTEC associated 
genes.  Collectively, data discussed thus far identifies CD205+ cells at E15 as putative cTEC 
progenitors.  Further experiments were carried out in order to demonstrate this.  
 
3.3.7 Identification of a Putative Cortical Thymic Epithelial Cell Progenitor. 
 We propose that CD205+ cells in the E15 thymus represent immature cTECs that later 
differentiate into mature CD205+ cTECs.  Should this be correct, such immature and mature 
CD205+ cells should show a precursor-product relationship, which has previously been 
demonstrated during mTEC development.  Acquisition of CD40 expression by CD205+ 
cTECs correlates with an increase in thymus maturity during ontogeny (section 3.3.4).  In 
addition, MHC II expression can also be used as an indication of TEC maturity.  Therefore, to 
identify if CD205+ cTECs in an E15 thymus represent putative progenitors of more mature  
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Figure 3.8 Identification of a Putative Cortical Thymic Epithelial Cell Progenitor. 
Freshly isolated E15 WT thymus lobes and E15 lobes placed in fetal thymus organ 
culture (FTOC) for 7 days were enzymatically digested to obtain cell suspensions of thymic 
stromal cells.  Cells were stained for flow cytometry for CD45, EpCAM-1 and CD205.  CD40 
and MHC II expression on CD45- EpCAM-1+ CD205+ cells are shown for both immature 
cortical cells (A-C) and mature cortical cells (D-F).  Percentages of cells within gated areas 
are indicated.  Shaded grey areas on histograms represent the negative control.  Data 
representative of at least three experiments.  hi, high, lo, low. 
By quantitative RT-PCR the relative mRNA levels of β5T and cathepsin L, 
normalised to the housekeeping gene β-actin was measured in E15 CD45- CD205+ cortical 
cells and compared to CD45- EpCAM-1+ CD205+ cortical cells from 7d FTOC (G and H).  
PCRs were carried out in triplicate and error bars indicate the standard error of the mean.  
Data representative of at least two distinct sorting experiments.  
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CD205+ cTECs, CD40 and MHC II expression was analysed in E15 CD205+ cTECs and 
compared to mature CD205+ cTECs from 7 day FTOCS (figure 3.8).  Stromal cell 
suspensions from freshly dissected E15 lobes and organ-cultured lobes were stained for 
CD45, EpCAM-1, CD205 and either CD40 or MHC II.  CD40 or MHC II expression was 
analysed in a cTEC population defined as CD45- EpCAM-1+ CD205+ in both E15 and FTOC 
lobes (3.8A and D).  Whilst a small proportion of cTECs at E15 expressed CD40 (figure 
3.8B), mature cTECs from 7 day FTOCs were all positive for CD40 (figure 3.8E).  Similarly, 
cTECs from E15 showed a relatively heterogeneous expression of MHC II with the presence 
of cells expressing low levels of MHC II (figure 3.8C).  However, cTECs from 7 day FTOCs 
were all expressing high levels of MHC II with a notable reduction in the proportion of cells 
expressing low levels of MHC II (figure 3.8F).  
 We subsequently compared expression of the cTEC associated genes β5T and 
cathepsin L in CD205+ cells sorted from both E15 and 7 day FTOC lobes.  Quantitative RT-
PCR analysis showed that mature CD205+ cTECs from 7 day FTOCs expressed higher levels 
of both genes compared to immature CD205+ cTECs from E15 lobes (figure 3.8G and H). 
Collectively, the data presented above confirms that CD205+ cells at E15 are 
immature cTEC progenitors that increase in maturity to become mature CD205+ cTECs 
expressing high levels of CD40, MHC II, β5T and cathepsin L.  
 
3.3.8 Induction of MHC II Expression and Proliferative Status Define Distinct Stages 
During cTEC Development. 
 As described above, the acquisition of MHC molecules during TEC development is 
indicative of their maturity and is essential for their ability to mediate positive selection of the 
developing TCR repertoire.  Hence, MHC II expression has previously been used to identify 
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precursor-product relationships within the mTEC lineage (Gray et al., 2006).  However, in the 
context of cTEC development changes in MHC II expression are unclear.  To investigate this, 
MHC II expression was measured in developing TEC populations at E15 (3.9B-E) and 
compared to mature TECs in FTOCs (figure 3.9K and L).  In contrast to the uniform high 
levels of MHC II in mature CD205+ cTECs in 7d FTOC (figure 3.9K), CD205- CD40- TECs 
at E15 are largely negative for MHC II (figure 3.9B).  However, CD205+ CD40- cTECs 
display heterogeneity with regard to their MHC II expression with the presence of an MHC II-
/low subset still evident (figure 3.9C).  Following the up-regulation of CD40 expression, the 
CD205+ cTECs become predominantly MHC II+ (figure 3.9D).  Interestingly, this data also 
suggests that MHC II induction occurs prior to CD40 expression.   
 TECs are known to undergo phases of proliferation during their development to aid 
their expansion (Gray et al., 2006; Jenkinson et al., 2003) but how this relates to the 
development of the cTEC lineage is unknown.  In order to investigate this, freshly isolated 
E15 thymus lobes and E15 thymus lobes placed in FTOC for 7 days were pulsed with BrdU 
overnight.  Incorporation of BrdU in dividing cells was measured by flow cytometry in 
developing TEC populations at E15 (figure 3.9F-I) and compared to mature TECs in FTOCs 
(figure 3.9M and N).  Analysis of the proliferative status of the different TEC subsets at E15 
showed that the majority of CD205- CD40- TECs incorporate BrdU suggesting that these cells 
are highly proliferating (figure 3.9F).  Acquisition of CD205 and then CD40 expression 
correlated with a decline in the proliferative status of these cells (figure 3.9G and H).  In 
marked contrast, mature CD205+ CD40+ cells in 7 day FTOCs do not incorporate BrdU and 
so indicates that these cells are quiescent non-dividing cells (figure 3.9M).  
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Figure 3.9 MHC II Expression and Proliferative Status Defines Distinct Stages During 
Cortical Thymic Epithelial Cell Development. 
Freshly isolated E15 WT thymus lobes and E15 lobes placed in FTOC for 7 days were 
enzymatically digested to obtain cell suspensions of thymic stromal cells.  MHC II expression 
(B-E, K and L) and BrdU incorporation (F-I, M and N) was analysed in CD45- EpCAM-1+ 
TECs subdivided on the basis of CD205 and CD40 expression in E15 (A) and 7d FTOC (J) 
lobes.  Histograms shown are generated by gating on CD40 and CD205 subsets of EpCAM-1+ 
TECs depleted of CD45+ cells using magnetic beads prior to staining.  Shaded grey areas 
represent the negative controls and numbers in histograms indicate percentage of cells within 
the gates.  Data representative of at least three separate experiments.   
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MHC II expression and BrdU incorporation was also measured in the CD205- CD40+ 
immature and mature mTEC population at E15 and in 7d FTOC lobes respectively.  
Interestingly, whilst we show that immature CD205- CD40+ mTECs are rapidly proliferating 
as illustrated by the high incorporation of BrdU (figure 3.9I), a majority of these cells are 
expressing high levels of MHC II (figure 3.9E).  Whilst the more mature CD205- CD40+ 
mTECs from cultured lobes have retained their high levels of MHC II (figure 3.9L), they have 
lost their proliferative capabilities as indicated by their lack of BrdU incorporation (figure 
3.9N).   
To summarise, the above data thus demonstrates that the sequential acquisition of 
CD205 and CD40 during cTEC development correlates with a decline in proliferation as 
indicated by BrdU incorporation and also an increase in maturity as indicated by MHC II 
expression.    
 
3.3.9 Thymocytes Are Required For Induction of CD40 Expression On Thymic 
Epithelial Cells.  
Lymphostromal interactions are important in the maintenance of thymic 
microenvironments via a process of thymic crosstalk.   Therefore, we aimed to determine if 
the absence of thymocytes affects the expression of CD205 and CD40 on TECs by 
investigating the development of these cells in mice with blocks in thymocyte development at 
different stages.  CD205 and CD40 expression on TECs was analysed in RAG1-/- mice where 
thymocyte development is blocked at the double negative 3 (DN3) stage due to an absence of 
TCR gene rearrangement.  We also analysed TEC development in CD3εtg26 mice, which via 
an unknown mechanism, display a block at the very earliest stage of thymocyte development 
(DN1) (Wang et al., 1995). 
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Figure 3.10 Thymocytes Are Required For Induction of CD40 Expression On Thymic 
Epithelial Cells. 
 Freshly isolated E15 thymus lobes and E15 lobes placed in fetal thymus organ culture 
(FTOC) for 7 days from WT, RAG1-/- and CD3εtg26 mice were enzymatically digested to 
obtain cell suspensions of thymic stromal cells.  7d FTOCs supplemented with 2-
deoxyguanisine (2-dGuo) to eliminate lymphoid cells were also analysed.  CD205 and CD40 
expression was analysed in CD45- EpCAM-1+ TECs (A-G).  Percentages of cells within gated 
areas are indicated.  Data representative of at least three experiments.   
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To assess the contribution of thymocytes to the development of mature cTEC and mTECs, 7d 
FTOC lobes were treated with 2-deoxyguanisine (2-dguo), which selectively eliminates all 
lymphoid cells (figure 3.10E).   CD205 and CD40 expression on CD45- EpCAM-1+ TECs 
was measured and data reveals that whilst CD205 levels are relatively normal compared to 7d 
FTOC cultured in the absence of 2-dguo (figure 3.10D), CD40 levels are low. 
At E15, proportions of CD205+ CD40- cTECs were normal in RAG1-/- (figure 3.10B) 
mice and higher in CD3εtg26 mice (figure 3.10C) compared to a WT (3.10A).  However, 
whilst RAG1-/- mice show a relatively normal level of expression of CD40, there was a 
marked reduction of TECs expressing CD40 in CD3εtg26 mice.  In contrast to WT 7 day 
FTOCS (figure 3.10D), E15 RAG1-/- 7 day FTOC lobes showed a slight decrease in CD40 
expression on TECs with the presence of a small population of CD40- cells (figure 3.10F). 
E15 CD3εtg26 7 day FTOC lobes showed a much larger decrease in TECs expressing CD40 
with the presence of a large population of CD40- cells (figure 3.10G).  
 
 
3.3.10 Stage Specific Requirement for Thymocyte Crosstalk During Later Stages of 
cTEC Development.  
 As illustrated in section 3.3.9, thymocytes are important during TEC development. 
However, with regard to the development of the cortex, the precise thymocyte subsets and the 
stages of cTEC development they regulate are unclear.  Therefore, we aimed to further 
analyse cTEC development in mutant mice in which thymocyte development is blocked at 
different stages (figure 3.11).  Stromal cell suspensions were obtained from E15 background 
matched WT, RAG1-/- and CD3εtg26 mice and analysed for CD45, EpCAM, CD205 and 
either CD40 or MHC II expression and BrdU incorporation.  Levels of CD40, MHC II and 
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BrdU incorporation were measured in the cTEC population defined as CD45- EpCAM-1+ 
CD205+.  By comparison to E15 WT, EpCAM-1+ CD205+ cTECs are present in both E15 
RAG1-/- and CD3εtg26 mice at similar proportions (figure 3.11A-C).  However, whilst 
EpCAM-1+ CD205+ cTECs from E15 RAG1-/- mice show further evidence of maturation as 
demonstrated by the similar levels of CD40 and MHC II expression compared to WT (figure 
3.11E and H), EpCAM1+ CD205+ cTECs from E15 CD3εtg26 mice show a dramatic absence 
of cells expressing both CD40 and MHC II (figure 3.11F and I).  This data suggests that 
whilst the initial stages of cTEC development occur independently of thymocytes, the 
presence of DN1-DN3 cells are essential for further maturation of CD205+ cTEC. 
 Proliferative status of EpCAM1+ CD205+ cTECs was also analysed in both mutant 
mice and interestingly the presence of thymocytes are not required for the proliferation of 
these cells as indicated by the incorporation of BrdU, albeit at lower levels compared to WT 
(figure 3.11J-L). 
 
3.4 Discussion. 
The development of cTECs is an essential step in the formation of a functional thymic 
microenvironment capable of supporting early stages of T cell development and positive 
selection of developing thymocytes. cTECs derive from common bTECs, which are known to 
also give rise to TEC cells of the medullary lineage (Rossi et al., 2006).  By contrast to the 
advances made with regard to mTEC development (as outlined in section 1.3.6), mechanisms 
and stages of bTEC differentiation into cTECs have not previously been identified.  
Therefore, the aim of this chapter was to characterise cTEC development 
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Figure 3.11 Requirement for thymocyte crosstalk during later stages of cortical thymic 
epithelial cell development. 
Freshly isolated E15 thymus lobes from WT, RAG1-/- and CD3εtg26 mice were 
enzymatically digested to obtain cell suspensions of thymic stromal cells.  CD40 and MHC II 
expression and BrdU incorporation was measured in gated CD45- EpCAM-1+ CD205+ cortical 
cells (A-C).  Histograms (D-L) shown are generated by gating on EpCAM-1+ CD205+ cTECs 
depleted of CD45+ cells using magnetic beads prior to staining.  Shaded grey areas represent 
the negative controls and numbers in histograms indicate percentage of cells within the gates.  
Data representative of at least three separate experiments. 
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downstream of bipotent progenitors and to identify molecular and cellular regulators of this 
pathway.  Based on the data presented in this chapter, we now propose a new model of cTEC 
development as well as providing novel evidence for the existence of a cTEC progenitor 
(figure 3.12 summarises the data presented in this chapter as a proposed model of cTEC 
development). 
In our study we used the endocytic receptor CD205 to identify cells of the cortical 
lineage.  CD205 is also expressed by DCs, which shares a common feature with cTECs in 
their ability to present MHC-bound peptides to T cells.  However, by contrast to DCs, instead 
of inducing T cell activation or negative selection, cTECs induce positive selection.  
Expression of CD205 by cTECs reflects their functional specialisation as efficient mediators 
of positive selection.  By employing an ontogenetic approach, we have identified a previously 
unreported population of cortical epithelial cells expressing CD205 in the early embryo.  
These CD205+ cTECs in the early embryo differ from more mature CD205+ cTECs with 
regard to their expression of the co-stimulatory molecule CD40 and MHC II.  Moreover, these 
immature CD205+ cortical cells in the early embryo have lower levels of expression of the 
cortical associated genes β5T and cathepsin L and are highly enriched for proliferating cells.  
These findings provide convincing evidence for a possible precursor-product relationship 
where mature CD205+ cTECs develop from immature CD205+ cTECs.  Herein, we propose 
that CD205+ cells in the early embryo represent a cTEC progenitor population that develops 
downstream of bTEC progenitors and later develops into mature cTECs.  
It was previously thought that at day 12 of embryonic gestation, TEC cells are 
homogenous and mostly represent cells at the bipotent stage of development, which have not 
yet differentiated towards a cTEC and mTEC lineage (Klug et al., 2002; Rossi et al., 2006).  
Interestingly, in our ontogeny experiment we observed the presence of CD205+ cTECs at E12 
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of development, which correlated with the expression of β5T, thereby reflecting heterogeneity 
at this early stage of thymus development.  Moreover, preliminary experiments in our lab 
have demonstrated further heterogeneity with regard to expression of the cTEC marker ly51 
with the presence of a population of Ly51+ CD205- and Ly51- CD205+ cells (data not shown).  
Collectively, this data implies that the cTEC lineage appears during thymus ontogeny earlier 
than previously thought.  Experiments are currently underway in our lab to investigate if the 
appearance of the cTEC lineage occurs before E12 by dissecting out the pharyngeal pouch, 
containing the thymus rudiment, from E11 FoxN1-GFP transgenic mice and looking for 
CD205 expression.   
We have also demonstrated that the initial appearance of CD205+ cTECs expressing 
β5T at E12 occurs in a FoxN1 dependent manner.  Nude mice, which have a deficiency in the 
FoxN1 gene, displayed a notable absence of the cTEC lineage at E12 and this remained 
through to E15.  This finding confirms the notion that FoxN1 deficient TECs are likely to 
represent bTECs that are unable to differentiate into the cortical and medullary lineages 
(Bleul et al., 2006). 
Whilst a normal programme of T cell development is thought to play a role in cTEC 
development (Hollander et al., 2006), it was previously unclear which thymocyte subsets are 
involved and the stages of cTEC development they regulate.  Our findings demonstrate for the 
first time the stage specific requirement for thymocyte crosstalk.  In our study we used 
CD3εtg26 mice, which due to over-expression of human CD3ε gene, have a block at the 
earliest stage in T cell development (CD4- CD8- CD44+ CD25-, DN1) (Hollander et al., 1995).  
Previous studies have shown that these mice have a small thymus with severe abnormalities in 
cortical and medullary development and organisation and a poor demarcation between these 
two regions (Hollander et al., 1995; Wang et al., 1994; Wang et al., 1995).  In our study we 
 133 
also looked at RAG1 deficient mice where T cell development proceeds to a later stage (CD4- 
CD8- CD44- CD25+, DN3).  It has previously been shown that the thymus in these mice show 
a relatively well developed cortex but abnormal medullary architecture (Wang et al., 1995).  
In the present study we demonstrate that thymocyte derived signals are not required for the 
initial development of the cortex, as illustrated by the normal expression of CD205+ cells in 
mice with perturbed thymocyte development (both RAG1-/- and CD3εtg26 mice) and this is in 
line with previous reports that cTEC development can occur in the absence of a normal 
programme of T cell development (Gray et al., 2006).  However, further analysis of the 
CD205+ population revealed that DN1-DN3 thymocytes are required for the further 
maturation and/or maintenance of cTECs as defined by the lack of CD40 and MHC II 
expression in mice with a block at the earliest stage of T cell development (CD3εtg26 mice).  
However, it is interesting to note that TECs were still able to undergo proliferation, although 
to a lesser extent than WT, suggesting a normal programme of T cell development is not 
essential for the proliferation of developing cTECs.  It is currently unclear precisely how DN 
thymocytes may influence cTEC development.  However, it is known that DN cells play a 
role in cTEC remodelling and for the formation of the typical three-dimensional reticular 
arrangement of cTECs (van Ewijk et al., 2000).   
The failure of CD3εtg26 mice, to acquire CD40 expression on the cortical CD205+ 
cells and the small proportion of CD40+ medullary cells in the early thymus and organ 
cultured thymus of these mice demonstrates the importance of thymocyte derived signals in 
CD40 expression. CD40 belongs to a family of TNF receptors and signals via the NFκB 
pathway to mediate mTEC development (Gray et al., 2006).  CD40 binds to CD40L 
expressed by single positive CD4 (SP4) thymocytes, which induce signals for mTEC 
development by possibly regulating AIRE+ mTEC turnover and/or survival (White et al., 
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2008). Whilst our study shows that CD40 is induced on cTECs and thymocyte derived signals 
are important for this, it is not clear what role CD40 signalling has in the cortex with no 
previous reports of severe cTEC abnormalities in CD40-/- mice having been identified so far 
(Akiyama et al., 2008).  
This study also demonstrates for the first time that different stages during cTEC 
development have different proliferative capacities.  Progenitor populations rely on their 
proliferation for their maintenance and phenotypic differentiation.    Immature CD205+ 
cTECs are a rapidly proliferating population of cells, whereas more mature CD205+ cTECs do 
not have any proliferative capacity.  Whilst we show that TEC proliferation is thymocyte 
independent, it is currently unclear what is regulating this proliferation.  However, 
mesenchyme could be a likely candidate as studies have shown that these cells provide 
fibroblast growth factors such as FGF7 and 10 to induce proliferation of TECs at E12 of 
development (Jenkinson et al., 2003). 
In summary, the data presented in this chapter defines stages in cTEC development 
and identifies important checkpoints in the development of the cortical lineage.  This data 
should help in understanding how these cells become specialised in their ability to support 
positive selection. 
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Figure 3.12 A New Model of Cortical Thymic Epithelial Cell Development. 
Figure summarises data presented in this chapter to provide a new model of cortical 
thymic epithelial cell (cTEC) development where a bipotent thymic epithelial cell (bTEC) 
develops into a mature cTEC via cTEC progenitor populations expressing CD205.   
Circular arrows indicate levels of proliferation.  Red and orange arrows indicates 
requirement for FoxN1 and thymocytes respectively.  Also indicated is the increase in 
expression of cTEC genes through cTEC development. 
Imm, immature, mat, mature.  
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4.1 Introduction. 
Intra-thymic development of T cells is highly stringent and is defined by the migration 
of developing thymocytes through discrete regions of the thymus where immature T cell 
precursors receive signals from thymic stromal cells for differentiation, survival and selection.  
The stratified positioning of thymocyte subsets within the thymus forms distinct and 
specialised thymic microenvironments.  The localisation of double positive (DP) thymocytes 
in the cortex is essential to support positive selection of developing thymocytes via their low 
affinity interactions with self-peptide/MHC complexes presented by cortical thymic epithelial 
cells (cTECs) (Anderson and Jenkinson, 2001).  By contrast, migration and localisation of 
single positive (SP) thymocytes to the medulla is necessary to support the later stages of T 
cell development where potentially auto-reactive T cells are deleted via a process of negative 
selection mediated at least in part by medullary thymic epithelial cells (mTECs) (Takahama, 
2006).  Despite these clearly defined roles for thymocyte localisation to the cortex and 
medulla, the importance of the subcapsular zone (SCZ) during T cell development is yet to be 
fully defined.  The SCZ is the region that lies directly adjacent to the capsule and is known to 
house developing thymocytes at the double negative 3 (DN3) stage of development (defined 
as CD4- CD8- CD25+ CD44-) (Lind et al., 2001).  This region provides a suitable 
microenvironment to support proliferation of DN cells emerging from β-selection and 
transition to the DP stage of T cell development.  
The signals that establish the formation of the SCZ and other thymic 
microenvironments are yet to be fully characterised.  Many studies have now reported that 
chemokines play a role in directing the intra-thymic trafficking of thymocytes through the 
SCZ, cortex and medulla (Takahama, 2006).  Studies on mice deficient for certain 
chemokine-chemokine receptor pairs reveal perturbed thymocyte migration as a result.  In 
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particular, CXCL12 and its receptor CXCR4 has been identified as essential for the proper 
localisation of DN cells in the cortex (Plotkin et al., 2003).  Similarly, CCL25 and its receptor 
CCR9 are known to be important for the localisation of DN3 cells to the SCZ (Benz et al., 
2004).  However, later stages of T cell development are known to involve CCL19 and CCL21 
signalling via their receptor CCR7 and this has been identified as essential for cortex to 
medulla migration of developing thymocytes (Ueno et al., 2004).  
For cells to chemotax, they must first acquire a polarised morphology to form a 
leading lamellipodium and this requires a complex intracellular signalling cascade (Reif and 
Cyster, 2002).  Chemokine receptors signal via heterotrimeric G-protein-coupled receptors.  
When chemokines bind to their receptors, a variety of signalling pathways are initiated that 
activate the Rho family of GTPases, in particular Rac, to drive membrane polarisation and 
cytoskeletal changes, essential for cell migration (Kunisaki et al., 2006).  The Rac protein is a 
key regulator of cell motility by controlling F actin polymerisation and lamellipodia formation 
(Nombela-Arrieta et al., 2007).  DOCK2 (dedicator of cytokinesis 2) is a novel member of the 
CDM family of scaffold proteins (Reif and Cyster, 2002).  DOCK2 is a haematopoietic cell 
specific protein that functions as a guanine exchange factor for Rac and is a central regulator 
of chemokine-mediated Rac-activation and cytoskeletal reorganisation in lymphocytes, 
neutrophils and a small fraction of DCs (Fukui et al., 2001; Gotoh et al., 2008; Kunisaki et al., 
2006).  However, there is evidence to suggest that phosphoinositide-3-kinase (PI3K) isoforms 
are involved in DOCK2 independent chemokine-induced migration (Nombela-Arrieta et al., 
2004).  Figure 4.1 represents a simplified scheme for the role of DOCK2 during chemokine-
induced lymphocyte migration. 
In the absence of DOCK2, chemokine induced F actin polymerisation and short-term 
homing are disrupted in T and B cells (Nombela-Arrieta et al, 2007).  It has also been 
reported that mice deficient in DOCK2 exhibit impaired T lymphocyte migration in response 
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to several homeostatic chemokines including CXCL12, CCL19 and CCL21 (Fukui et al., 
2001; Gotoh et al., 2008; Shulman et al., 2006), indicating a role for DOCK2 downstream of 
chemokine receptor signalling.  This defect is manifested in the secondary lymphoid organs, 
which have abnormal architectures in DOCK2-/- mice (Fukui et al., 2001).  These mice exhibit 
severe atrophy in T and B cell areas in all secondary lymphoid organs due to defective 
homing of DOCK2-/- lymphocytes to the spleen and lymph nodes.  It has also been shown that 
the number of splenocytes and CD4+ T cells in the lymph nodes and thymus were markedly 
reduced in DOCK2-/- mice (Fukui et al., 2001).  Interestingly, this study also reported that SP4 
and SP8 cells were abnormally distributed throughout the thymic cortex as small patches.  
Whilst the phenotype of DOCK2-/- mice has been relatively well studied with relation to the 
secondary lymphoid organs, the precise role of DOCK2 in the thymus is yet to be fully 
characterised.  Furthermore, previous studies have not analysed the nature of the SCZ in 
DOCK2-/- mice.  Thus, due to the importance of DOCK2 as a central regulator of chemokine 
induced lymphocyte migration, it was of interest in this study to investigate the role of 
DOCK2 during T cell development and establishment of thymic microenvironments.   
Therefore, the aims and objectives of this chapter are as follows; 
• To study the establishment of thymic microenvironments with particular emphasis on 
the SCZ. 
• To employ a method to study the thymic anatomical compartmentalisation of 
chemokines known to be important during T cell development. 
• To study the requirement for DOCK2 during T cell development and organisation of 
thymic microenvironments with a view to further understand chemokine-induced 
migration of thymocytes and their role in the establishment of thymic 
microenvironments. 
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Figure 4.1 A Schematic Representation of the Role for DOCK2 During Chemokine 
Induced Lymphocyte Migration. 
 Secreted chemokine binds to G protein coupled chemokine receptors on the surface of 
lymphocytes initiating a chemokine-signalling cascade that activates Rac.  A 
phosphatidylinositol-3-OH kinase (PI3K) dependent pathway exists along with a PI3K 
independent DOCK2 pathway.  DOCK2 functions downstream of chemokine-chemokine 
receptor engagement to activate Rac, which subsequently initiates cell polarisation, actin 
cytoskeletal rearrangements and lamellipodia formation essential for cell migration.  For 
simplicity, potential intermediates in the signalling pathways are not shown.  
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4.2 Specialised Materials and Methods. 
4.2.1 Laser Capture Microdissection.  
 In order to study the anatomical compartmentalisation of chemokines within the 
thymus, a laser capture microdissection (LCM) technique was employed.  This technique 
avoids the technical difficulties sometimes associated with measuring chemokine expression 
by conventional methods such as flow cytometry and confocal microscopy.  Therefore, LCM 
is a more useful technique, which allows for the investigation of gene expression within 
specified areas of tissue.   
Figure 4.2 summarises the overall process of LCM. 5µm thick sections of frozen adult 
thymus were cut and mounted onto membrane covered nuclease free slides (PALM).  Slides 
were allowed to dry for 30 minutes before fixation in acetone (Baker) for 20 minutes.  
Following fixation, slides were stored at -79°C until required.  Slides were removed from -
79°C and allowed to air dry for 1 minute before staining.  In order to visualise the tissue 
sections and identify regions, slides were stained with the nuclear dye cresyl violet (figure 
4.2A).  Cresyl violet-stained thymus sections identifies cortical areas as a darker violet 
compared to the medulla.  The cresyl violet solution was prepared by dissolving the cresyl 
violet acetate powder (Sigma) in absolute molecular biology grade ethanol (Sigma) at a 1% 
W/V ratio.  This was then placed on a rotor and allowed to dissolve overnight.  After the 
overnight incubation, the cresyl violet solution was filtered to remove any precipitate.  Prior 
to staining, slides were dipped sequentially into 100, 70 and 50% solutions of absolute 
molecular biology grade ethanol.  Slides were immediately stained with the cresyl violet 
solution for approximately 6 minutes.  Slides were then washed by sequential dipping in the 
ethanol solutions in the reverse order (i.e. 50, 70 and 100%).  All dilutions of ethanol were 
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prepared in BPC grade water (Sigma).  Slides were left to air dry for 1 minute before 
microdissection.  All equipment and solutions were kept RNase free and incubations were 
kept to a minimum to ensure negligible RNA degradation.  
Using a laser microdissecting microscope Microbeam HT (Palm Microlaser 
Technologies, Bernried, Germany) sections of subcapsular, cortical and medullary areas were 
microdissected.  Using the microscope software, circles or boxes (sizes of which were kept 
consistent throughout) were drawn within cortical and medullary regions (figure 4.2B).  For 
the SCZ, boxes (sizes of which were kept consistent throughout) were drawn in the 
approximated region directly beneath and including the capsule.  This allows for the precise 
identification and isolation of these specific areas of interest with negligible contamination 
from adjacent cells. Microdissected sections were transferred by laser pressure catapulting 
into the caps of 0.5ml RNase free eppendorffs containing 9µl of lysis buffer (figure 4.2C).  
Multiple sections (approximately 30) were microdissected from each region of interest and 
pooled into three separate tubes.  As a positive control, approximately 10 sections of equal 
size were microdissected from each region and pooled into one tube (mix sample).  Following 
microdissection, tubes were microfuged in a temperature controlled microfuge at 4°C to allow 
the lysis buffer containing the dissected tissue sections to transfer from the cap of the tube to 
the bottom.  Tubes were stored at -79°C before mRNA extraction.  Quantitative RT-PCRs 
were carried out in collaboration with S. Parnell, University of Birmingham (as detailed in 
section 2.8).  Ct values were normally obtained using standard curves from cDNA from 
FTOCs.  Relative expression values for samples normalised to β-actin were obtained.    
4.2.2 Statistical Analysis. 
All data was analysed by using the unpaired student t test using GraphPad software.  P 
values below 0.05 were considered significant. 
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Figure 4.2 Laser Capture Microdissection.  
 Cresyl violet stained sections of adult WT thymus reveals the cortex as a darker violet 
compared to the medulla (A). Using the LCM software, boxes were drawn around the 
approximated region of the subcapsular zone (SCZ) and within the cortex and medulla (B).  
These areas were then microdissected and transferred to separate tubes by laser pressure 
catapulting (C).  As a positive control, microdissected sections from each region were pooled 
into one tube (mix). 
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4.3 Results. 
4.3.1 Thymocyte Subsets Are Localised in Defined Regions of the Adult Thymus. 
To identify the anatomical location of the different thymocyte subsets, thymus 
sections from a 4-6 week old mouse was stained for confocal microscopy analysis for CD25 
to allow for identification of DN cells (CD25 is expressed on both DN2 and DN3 subsets) and 
CD4 and CD8 to allow for identification of DP and SP cells.  Defined regions of subcapsular, 
cortex and medulla containing thymocytes at different stages of development were identified 
(figure 4.3A-C).  The thymus has a subcapsular zone, the area directly beneath the capsule, 
containing DN thymocytes that tend to be at the DN3 stage of development, as identified by 
the expression of CD25 (figure 4.3A).  The cortex provides an environment for DP 
thymocytes, as identified by expression of both CD4 and CD8 (figure 4.3A).  The medulla 
constitutes thymocytes at the SP stage of development.  I.e. mature CD4+ CD8- or CD4- CD8+ 
cells (figure 4.3B and C).  Cortical and medullary regions were identified on the basis of 
DAPI staining (not shown).   
 
4.3.2 The Emergence of the Subcapsular Zone During Thymus Ontogeny. 
 Due to the importance of the SCZ for supporting localisation of DN3 cells, which are 
defined as CD4- CD8- CD25+ CD44-, we aimed to identify the emergence of this region 
during thymus ontogeny.  Sections of thymus dissected from embryos at day 14, 16 and 18, a 
day 1 neonate and a 4-6 week old adult were stained for CD25, CD4 and CD8 for confocal 
microscopy analysis (figure 4.4).  At E14 and E16, there is a distinct absence of CD4 and 
CD8 expressing cells (figure 4.4A and B).  
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Figure 4.3 Thymocyte Subsets Are Localised in Defined Regions of the Adult Thymus. 
Frozen thymus sections from a 4-6 week old WT mouse was stained for CD25 
(identifies double negative thymocytes) and CD4 and CD8 (identifies double positive and 
single positive thymocytes) (4.3A-C).   
The solid line denotes the edge of the tissue, the dotted line denotes the approximated 
region of the subcapsular zone and the dashed line represents the corticomedullary junction.  
Bar indicates scale of 50µm.  SCZ, subcapsular zone, C, cortex, M, medulla.  
 
  
 
 149 
 
 
  
 
 150 
At these stages of thymus development, the thymus constitutes thymocytes at the DN stage of 
development with the CD25+ cells scattered throughout the thymus.  However, by E18 the 
appearance of CD4+ CD8+ (DP) cells was identified (figure 4.4C).  Most striking was the 
observation that the CD25+ DN cells are beginning to migrate outwards towards the capsule 
forming an elementary SCZ microenvironment where the DP cells were typically absent 
(figure 4.4D).  A day 0 thymus mostly constitutes DP cells located in the cortex and an 
appearance of small medullary patches containing CD4+ CD8- (SP4) and CD4- CD8+ (SP8) 
cells were also observed (figure 4.4E).  A clearly defined SCZ has now formed providing a 
microenvironment for the CD25+ DN3 cells to localise (figure 4.4F).  It is particularly 
interesting to note that similar to E18, DP cells remain largely absent from the SCZ, which 
mostly constitutes CD25+ DN3 cells.  This pattern of DN3 localisation to the SCZ does not 
remain as conserved in the adult thymus (figure 4.4G and H).  In contrast to E18 and day 0, 
the SCZ in the adult is not as clearly defined and appears to occupy a smaller fraction of the 
thymus.  In further contrast to E18 and day 0, DP cells were observed in this region along 
with the CD25+ DN3 cells. 
 
4.3.3 Laser Capture Microdissection as a Method to Study Gene Expression Within 
Specified Areas of the Thymus. 
 Thus far we have established that distinct microenvironments are present within the 
thymus and that these regions develop during ontogeny.  To investigate the role of 
chemokines in organising thymic microenvironments, a laser capture microdissection (LCM) 
technique was employed. To evaluate the effectiveness of using LCM to study gene 
expression within specified areas of the thymus, we initially looked at the expression of the 
autoimmune regulator gene (AIRE) within microdissected regions of SCZ, cortex and  
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Figure 4.4 The Emergence of The Subcapsular Zone During Thymus Ontogeny. 
 Frozen sections of WT thymus dissected from mice at the indicated ages of 
development were stained for CD25, CD4 and CD8.  Distribution of thymocytes at different 
stages of T cell development is shown as defined by the differential expression of the above 
markers (A-H).   
 Low power (A-C, E and G) and high power images are shown (D, F, H). The solid line 
denotes the edge of the tissue, the dotted line is the approximated region of subcapsular zone 
and the dashed line represents the corticomedullary junction. Bar indicates scale of 50µm. 
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medulla (figure 4.5).  As illustrated in figure 4.5A, AIRE is exclusively expressed in the 
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medullary region of the thymus (usually associated with keratin 5+ mTECs) and not the 
cortex.  To confirm this by LCM, dissected regions of SCZ, cortex and medulla of the thymus 
were converted to cDNA and the expression of AIRE was examined by quantitative RT-PCR. 
A mix sample containing pooled sections from all regions was used as a positive control.  
Relative gene expression was calculated for samples normalised to the housekeeping gene β-
actin.  As expected, AIRE expression was found in the positive control mix sample and in the 
medulla, with undetectable expression levels in the SCZ and cortex (figure 4.5B).  
 
4.3.4 Distinct Regions of the Thymus Reveal Differential Gene Expression Patterns of 
Chemokines. 
 Section 4.3.3 establishes the success of LCM as a method for studying gene expression 
in various thymus areas.  This technique was then employed to determine niche specific 
expression of chemokines and chemokine receptors that are known to be important during T 
cell development.  Quantitative RT-PCR was carried out on cDNA obtained from laser 
microdissected areas of SCZ, cortex and medulla from adult thymus (6-8 weeks old). A mix 
sample containing pooled sections from all regions was used as a positive control.  Relative 
gene expression was calculated for samples normalised to β-actin.   Data was initially 
obtained by semi-quantitative PCR (data not shown) before confirmation by quantitative RT-
PCR.   
 CCL25 (TECK) has previously been known to act on immature DP cells and mature SP 
cells.  In the present study CCL25 was found to be located throughout the thymus but most 
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Figure 4.5 Laser Capture Microdissection as a Method to Study Gene Expression 
Within Specified Areas of the Thymus. 
 Frozen sections of adult thymus were stained for the medullary specific epithelial cell 
marker keratin 5 and the autoimmune regulator AIRE for confocal analysis (A).   
 Scale of image is indicated.  C, cortex, M, medulla.  Image courtesy of S. Rossi, 
University of Birmingham.   
 Quantitative RT-PCR was carried out on cDNA obtained from laser microdissected 
areas of subcapsular zone (SCZ), cortex and medulla to determine AIRE expression in each of 
the areas.  Relative mRNA expression of AIRE normalised to β-actin is shown (B).  PCRs 
were carried out in duplicates and error bars indicate the standard error of the mean.  Data 
representative of two distinct experiments. 
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interestingly was predominantly expressed in the SCZ (figure 4.6A).  The receptor for CCL25 
is CCR9 and expression of which was highest in the cortex and SCZ with minimal levels 
found in the medulla (figure 4.6B).  CXCL12 (SDF-1) preferentially attracts DN cells and DP 
cells and its receptor CXCR4 is known to be highly expressed in these cells.  Interestingly, in 
this study CXCL12 was expressed predominantly in the SCZ, with minimal expression levels 
in the cortex and medulla (figure 4.6C).  Similarly, expression of the receptor for CXCL12, 
CXCR4 was highest in the SCZ but also the cortex (figure 4.6D).  Low levels of expression 
were found in the medulla.  By contrast to the expression of CCL25, CXCL12 and their 
respective receptors, the expression patterns of the chemokines CCL19 and CCL21 were 
much different.  Both chemokines have been reported to be important in the later stages of T 
cell development and are chemoattractive for SP thymocytes (Ueno et al., 2004).  In line with 
this, we confirmed that CCL19 and CCL21 were present exclusively in the medulla with 
almost undetectable levels in the SCZ and cortex (figure 4.6E and F).  By comparison, 
expression of the receptor for both CCL19 and CCL21, CCR7 was predominant in the 
medulla, with low-level expression in the cortex and undetectable expression levels in the 
SCZ (figure 4.6G).     
 To summarise, data presented in this section confirms that chemokine-chemokine 
receptors associated with particular stages of T cell development are expressed in defined 
regions of the thymus. 
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Figure 4.6 Distinct Regions of the Thymus Reveal Differential Gene Expression Patterns 
of Chemokines. 
 Subcapsular, cortical and medullary regions were laser microdissected from frozen 
sections of WT adult thymus (6-8 weeks old).  As a positive control, microdissected sections 
from all regions were pooled into a single tube (mix).   
 Quantitative RT-PCR was carried out for the indicated chemokines and their receptors.  
Relative mRNA expression of indicated chemokine/chemokine receptors normalised to β-
actin is shown (A-G).   
 PCRs were carried out in duplicate and error bars indicate standard error of the mean.  
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4.3.5 Abnormal Localisation of Double Positive Thymocytes to the Subcapsular Zone in 
CCR9-/- Neonatal Mice. 
 So far we have demonstrated that thymocytes at different stages of T cell development 
occupy different areas of the thymus and these areas constitute specific chemokine 
distribution.  Therefore, with regard to the SCZ we were interested in whether deficiency in 
chemokines could result in perturbed localisation of thymocytes to the SCZ.  In particular, we 
studied mice deficient for CCR9.  A previous study has demonstrated that CCR9-/- adult mice 
have abnormal distribution of CD25+ DN3 cells, away from the SCZ (Benz et al., 2004).  We 
aimed to extend this study by looking to see if deficiency in CCR9 also leads to perturbed DP 
cell distribution in the SCZ of both adult and neonatal mice.  Thymus sections from 2 week 
old and a day 0 (day of birth) WT and CCR9-/- mice were stained for confocal microscopy 
analysis for CD25, CD4 and CD8 (figure 4.7).  As illustrated in figure 4.7A and B, CD25+ 
DN3 cells commonly occupy the subcapsular region of the thymus in a day 0 neonate, with 
DP cells typically absent.  However, in CCR9-/- day 0 mice there is a dramatic change in the 
cellular composition of the SCZ (figure 4.7C and D).  Whilst some CD25+ cells are still able 
to localise to the SCZ, more CD25+ cells can be observed in the cortex compared to WT day 
0.  Most importantly, DP cells that are distinctly absent in a WT day 0 thymus were aberrantly 
located in the SCZ of the CCR9-/- day 0 thymus.  
 In a WT adult thymus, localisation of DP cells to the SCZ correlates with fewer CD25+ 
cells localising to this region resulting in a less defined SCZ (figure 4.7E and F).  In a CCR9-/- 
adult, fewer CD25+ cells localise to the SCZ with more cells distributed throughout the cortex.  
(figure 4.7G and H).  By comparison to a WT adult and a day 0 CCR9-/- thymus, DP cells are 
located in the SCZ of a CCR9-/- thymus. 
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Figure 4.7 Abnormal Localisation of Double Positive Thymocytes to the Subcapsular 
Zone in CCR9-/- Mice. 
 Frozen sections of thymus dissected from day 0 and 2 week adult WT and CCR9-/- mice 
were stained for CD25, CD4 and CD8.  Distribution of thymocytes at different stages of T 
cell development is shown (A-H).  Low power (A, C, E and G) and high power (B, D, F and 
H) images for each mouse analysed are shown.   
 The solid line denotes the edge of the tissue, the dotted line is the approximated region 
of subcapsular zone and the dashed line represents the corticomedullary junction. Bar 
indicates scale of 50µm. 
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4.3.6 DOCK2, An Important Regulator of Chemokine Induced Cell Migration, Is 
Expressed By Thymocyte Subsets. 
 DOCK2 is a novel haematopoietic specific protein that is thought to play an important 
role in chemokine-induced lymphocyte migration by functioning downstream of chemokine 
receptors including CCR7 and CXCR4.  The precise role of DOCK2 in the thymus has not 
been fully characterised.  Thus, in the final part of this chapter, we aim to define the role that 
DOCK2 may have during thymocyte development and organisation of thymic 
microenvironments.   
 Firstly, we sought to determine which thymocyte subsets express DOCK2 (figure 4.8).  
Thymocytes from a 4-6 week old WT thymus were stained for TCR, CD4 and CD8.  Cells 
were MoFlo sorted for TCR- DN cells (CD4- CD8-), TCRlow DP cells (CD4+ CD8+), TCRhigh 
SP4 and SP8 cells (CD4+ CD8- and CD4- CD8+).  Quantitative RT-PCR for DOCK2 shows 
that DOCK2 is expressed in all thymocyte subsets, with DP and SP4 cells showing the 
highest level of expression (figure 4.8A).  To determine expression of DOCK2 in different 
DN subsets, thymocytes from embryonic day 15 thymus were stained for CD25 and CD44.  
Cells were MoFlo sorted for DN1 cells (CD25- CD44+), DN2 cells (CD25+ CD44+) and DN3 
cells (CD25+ CD44-).  Quantitative RT-PCR for DOCK2 shows that DOCK2 is expressed by 
DN1-DN3 thymocytes, with DN3 cells showing the highest level of expression (figure 4.8B). 
 
4.3.7 Quantification of Thymocyte Subsets In DOCK2-/- Mice. 
 Following our identification of DOCK2 expression on various thymocyte subsets, we 
then went on to determine the effect DOCK2 deficiency may have during T cell development 
by quantifying numbers and proportions of thymocyte subsets in DOCK2-/- mice (figure 4.9). 
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Figure 4.8 DOCK2, An Important Regulator of Chemokine Induced Cell Migration, Is 
Expressed On Thymocyte Subsets. 
 Thymocytes from a WT adult were cell sorted for TCR- DN cells (CD4- CD8-), TCRlow 
DP cells (CD4+ CD8+), TCRhigh SP4 and SP8 cells (CD4+ CD8- and CD4- CD8+).  
Thymocytes from E15 thymus were cell sorted for DN1 cells (CD25- CD44+), DN2 cells 
(CD25+ CD44+) and DN3 cells (CD25+ CD44-).  Relative mRNA expression of DOCK2 
normalised to β-actin on the indicated thymocyte subsets are shown (A and B).   
 PCRs were carried out in triplicate and error bars indicate standard error of the mean.  
Data representative of two distinct sorting experiments. 
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Thymocytes were obtained from eight 6-8 week old WT and DOCK2-/- mice.  Absolute 
numbers of thymocytes from each mouse was analysed (figure 4.9A).  Deficiency in DOCK2 
results in a pronounced and significant reduction in thymus cellularity compared to WT mice 
(p=0.001).  However, despite this marked reduction in thymus cellularity, T cell development 
appeared to proceed normally in DOCK2-/- mice compared to WT mice with all four major 
thymocyte subsets present (figure 4.9B and C).  Further analysis of proportions (figure 4.9D-
G top panels) and actual cell numbers (figure 4.9D-G lower panels) of each thymocyte subset 
from WT and DOCK2-/- mice was carried out.  Data reveals interesting differences in some of 
the subsets.  The proportions of DN cells (defined as CD4- CD8-) in DOCK2-/- mice were 
significantly higher compared to WT mice (p=0.009), with some DOCK2-/- mice showing 
more than double the proportions of DN cells (figure 4.9D top graph).  Proportions of DP 
cells (defined as CD4+ CD8+) in DOCK2-/- mice were slightly but significantly reduced 
(p=0.02) (figure 4.9E top graph) and proportions of SP4 cells (defined as CD4+ CD8-) in 
DOCK2-/- mice were also significantly reduced (p=0.0007) (figure 4.9F top graph).  
Collectively this data shows that whilst DOCK2 appears to be important during some stages 
of T cell development, overall it is not essential for normal T cell development to occur. 
 
4.3.8 Quantification of Double Negative Thymocyte Subsets In DOCK2-/- Mice. 
 In the previous section we demonstrate a possible role for DOCK2 during the DN stage 
of T cell development as evidenced by the significant increase in DN proportions in DOCK2-/- 
mice compared to WT.  We went on to investigate this further by quantifying numbers and 
proportions of the different DN subsets in DOCK2-/- mice (figure 4.10).  Thymocytes from 
three 6-8 week old WT and DOCK2-/- mice were stained for a cocktail of lineage markers that 
included CD11b (macrophage marker), B220 (B cell marker), LY-6G (erythroid cell marker)  
 168 
 
 
 
 
 
 
 
Figure 4.9 Quantification of Thymocyte Subsets In DOCK2-/- Mice. 
 Thymocytes were obtained from eight 6-8 week old WT and DOCK2-/- mice and stained 
for CD4 and CD8.  Absolute thymus cellularity is shown (A).  Thymocytes subsets present, 
based on the differential expression of CD4 and CD8, in WT and DOCK2-/- are shown (B and 
C).  Percentages of cells within gated areas are indicated.   
 Proportions of the indicated thymocyte subsets are shown (D-G top panels) and actual 
cell numbers of each thymocyte subset was calculated (D-G lower panels).  Each point 
represents one mouse.  Horizontal bars represent the calculated mean values.  Levels of 
significance are shown. (NS, not significant, *, p<0.05, **, p<0.01, ***, p<0.001). 
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and CD4 and CD8 (T lineage markers) along with the DN markers CD25 and CD44.  By 
gating on lineage negative (lin-) cells, CD25 and CD44 expression was analysed on true DN 
thymocytes in WT and DOCK2-/- mice (figure 4.10A and B).  Differential expression of CD25 
and CD44 on WT lin- thymocytes revealed the presence of four distinct DN subsets.  DN1 
cells were identified as CD25- CD44+, DN2 cells as CD25+ CD44+, DN3 cells as CD25+ 
CD44- and DN4 cells as CD25- CD44-.  Analysis of these subsets in DOCK2-/- mice revealed 
that DOCK2 is not required for differentiation through the DN stages as illustrated by the 
presence of all four subsets in these mice (figure 4.10B).  However, further analysis of 
proportions and actual cell numbers of each DN thymocyte subset from WT and DOCK2-/- 
mice revealed some differences.   Surprisingly, despite DN1 cells having low expression of 
DOCK2 (figure 4.8B), proportions of DN1 cells were significantly reduced in DOCK2-/- mice 
compared to WT (p=0.02) (figure 4.10C top graph).  Interestingly, a significant increase in 
DN3 proportions was observed in DOCK2-/- mice compared to WT (p=0.01) (figure 4.10E top 
graph) and this correlated with a significant reduction in proportions of DN4 cells in DOCK2-
/- mice compared to WT (p=0.03) (figure 4.10F top graph).  This suggests a potential block at 
the DN3-DN4 stage.  Calculation of actual lin- DN1-4 cells did not reveal any significant 
differences between DOCK2-/- and WT mice (figure 4.10C-F lower graphs). 
 
4.3.9 Quantification of Immature Single Positive Cells in DOCK2-/- Mice. 
 In the previous section, a potential block at the DN3-DN4 stage was observed.  Cells at 
this stage of development are beginning to assemble the pre-TCR and acquire CD4 and CD8 
to become DP thymocytes.  This intermediate stage of development is defined by immature 
single positive (ISP) cells that have low surface level expression of TCRβ and are CD8+.  
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Figure 4.10 Quantification of Double Negative Thymocyte Subsets in DOCK2-/- Mice. 
 Thymocytes were obtained from three 6-8 week old WT and DOCK2-/- mice and stained 
for a cocktail of lineage markers and the DN markers CD25 and CD44.  Gating on lineage- 
(lin-) cells in both WT and DOCK2-/- mice shows different DN subsets based on the 
differential expression of CD25 and CD44 (A and B).  Percentages of cells within gated areas 
are indicated.   
 Proportions of the indicated DN thymocyte subsets are shown (C-F top panels) and 
actual cell numbers of each DN thymocyte subset was calculated (C-F lower panels).  Each 
point represents one mouse.  Horizontal bars represent the calculated mean values.  Levels of 
significance are shown (NS, not significant, *, p<0.05). 
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Numbers and proportions of CD8 ISP cells were quantified in four 6-8 week old WT and 
DOCK2-/- mice (figure 4.11).  Thymocytes were stained for TCRβ, CD4 and CD8 and ISP 
cells were identified as CD8+ TCRβlow (figure 4.11A and B).  Proportions of CD8 ISP cells 
appeared to be marginally higher in DOCK2-/- mice compared to WT (figure 4.11C).  
However, this was not found to be significant (p=0.08).  Calculation of actual ISP cell 
numbers revealed no significant differences between WT and DOCK2-/- mice (p=0.5) (figure 
4.11D). 
 
4.3.10 Quantification of Mature Thymocyte Subsets in DOCK2-/- Mice. 
 To clarify if DOCK2 has a role in the generation of mature T cells, thymocytes from 
four 6-8 week old WT and DOCK2-/- mice were stained for TCRβ, CD4 and CD8.  Numbers 
and proportions of mature CD4 and CD8 thymocytes were analysed in WT and DOCK2-/- 
mice (figure 4.12). Analysis shows that DOCK2 is not essential for the generation of mature 
CD4+ and CD8+ thymocytes when compared to WT mice (figure 4.12A and B).  However, 
analysis of the total proportions of mature thymocytes as defined by high expression of TCRβ 
revealed that DOCK2-/- mice have a significant reduction of these cells (p=0.003) (figure 
4.12C top graph).  Calculation of actual mature thymocytes also reveals a significant 
reduction (p=0.0001) of these cells in DOCK2-/- mice (figure 4.12C lower graph).  
Surprisingly, despite this marked reduction of total TCRβhigh cells in DOCK2-/- mice, 
proportions of mature CD4 and CD8 thymocytes, defined as TCRβhigh CD4+ or TCRβhigh 
CD8+ respectively, were not significantly altered (mature CD4+, p=0.1, mature CD8+, p=0.4).  
However, calculation of actual numbers of mature CD4 and CD8 thymocytes reveals  
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Figure 4.11 Quantification of Immature Single Positive Cells in DOCK2-/- Mice. 
 Thymocytes were obtained from four 6-8 week old WT and DOCK2-/- mice were 
stained for TCRβ, CD4 and CD8.  Immature single positive (ISP) CD8 cells, defined as CD8+ 
TCRβlow, are shown for both WT and DOCK2-/- mice (A and B).  Percentages of cells within 
gated areas are indicated.   
 Proportions and actual cell numbers of CD8 ISP cells are shown (C and D).  Each point 
represents one mouse.  Horizontal bars represent the calculated mean values.  Levels of 
significance are shown (NS, not significant). 
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Figure 4.12 Quantification of Mature Thymocyte Subsets In DOCK2-/- Mice. 
 Thymocytes were obtained from four 6-8 week old WT and DOCK2-/- mice and stained 
for TCRβ, CD4 and CD8.  Mature CD4+ and CD8+ thymocyte subsets present within the 
TCRβhigh population, in WT and DOCK2-/- are shown (A and B).  Percentages of cells within 
gated areas are indicated.   
 Proportions of the indicated thymocyte subsets are shown (C-E top panels) and actual 
cell numbers of each subset was calculated (C-E lower panels).  Each point represents one 
mouse.  Horizontal bars represent the calculated mean values.  Levels of significance are 
shown (NS, not significant, **, p<0.01, ***, p<0.001). 
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significant reductions of both subsets in DOCK2-/- mice (mature CD4, p=0.0005, mature 
CD8, p=0.0004). (figure 5.12D and E lower graphs). 
 
4.3.11 Composition of Thymic Microenvironments in DOCK2-/- Mice. 
 To determine whether DOCK2-/- mice have abnormal cortex and medullary 
architectures in the thymus, frozen thymic tissue from adult WT and DOCK2-/- mice were 
stained for CD4, CD8 and the medullary marker keratin 5 for confocal microscopy analysis 
(figure 4.13 and 4.14).  Tile scans at x10 magnification were taken of the entire thymus for 
three 4-6 week old WT and DOCK2-/- mice (figure 4.13A and B show representative tile scan 
images of WT and DOCK2-/- mice).  Cortex and medullary regions were identified on the 
basis of keratin 5 expression and DAPI staining (DAPI not shown).  Data shows that whilst a 
WT thymus has clearly defined and contiguous areas of medulla containing SP4 and SP8 
cells, DOCK2-/- mice show smaller and more numerous areas of medulla distributed 
throughout the cortex.  The size (µm x µm) of the medullary regions was quantified in both 
WT and DOCK2-/- mice using the LSM software by measuring the total area of the thymus 
and the medullary regions.  Size of the medullary areas was calculated as a percentage of the 
total thymus area (figure 4.13C).  Data shows that DOCK2-/- mice appear to have smaller 
areas of medulla compared to WT mice.  However, this was not found to be significant 
(p=0.4) and clearly similar analysis will need to be carried out on more mice. 
 Despite the apparent abnormal medullary architecture in DOCK2-/- mice, thymocyte 
composition of both the cortex and medulla was normal (figure 4.14).  Comparable to a WT 
thymus (figure 4.14A and C), DP cells were correctly located in the cortex and SP cells were 
still able to localise to the medulla (figure 4.14B and D) in the thymus of DOCK2-/- mice.  
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Figure 4.13 DOCK2-/- Mice Have Abnormal Medullary Architecture in the Thymus. 
 Frozen tissues sections of three 6-8 week old adult WT and DOCK2-/- mice were 
stained for CD4, CD8 and keratin 5 for confocal analysis.  Tile scans taken at x10 
magnification of the entire thymus from one WT and DOCK2-/- mouse are shown (A and B). 
Solid line denotes the edge of the tissue; dashed line denotes the corticomedullary junction.  
Bar indicates scale of 500µm. 
The size (µm x µm) of the medullary regions of each mouse, calculated as a 
percentage of the total thymus area (µm x µm), is shown (C).  Each point represents one 
mouse.  Levels of significance shown (NS, not significant).  
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Figure 4.14 DOCK2-/- Mice Have Normal Thymocyte Distribution. 
 Frozen sections of thymus from 6-8 week old WT and DOCK2-/- mice were stained 
for CD4, CD8 and keratin 5.  Low power images for each mouse show thymocyte distribution 
in the cortex and medulla (as identified on the basis of keratin 5 expression) (A and B).  High 
power images of cortex and medulla in both mice are also shown (C and D). 
 Dashed line denotes the corticomedullary junction.  Bar indicates scale of 50µm. 
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Furthermore, co-expression of keratin 5 in the SP4 and SP8 patches that were scattered 
throughout the cortex in the DOCK2-/- thymus confirmed these patches as medullary regions 
and not abnormally located SP cells in the cortex. 
 
4.3.12 Localisation of CD25+ Cells in the Thymus of DOCK2-/- Neonatal and Adult Mice. 
 To investigate CD25+ cell localisation to the SCZ in DOCK2-/- mice, frozen tissue 
sections of thymus from of 6-8 week old day 3 neonatal WT and DOCK2-/- mice were stained 
for CD25, CD4 and CD8 for confocal analysis (figures 4.15 and 4.16).  Numbers of CD25+ 
cells in subcapsular, cortical and medullary regions were quantified.  The SCZ was identified 
by drawing a box around the approximated region directly beneath and including the capsule.  
This was kept consistent throughout.  Cortex was identified as the region containing DP cells, 
whereas the medulla was identified as the region containing SP cells.  Additionally, cortex 
and medulla was also identified on the basis of DAPI staining (not shown).  Boxes were 
drawn around these areas.  CD25+ cells were counted in 3-5 areas of subcapsular, cortex and 
medulla for three separate adult and neonatal WT and DOCK2-/- thymi.  Number of cells was 
divided by the measured area of the drawn boxes (µm x µm).  Numbers of cells per µm2 were 
multiplied by 106 to give numbers of cells per mm2.  Mean values were calculated for the 3-5 
areas of SCZ, cortex and medulla for each mouse and number of cells per mm2 was plotted 
(figure 4.15G and 4.16G). 
 DOCK2 deficiency in neonatal mice, by comparison to WT (figure 4.15A-C), did not 
appear to have any significant detrimental effects on CD25+ cell distribution as these cells 
were found in their normal location in the SCZ with few cells found in the cortex and medulla 
(figure 5.15D-F).  Also DP cells were not mislocalised in the SCZ, which is in contrast to 
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CCR9-/- mice, which already show DN and DP localisation defects at the neonatal stage.   
 Surprisingly, differences in CD25+ cell distribution become more apparent in the 
DOCK2-/- adult (figure 4.16).  Whilst the CD25+ cells still retained the ability to localise to the 
SCZ (figure 4.16D), the numbers of these cells were increased in the cortex of DOCK2-/- adult 
mice (figure 4.16E) compared to WT (figure 4.16B) and calculation of numbers of CD25+ 
cells revealed that this increase was significant (p=0.002) (figure 4.16G).  Furthermore, these 
CD25+ cells were not CD4+ or CD44+, confirming that these cells are not Tregs or DN2 cells 
and are in fact DN3 cells (data not shown).  No significant differences observed in CD25+ cell 
distribution in SCZ (p=0.5) and medulla (p=0.4) between WT and DOCK2-/- mice.  
 
4.3.13 Increased proportions of CD25+ cells in DOCK2-/- mice. 
 Data in section 4.3.12 indicates mislocalisation of CD25+ cells in the cortex of DOCK2-
/- mice.  As numbers of CD25+ cells in the SCZ and medulla were comparable between the 
DOCK2-/- and WT mice, this would suggest that DOCK2-/- mice will have an increase in total 
proportions of CD25+ cells compared to WT.  Thymocytes from three WT and DOCK2-/- 
mice were stained for CD25 and proportions and total numbers of CD25+ cells were analysed 
(figure 4.17).  Data shows that DOCK2-/- mice have significantly increased proportions of 
CD25+ cells compared to WT (p=0.0001) (figure 4.17C).  Calculation of actual CD25+ cells 
revealed no significant differences between WT and DOCK2-/- mice (p=0.5) (figure 4.17D).   
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Figure 4.15 Normal Localisation of CD25+ Cells to the SCZ in DOCK2-/- Neonatal Mice. 
 Frozen sections of thymus from 3 neonatal (day 3) WT and DOCK2-/- mice were 
stained for CD25, CD4 and CD8.  Representative images of CD25+ cell distribution in SCZ, 
cortex and medulla are shown in both WT and DOCK2-/- mice (A-F).   
 Numbers of CD25+ cells in each area was quantified by counting cells in 3-5 areas of 
SCZ, cortex and medulla from 3 WT and DOCK2-/- mice.  Number of cells was divided by 
the area of these regions (µm x µm).  Number of cells per µm2 was multiplied by 106 to give 
number of cells per mm2.  Plot shows the mean number of cells per mm2 calculated from the 
3-5 areas of SCZ, cortex and medulla.   
Each point represents one mouse.  Horizontal bars indicate the calculated mean.  
Levels of significance shown (NS, not significant).  (Note: only 2 points are shown for 
DOCK2-/- medulla as the third mouse did not have large enough areas of medulla to allow for 
quantification).  
 186 
 
 
 187 
 
 
Figure 4.16 Abnormal Localisation of CD25+ Cells in the Cortex of DOCK2-/- Adult 
Mice. 
 Frozen sections of thymus from 3 adult (6-8 week old) WT and DOCK2-/- mice were 
stained for CD25, CD4 and CD8.  Representative images of CD25+ cell distribution in SCZ, 
cortex and medulla are shown in both WT and DOCK2-/- mice (A-F).   
 Numbers of CD25+ cells in each area was quantified by counting cells in 3-5 areas of 
SCZ, cortex and medulla from 3 WT and DOCK2-/- mice.  Number of cells was divided by 
the area of these regions (µm x µm).  Number of cells per µm2 was multiplied by 106 to give 
number of cells per mm2.  Plot shows the mean number of cells per mm2 calculated from the 
3-5 areas of SCZ, cortex and medulla.   
Each point represents one mouse.  Horizontal bars indicate the calculated mean.  
Levels of significance shown (NS, not significant, **, p<0.01). 
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Figure 4.17 Increased Proportions of CD25+ Cells in DOCK2-/- Mice. 
 Thymocytes from three adult WT and DOCK2-/- mice were stained for CD25 for flow 
cytometry analysis.  Histograms show CD25 expression within live-gated cells from WT (A) 
and DOCK2-/- (B) mice. Percentages of cells within gated areas are indicated.   
 Proportions of CD25+ cells are shown (C) and actual CD25+ cell numbers was 
calculated (D).   
 Each point represents one mouse.  Horizontal bars represent the calculated mean values.  
Levels of significance are shown. (NS= not significant, ***p<0.001). 
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4.4 Discussion. 
4.4.1 Establishment of the Subcapsular Zone and A Role For CCR9 Signalling.   
 T cell development is defined by the ordered migration of developing thymocytes 
through distinct thymic niches.  Whilst the migration of thymocytes to cortical and medullary 
regions are known to be associated with positive and negative selection respectively, the 
importance of thymocyte homing to the SCZ remains speculative.  The SCZ is the area that 
lies directly adjacent to the mesenchymal cell derived capsule surrounding the thymus.  This 
region is thought to provide a suitable microenvironment to support the differentiation of 
DN3 cells.  Pre-TCR signalling defines this stage of T cell development, where rapidly 
proliferating cells undergoing TCR gene rearrangements emerge from a process of β-selection 
to begin their transition to the DP stage of T cell development (Lind et al., 2001).  Thus, 
identifying the signals that govern SCZ formation is crucial to our understanding of an 
important early checkpoint in T cell development.  This study aimed to elucidate the 
establishment of the SCZ during ontogeny and highlight the role for chemokine directed 
migration.  
In the present study, CD25+ DN cells were scattered throughout the early embryonic 
thymus (E14-E16) and localisation to a subcapsular niche was distinctly absent.  However, 
during late embryonic gestation (E18) when DP cells are beginning to develop, establishment 
of the SCZ occurs providing a niche for CD25+ DN3 cells to localise.  By postnatal day 0 a 
clearly defined SCZ containing CD25+ cells was present and most strikingly, DP cells located 
in the cortex were distinctly absent from the SCZ at both E18 and day 0.  The high 
proliferative burst associated with DN to DP transition may generate a physical force that 
helps to propel newly generated DP cells out of the SCZ, possibly explaining the absence of 
DP cells in this region.  In a 6-8 week old adult thymus the SCZ appeared less defined with 
 192 
fewer CD25+ cells localising to this region and DP cells clearly present.  Previous reports 
highlight the importance of chemokine directed migration in regulating the complex 
trafficking of thymocytes (Takahama, 2006) and in line with this our study demonstrates 
compartmentalisation of chemokines in discrete thymus regions.  By employing a laser 
capture microdissection (LCM) technique, we identified that expression of CXCL12, CCL25 
and their respective receptors CXCR4 and CCR9 were mostly confined to the SCZ and 
cortex, whereas expression of CCL19, CCL21 and their receptor CCR7 were almost exclusive 
to the medulla.  This differential chemokine expression pattern suggests that chemokine 
induced migration is important in regulating the stratified positioning of thymocytes.  This 
data is in line with Ueno et al (2004) who report the importance of CCR7 signalling in 
regulating cortex to medulla migration of SP thymocytes and those who report the importance 
of CCR9 and CXCR4 signalling in regulating DN localisation in the cortex and SCZ (Benz et 
al., 2004; Lind et al., 2001; Plotkin et al., 2003).  However, in the context of this study it was 
of interest to study the requirement for CCR9-CCL25 signalling during thymocyte trafficking 
to the SCZ.   
In CCR9-/- adults CD25+ cells were found scattered throughout the cortex and failed to 
localise to the SCZ, in accordance with Benz et al (2004) who suggest that localisation of 
CD25+ DN2/3 cells in the adult is dependent on CCR9 signalling.  However, the present study 
extends previous findings by demonstrating a more dramatic difference in thymocyte 
localisation to the SCZ in CCR9-/- neonates.  In contrast to WT neonates, CCR9-/- neonates 
had fewer CD25+ cells localising to the SCZ but most importantly displayed perturbed 
localisation of DP cells to the SCZ.  Thus, these mice resembled a WT adult with regard to 
their thymocyte composition in the SCZ.  This data potentially suggests a different or a more 
complex role for CCR9 signalling during thymocyte localisation to the SCZ, than previously 
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thought.  Rather than acting on CD25+ cells, CCL25 could be regulating localisation of DP 
cells instead.  Norment et al (2000) report that CCR9 expression is up-regulated on DN cells 
following assembly of the pre-TCR as DN cells undergo transition to the DP stage.  
Furthermore, initiation of the pre-TCR signal correlated with a higher migratory capacity of 
thymocytes in response to CCL25.  In view of this, our data suggest that in a WT neonatal 
thymus, DN cells that have migrated to the SCZ (possibly in response to CXCL12) undergo a 
pre-TCR signal and up-regulate expression of CCR9 and the CD4 and CD8 co-receptors 
before moving out of the SCZ into the cortex in response to CCL25.  However, in the absence 
of CCR9, DP cells emerging from pre-TCR signalling are unable to receive a CCL25 signal 
so preventing their migration out of the SCZ and into the cortex, potentially explaining why 
DP cells accumulate in the SCZ of CCR9-/- neonates.  Clearly, in these mice a majority of DP 
cells can still localise to the cortex and this may reflect either a compensatory mechanism for 
DP cell localisation in the absence of CCR9 or the fact that all DP cells cannot physically 
occupy such a small region of the thymus.  In further support of our hypothesis, Uehara et al 
(2006) show that the premature expression of CCR9 in DN thymocytes (i.e. prior to receiving 
a pre-TCR signal) leads to the accumulation of CD25+ cells in the cortex.  Whilst they suggest 
that this retention of DN cells in the cortex is due to failure of DN cells to migrate towards the 
SCZ, data in the present study may alternatively suggest that early CCR9 signalling could 
result in a premature migration signal to the CD25+ cells, such that these cells exit the SCZ 
before completing pre-TCR signalling and transition to the DP stage.   
In this study a striking difference in DP cell localisation to the SCZ was observed in 
WT neonates compared to adults.  In light of the finding that CCR9-/- neonates resemble WT 
adults, one can speculate that a differential requirement for CCR9 signalling exists between 
the neonate and an adult.  Certainly, the requirement for chemokine signalling is already 
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known to differ between the fetal and post-natal stages during thymus development.  Thus, it 
is possible that DP cells in a WT adult do not require CCL25 signalling to move out of the 
SCZ.  Reports suggest that whilst late stage DN cells have low levels of CCR9, a small 
proportion of DN2/3 cells do have the capacity to migrate in response to CCL25 signalling 
(Uehara et al., 2002; Wurbel et al., 2000).  This may explain why in the WT adult a 
proportion of CD25+ DN cells do localise to the SCZ and why deficiency in CCR9 results in 
an almost complete failure of CD25+ cells to localise to the SCZ as demonstrated in this study 
and by Benz et al (2004).  Alternatively, differences observed in DP cell localisation to the 
SCZ in the adult and neonate may be explained by an increased efficiency in DN cell 
differentiation, where adult DN cells are faster at becoming DP cells and so have already 
undergone pre-TCR signalling and expression of the co-receptors before reaching the SCZ. 
Given that T cell development is characterised by the ordered migration of each 
substage through the distinct regions of the thymus, it could be presumed that impaired 
migration of DN or DP thymocytes into or out of the SCZ may lead to a defect in pre-TCR 
signalling and a subsequent block in the DN-DP stage.  However, perturbed localisation of 
DP and SP cells was not observed in CCR9-/- neonates and adults in this study.  Furthermore, 
previous studies did not demonstrate reduced proportions of DP cells or abnormal T cell 
development overall in CCR9-/- mice (Benz et al., 2004; Wurbel et al., 2001).  Such findings 
indicate that localisation of thymocytes to the SCZ may not be an essential requirement for 
early T cell development.  This fits with the notion that the pre-TCR complex regulates T cell 
development in a ligand independent manner, which also argues against the need for a 
‘physical niche’ for DN to DP cell transition (Irving et al., 1998; Yamasaki et al., 2006).  
However, a more recent study finds that when CCR9-/- DN cells were placed in a competitive 
environment with WT DN cells, they were impaired in their ability to generate DP compared 
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with WT cells (Svensson et al., 2008).  This supports the notion that pre-TCR induced CCR9 
expression may have a non-redundant role during pre-TCR signalling and transition to the DP 
stage.  Furthermore, this study also demonstrated that CCR9-/- DP cells were disadvantaged in 
their ability to generate SP4 cells when in competition with WT DP cells. 
To summarise, not only do our findings reinforce the view that CCR9-CCL25 
signalling is important in the localisation of thymocytes to the SCZ, a novel finding that 
CCR9-CCL25 may also have a role in DP cell localisation in the SCZ was also reported.  
 
4.4.2 The Importance of DOCK2 During T Cell Development and Organisation of 
Thymic Microenvironments. 
 In line with previous data indicating a role for chemokines in thymocyte localisation, 
T cell development and compartmentalisation was also analysed in DOCK2-/- mice, which 
have been reported to have poorly characterised abnormalities in T cell development and 
thymocyte localisation.     
As evidenced by our quantitative RT-PCR data, DOCK2 gene expression is found in 
all thymocyte subsets, with DP and SP4 cells expressing the highest levels.  This suggests an 
important role for DOCK2 during these stages of T cell development, as will be discussed 
below.  Furthermore, DOCK2 expression was present in all DN subsets, with DN3 cells 
showing the highest level.  Contrary to flow cytometry data showing that DOCK2 deficiency 
leads to a significant reduction in proportions of DN1 cells, these particular cells express low 
levels of DOCK2.  To explain this apparent discrepancy, it is currently unclear if DOCK2 is 
expressed by all DN1 subsets including DN1a, b and c (as identified by Porritt et al., 2004) 
and whether all these subsets are present in our sorted populations. 
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Whilst it is unclear if DOCK2 has a chemokine independent function, the fact that it 
mediates lymphocyte migration by functioning downstream of CCR7 and CXCR4 signalling 
prompted us to determine if deficiency in DOCK2 would lead to abnormalities in T cell 
development and thymus organisation.  The present study reports that deficiency in DOCK2 
leads to a severe reduction in thymus cellularity. However, T cell development still occurs in 
a normal manner with the presence of all substages of T cell development and mature subsets 
of CD4+ and CD8+ T cells in the thymus.  Further analysis revealed that proportions of DN 
cells were increased in DOCK2-/- mice compared to WT, along with decreased proportions of 
DP and SP4 cells.  Observations of reduced thymic cellularity and increased proportions of 
DN cells are in accordance with previous claims (Fukui et al., 2001).  Due to this observed 
increase in DN proportions, the effect DOCK2 deficiency has on the development of 
thymocytes through the DN stages was investigated.  Increased proportions of DN3 cells and 
a reduction in DN4 proportions were observed and this correlated with a marginal increase in 
immature single positive (ISP) CD8+ cell proportions, which lie between the DN to DP stage 
of T cell development.  Pre-TCR signalling and subsequent development to the DP stage 
defines this important stage of T cell development.  These findings differ from what has been 
reported in CCR7-/- mice and mice deficient for the CCR7 ligands CCL19 and CCL21 (plt/plt 
mice), which show increased DN1 cells and DN1-2 cells (a transitional substage between the 
DN1 and DN2 stage), along with a decrease in DN3 and DN4 cells (Ueno et al., 2004). 
Observations of increased ISP cells in the present study tentatively suggest a block during the 
DN3-4 stage and a possible role for DOCK2 during pre-TCR signalling.  Indeed these 
findings correlate with our observations that deficiency in DOCK2 in adult mice leads to 
accumulation of CD25+ cells in the cortex.  A study by Sanui et al (2003) demonstrates that in 
the absence of DOCK2, TCR polarisation and clustering is disrupted during immunological 
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synapse formation (IS).  They conclude that DOCK2 is downstream regulator of TCR 
signalling and is essential for TCR mediated activation of Rac, thus implicating an important 
role for DOCK2 in the formation of the IS.  In the context of the present study, if DOCK2 is 
also an important regulator of pre-TCR signalling, DN cells that have accumulated in the 
cortex of DOCK2-/- mice have failed to receive a pre-TCR signal and so are blocked in their 
ability to give rise to DP cells.  Certainly if this scenario was true then this may account for 
the observed increase in DN proportions and decreased DP proportions. 
Our observations of CD25+ cell accumulation in the cortex was only apparent in adult 
DOCK2-/- mice and was similar to our observations of CD25+ cell accumulation in the cortex 
of CCR9-/- adult mice.  However, by contrast to CCR9-/- adults, a large fraction of CD25+ cells 
could still accumulate in the SCZ of DOCK2-/- mice, suggesting the existence of a DOCK2 
independent pathway.  This data is also in contrast to CCR7-/- and plt/plt mice, which have 
less abundant CD25+ DN3 cells in the outer cortex and SCZ and an accumulation of DN2 
cells at the cortico-medullary junction (Ueno et al., 2004).  
In the present study reduced proportions SP4 cells in DOCK2-/- mice were observed.  
A previous study has reported that DOCK2 deficiency leads to reduced efficacy of positive 
selection (Sanui et al., 2003).  Collectively, this data may suggest a reduced ability of 
DOCK2-/- DP cells to form stable interactions with thymic epithelial cells (TECs). Indeed 
preliminary experiments in the lab using thymocyte-epithelial cell conjugate assays where 
cell-cell contact is dependant on TCR-MHC interactions, suggest that DOCK2-/- DP cells are 
less able to form stable conjugates with TECs compared to WT DP cells (Will Jenkinson, 
unpublished data).  This suggests a possible role for DOCK2 during initial stages of positive 
selection.    
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In this study we also show that deficiency in DOCK2 leads to abnormal medullary 
architecture, where medullary regions are reduced in size and are scattered throughout the 
cortex as small patches.  This suggests an important role for DOCK2 in the development of 
normal medullary regions.  The abnormalities we observe in the DOCK2-/- mouse are in 
accordance to those seen in mice deficient for CCR7 and plt/plt mice, which also display 
small and sparsely distributed medullary regions throughout the cortex (Ueno et al., 2004).  
However, most importantly we show that despite the abnormal medullary architecture in 
DOCK2-/- mice there is still normal accumulation of SP thymocytes in the medulla and not the 
in cortex, which is in contrast to a previous study that reported mislocalisation of SP cells in 
the cortex of DOCK2-/- mice (Fukui et al., 2001).  This apparent discrepancy can be explained 
by the fact the in our study we used the medullary marker keratin 5 to characterise the precise 
location of these SP4 and SP8 patches.  In CCR7-/- mice, accumulation of SP cells in the 
medulla is poor suggesting that CCR7 signals are essential for guiding SP cells through the 
medulla and is essential for maintaining proper thymic morphology (Ueno et al., 2004).  
Clearly, if DOCK2 is functioning downstream of CCR7 signalling then this may account for 
the abnormalities observed in the medulla in our study.  With regard to the secondary 
lymphoid organs T and B cell segregation is absent in plt/plt mice and this is in contrast to 
DOCK2-/- mice (Reif and Cyster, 2002).  This suggests that CCR7 can signal in a DOCK2 
independent manner and this could potentially explain why the thymic abnormalities we 
observe are not quite as severe as those observed in the CCR7-/- mice.  Furthermore, Ueno et 
al (2004) report that the phenotype of the CCR7-/- mouse becomes more aggravated with age 
(8 months). So whilst we see modest detrimental effects on T cell development in DOCK2-/- 
mice that are 6-8 weeks old, we may see more pronounced defects if were to investigate T cell 
development in older mice.  
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The study by Fukui et al (2001) also suggest that DOCK2-/- mature thymocytes, that 
are failing to respond to CCL19, have a thymic emigration defect, which accounts for the T 
lymphocytopenia they observed in the periphery of the DOCK2-/- mice.  However, in our 
study we did not observe increased proportions of mature CD4+ or CD8+ T cells in DOCK2-/- 
mice, suggesting no defects in thymocyte export.  Clearly, this should be investigated further 
by analysing proportions of recent thymic emigrants based on expression of CD62L and Qa-2, 
which are indicative of the most mature SP cells.  Indeed, preliminary data in this study shows 
increased numbers of Qa-2+ CD4+ thymocytes in the thymus of DOCK2-/- mice compared to 
WT (data not shown) indicating that there may indeed be an emigration defect in DOCK2-/- 
mice. 
This study shows that a majority of DOCK2-/- thymocytes clearly still retain the ability 
to respond to chemokines as evidenced by the overall normal organisation of DP and SP cells.  
This may suggest the existence of an alternative pathway that operates in the absence of 
DOCK2 or the chemokines (CCL19, CCL21 and CXCL12).  Whether this alternative 
pathway operates in the presence of DOCK2, as is the case in WT mice, or if this pathway 
becomes activated in the absence of DOCK2, requires further investigation.  Molecules, other 
than DOCK2, may exist that might be involved in relaying CCR7 and CXCR4 mediated 
signals to induce cell migration.  These may include the structurally related CDM proteins 
DOCK180, DOCK10 and DOCK11, which are all known to be expressed by lymphocytes 
(Gotoh et al., 2008; Yelo et al., 2008) or even PI3K, which is known to be important for 
lymphocyte migration (Okkenhaug and Vanhaesebroeck, 2003).  Mice deficient for both 
DOCK2 and the above-related CDM proteins may help to understand this pathway further.  
Indeed, a recent study has used mice doubly deficient for DOCK2 and DOCK180 and found 
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reduced pre-vascular colonisation of the fetal thymus, shedding further light on the role of 
these pathways in the thymus (Lei et al., 2009). 
To summarise, DOCK2 may be important for the migration and development of 
progenitors undergoing pre-TCR signalling as well as proper maintenance of thymus 
morphology.  However, T cell development still occurs in the absence of DOCK2 suggesting 
that chemokine signalling via DOCK2 is not a prerequisite for normal T cell development but 
may be important for optimal development of mature T cells with a diverse TCR repertoire.  
Certainly, competitive bone marrow transfer experiments (similar to those carried out by 
Svensson et al, 2008) where DOCK2-/- thymocytes are placed in direct competition with WT 
thymocytes will further elucidate the role of DOCK2 during T cell development.    
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CHAPTER 5 
PHENOTYPIC ANALYSIS OF MEDULLARY THYMIC 
EPITHELIAL CELLS AND THE THYMIC 
MESENCHYME 
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5.1 Introduction. 
 Following the identification of a bipotent thymic epithelial cell (bTEC) progenitor that 
can differentiate into mature cortical and medullary epithelium (Bleul et al., 2006; Rossi et al., 
2006), subsequent studies have begun to provide a more detailed account of the events 
leading to the differentiation of mature mTECs.  Namely, the identification of heterogeneous 
subsets within the mTEC lineage has been valuable.  The two major subsets of mTECs known 
to exist consist of an mTEClow subset defined as CD80- AIRE- MHC IIlow and an mTEChigh 
subset defined as CD80+ AIRE+ MHC IIhigh (Derbinski et al., 2005; Gray et al., 2007a; Rossi 
et al., 2007b).  According to the terminal differentiation model, these subsets are thought to 
share a precursor-product relationship where mature mTEChigh cells that express a wide array 
of tissue restricted antigens (TRAs) are derived from less mature mTEClow cells that express a 
limited array of TRAs (Derbinski et al., 2005; Yano et al., 2008).  Whilst the medullary 
epithelium is known to be essential for establishing immunological tolerance via the deletion 
of autoreactive thymocytes, the underlying signalling pathways and mechanisms that regulate 
mTEC development are yet to be fully defined.  However, RANKL signals derived from 
thymic lymphoid tissue inducer cells (LTi) and/or SP4 thymocytes have been identified as 
being important in regulating the development of CD80+ AIRE+ mTECs (Akiyama et al., 
2008; Hikosaka et al., 2008; Rossi et al., 2007b).  Thus, analysis of the mechanisms that 
regulate the differentiation of mTECs, particularly the subset expressing AIRE is essential to 
gain a better understanding of how central tolerance is regulated.  Whilst expression of co-
stimulatory molecules such as CD80 on mTECs is important for negative selection, the 
possible roles of other co-stimulatory markers are undefined.  The discovery of differential 
expression of the programmed death-1 (PD-1) ligands PD-L1 (on cortex and medulla) and 
PD-L2 (medulla only) within the thymus has further highlighted the heterogeneity of TECs 
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with regard to expression of co-stimulatory molecules (Liang et al., 2003).  Due to the 
importance of PD-1 signalling to deliver inhibitory signals to T cells to mediate peripheral T 
cell tolerance and the up-regulation of this receptor during positive selection (Keir et al., 
2008; Sharpe et al., 2007), it was thus of interest in this study to investigate the phenotype of 
mTECs with regard to PD-L1 and PD-L2 expression with a view to extend current knowledge 
on the role of PD-1 in the thymus. 
In the final part of this chapter, we also aim to investigate non-epithelial thymic 
stromal cells, which mostly comprise of mesenchymal cells that constitute the capsule, septae 
and the stromal cell network including fibroblasts.  Mesenchymal cells are known to play a 
crucial role in TEC proliferation in the fetal thymus through the provision of fibroblast 
growth factors (FGFs) (Jenkinson et al., 2003).  However, the precise role of the mesenchyme 
in the post-natal and adult thymus remains to be determined.  Despite the identification of 
subsets of mesenchyme expressing Ly51 (the so called ‘cortical mesenchyme’) (Muller et al., 
2005) and the fibroblast marker MTS15 (Gray et al., 2007b), knowledge about the precise 
phenotype and heterogeneity of these cells is limited.  Certainly, to begin to understand the 
developmental origins and thymus specific functions of these cells, elucidating the phenotype 
of these cells and identifying mesenchyme specific markers is vital. 
Thus the aims of this chapter are as follows: 
• Analyse co-stimulatory molecule expression in cTECs and distinct mTEC subsets. 
• Analyse the role of RANK signalling in mTEC development. 
• Define heterogeneity within non-epithelial thymic stromal cells by identifying 
mesenchyme specific markers and carrying out a genotypic analysis of such cells.  
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5.2 Specialised Methods. 
5.2.1 Addition of Anti-RANK to Fetal Thymus Organ Cultures. 
Day 15 embryonic lobes were placed in fetal thymus organ culture (FTOC) with or 
without 2-dguo to eliminate lymphoid cells as described in section 2.4.  After 7 days in 
culture half the 2-dguo FTOC lobes were placed on nucleopore filters in centre well organ 
culture dishes (BD) containing 200µl of DMEM, whereas the remaining half were placed in 
dishes containing 200µl of DMEM supplemented with 10µg/ml anti-RANK (R&D systems).  
After 4 days, lobes were removed from culture and treated for flow cytometry analysis.   
 
5.2.2 Intracellular AIRE Staining Protocol for Flow Cytometry. 
 AIRE is a nuclear protein and so an intracellular staining protocol (ebioscience) was 
employed to analyse AIRE expression in FTOC lobes. AIRE staining was carried out in 
collaboration with A.White, University of Birmingham. Stromal cell suspensions that were 
CD45 depleted using dynal beads (described in section 2.5.3) were surface stained with the 
relevant antibodies as described in section 2.6.  Following surface stain, cells were washed in 
200µl IC fixation buffer and vortexed before incubation at 4°C for approximately 40 minutes.  
Cells were then washed twice with 1ml of perm wash buffer (diluted 1:10 in dH20).  Washed 
cells were then incubated for 20 minutes with anti-AIRE diluted in perm wash buffer.  Cells 
were washed twice again as above before resuspension in PBS.  
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5.3 Results. 
5.3.1 Defining Heterogeneity in Cortical and Medullary Thymic Epithelial Cells. 
 To identify heterogeneity within TECs and to emphasise differences between the 
cortical and medullary lineages, thymus lobes dissected from embryos at day 15 of gestation 
were placed in FTOC for 7 days.  Suspensions of thymic stromal cells were stained for CD45, 
EpCAM-1, Ly51 and a panel of stromal cell markers.  Expression of the indicated stromal cell 
markers were analysed on cTECs, identified as CD45- EpCAM-1+ Ly51+ (figure 5.1) and on 
mTECs, identified as CD45- EpCAM-1+ Ly51- (figure 5.2).  
 Analysis of cTECs revealed that a majority of these cells lack expression of the co-
stimulatory molecule CD80 (B7.1) and are distinctly negative for the expression of AIRE 
(figure 5.1B and C).  By contrast, MHC II was expressed by a majority of cTECs (figure 
5.1D).  A majority of cTECs were found to express PD-L1 and PD-L2 (figure 5.1E and F). 
Similarly, gp38, which is expressed by stromal cells in T cell dependent areas of peripheral 
lymphoid tissues, was also expressed by a majority of cTECs (figure 5.1G).  The cell 
adhesion molecules VCAM-1 and ICAM-1 were also expressed by a majority of cTECs 
(figure 5.1H and I).  Expression of PDGFRα on cTECs was distinctly absent (figure 5.1J).
 Analysis of mTECs revealed a contrasting expression profile of the above stromal cell 
markers.  Expression of CD80 was heterogeneous with the presence of a CD80- population 
and a small population of CD80+ cells (figure 5.2B).  Expression of AIRE was restricted to a 
very small proportion of mTECs (figure 5.2C).  By contrast to the uniform high levels of 
MHC II expression on cTECs, expression on mTECs was more heterogeneous with the 
presence of mTECs expressing low to intermediate levels of MHC II (MHC IIlow) and high 
levels of MHC II (MHC IIhigh) (figure 5.2D).  By comparison to cTECs, PD-L1, gp38 and 
ICAM-1 were expressed by a majority of mTECs (figure 5.2E, G and I).  Most interestingly, 
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Figure 5.1 Phenotype of Cortical Thymic Epithelial Cells. 
Thymus lobes dissected at day 15 of gestation from WT mouse embryos were placed 
in fetal thymus organ culture (FTOC) for 7 days.  Following culture, lobes were 
enzymatically digested to obtain suspensions of thymic stromal cells.  Cells were stained for 
flow cytometry for CD45, EpCAM-1, Ly51 and the indicated stromal cell markers.  
Expression profile of EpCAM-1 and Ly51 is shown on CD45- cells (A).  Histograms show 
expression of the indicated stromal cell markers on cortical thymic epithelial cells (cTECs) 
defined as CD45- EpCAM-1+ Ly51+ (B-J).   
Shaded grey areas represent the negative control.  Percentages of cells within gated 
areas are indicated.  Data representative of at least 2 experiments.  
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Figure 5.2 Phenotype of Medullary Thymic Epithelial Cells. 
Thymus lobes dissected at day 15 of gestation from WT mouse embryos were placed 
in fetal thymus organ culture (FTOC) for 7 days.  Following culture, lobes were 
enzymatically digested to obtain suspensions of thymic stromal cells.  Cells were stained for 
flow cytometry for CD45, EpCAM-1, Ly51 and the indicated stromal cell markers.  
Expression profile of EpCAM-1 and Ly51 is shown on CD45- cells (A).  Histograms show 
expression of the indicated stromal cell markers on medullary thymic epithelial cells (mTECs) 
defined as CD45- EpCAM-1+ Ly51-(B-J).   
Shaded grey areas represent the negative control.  Percentages of cells within gated 
areas are indicated.  Data representative of at least 2 experiments.  
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in contrast to cTECs, PD-L2 and VCAM-1 expression was more heterogeneous with 
approximately only half of mTECs expressing these two molecules (figure 5.2F and H). 
Expression of PDGFRα on mTECs was distinctly absent (figure 5.2J).    
 The table in figure 5.3 summarises the proportion of cTECs and mTECs expressing 
the named stromal cell markers.  
 
5.3.2 Expression of PD-L1 and PD-L2 Does Not Discriminate Between mTEClow and 
mTEChigh Cells.  
 The precise roles of the PD-1 ligands PD-L1 and PD-L2 in the thymus are unclear and 
thus in this chapter we aimed to extend current knowledge on the phenotype of mTECs 
expressing these ligands.  As demonstrated in figure 5.2D, mTECs can be divided on the basis 
of varying levels of MHC II expression, with low level expression associated with mTEClow 
cells and high level expression associated with mTEChigh cells.  To determine if PD-L1 and 
PD-L2 can distinguish between these two cells types, expression was analysed on mTEClow 
and mTEChigh cells and this was compared to CD80 and AIRE expression on these two mTEC 
subsets (figure 5.4).  CD45 depleted stromal cell suspensions obtained from 7 day FTOC 
lobes were stained for Ly51, MHC II and either CD80, AIRE, PD-L1 or PD-L2.  MHC II and 
EpCAM-1 expression on Ly51- cells (figure 5.4A) revealed two populations of mTECs 
expressing low to intermediate (mTEClow) and high levels of MHC II (mTEChigh) (figure 
5.4B).  Analysis revealed that as expected, CD80 and AIRE expression was restricted to the 
mTEChigh  subset (figure 5.4C and D).  By contrast, expression of PD-L1 and PD-L2 was 
found on both mTEClow and mTEChigh cells (figures 5.4E and F).    
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Figure 5.3 Summary of the Phenotype of Cortical and Medullary Epithelial Cells. 
 Table summarises data from figures 5.1 and 5.2.  Proportion (% of gated cells) of 
cortical and medullary epithelial cells expressing the indicated stromal cell markers are 
shown.  
Key: -, 0-5%, +, 6-20%, ++, 21-70%, +++, 71-100%. 
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Figure 5.4 Expression of PD-L1 and PD-L2 Does Not Discriminate Between mTEClow 
and mTEChigh Cells. 
Thymus lobes dissected at day 15 of gestation from WT mouse embryos were placed 
in fetal thymus organ culture (FTOC) for 7 days.  Following culture, lobes were 
enzymatically digested to obtain suspensions of thymic stromal cells.  Cells were CD45 
depleted and stained for Ly51, EpCAM-1 and MHC II.  By gating on Ly51- cells (A), 
EpCAM-1 and MHC II expression was analysed (B).  Histograms show CD80, AIRE, PD-L1 
and PD-L2 expression on gated mTEClow cells defined as EpCAM-1+ MHC IIlow (C-F left 
panels) and mTEChigh cells defined as EpCAM-1+ MHC IIhigh (C-F right panels).   
Shaded grey areas represent the negative control.  Percentages of gated cells are 
shown.  Data representative of 3 experiments.  
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5.3.3 A Role for Thymic Crosstalk and RANK-RANKL Signalling During mTEC 
Development. 
 As thymic crosstalk is essential for the development of the thymic microenvironments, 
we then sought to determine if haematopoietic cells are important for the development of 
mTEC subsets and subsequently to identify if RANK-RANKL signalling is involved in this. 
E15 lobes placed in 2-dGuo FTOC for 7 days to deplete lymphoid cells were cultured with or 
without an agonistic antibody against RANK for a further 4 days.  Expression of PD-L1, PD-
L2, CD80, AIRE and MHC II was analysed on CD45- Ly51- EpCAM-1+ mTECs obtained 
from 7 day 2-dGuo FTOCs cultured for 4 days in DMEM or anti-RANK (figure 5.5).  As a 
positive control, 11 day FTOCs were analysed for the expression of the above markers (data 
not shown).   
 Figure 5.5A-E shows expression of the indicated markers on mTECs, when 
haematopoietic cells are absent.  mTECs expressing PD-L2, CD80 and AIRE were totally 
absent, indicating the importance of thymic crosstalk for the development of these mTEC 
populations (figure 5.5A, C and E left panel).  Most importantly, treatment of 7d 2-dguo 
FTOCs with anti-RANK induced the appearance of these mTECs expressing PD-L2, CD80 
and AIRE after 4 days in culture (figure 5.5A, C, and E right panel).  By contrast, 
haematopoietic cells were not essential for the development of mTECs expressing PD-L1 
lymphocytes (figure 5.5B left panel).  However, addition of anti-RANK induced further 
development of PD-L1+ mTECs (figure 5.5B right panel).  Interestingly, absence of 
haematopoietic cells was important for the development of mTEChigh cells as evidenced by 
the absence of mTECs expressing high levels of MHC II (figure 5.5D left panel).  Addition of 
anti-RANK induced the development of mTEChigh cells expressing high levels of MHC II 
(figure 5.5D right panel).   
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Figure 5.5 A Role for Thymic Crosstalk and RANK-RANKL Signalling During mTEC 
Development. 
E15 lobes placed in fetal thymus organ culture (FTOC) with 2-dGuo for 7 days, were 
subsequently cultured in the presence or absence of anti-RANK for a further 4 days.  
Following culture, lobes were enzymatically digested to obtain suspensions of thymic stromal 
cells.  Cells were stained for CD45, EpCAM-1, Ly51 and the indicated markers.  Plots show 
PD-L1, PD-L2, CD80, MHC II and AIRE expression on CD45- Ly51- EpCAM-1+ mTECs 
from 7 day 2-dGuo FTOC cultured in the presence (A-E right panels) and absence (A-E left 
panels) of anti-RANK.  
AIRE data courtesy of A. White, University of Birmingham. Percentages of cells 
within gated areas are indicated.  Data representative of at least 2 experiments.   
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5.3.4 PD-1, the Receptor for PD-L1 and PD-L2, is Expressed On Thymocyte Subsets. 
 Having demonstrated that PD-L1 and PD-L2 are expressed on TECs, it was of interest 
to determine the expression of their receptor PD-1 on different thymocyte subsets.  
Thymocytes obtained from a 4-6 week old adult WT mouse were stained for CD4, CD8, 
TCRβ and PD-1 (figure 5.6).  PD-1 expression was analysed on different thymocyte subsets 
defined by the differential expression of CD4 and CD8.  Analysis revealed that PD-1 was 
expressed mostly on DN (CD4- CD8-) (figure 5.6B) and SP4 (CD4+ CD8-) thymocytes (figure 
5.6D).  Expression of PD-1 on DP (CD4+ CD8+) (figure 5.6C) and SP8 (CD4- CD8+) (figure 
5.6E) thymocytes was minimal.  PD-1 expression was also analysed on mature thymocytes 
expressing high levels of TCRβ (figure 5.6F).  Data revealed that a proportion of mature SP4 
cells expressed PD-1 (figure 5.6G), with very few mature CD8 cells expressing PD-1 (figure 
5.6H).   
To further analyse expression of PD-1 on thymocyte subsets, adult thymocytes were 
also stained for CD69, which is an activation marker up-regulated following sustained TCR-
MHC interactions on developing thymocytes.  PD-1 expression was analysed on thymocyte 
subsets expressing high levels of CD69 (figure 5.7A). Data reveals that expression of PD-1 
expression is induced on DP thymocytes following TCR-MHC interactions (figure 5.7B).  
PD-1 was also expressed on a proportion of CD69+ CD4+ (figure 5.7C) and CD69+ CD8+ 
(figure 5.7D) thymocytes.  Furthermore, by subdividing CD4+ thymocytes on the basis of 
CD25 expression (figure 5.7E), PD-1 expression was found mostly on thymic Tregs defined 
as CD4+ CD25+ (figure 5.7G) as well as a smaller proportion of non-Tregs defined as CD4+ 
CD25- (figure 5.7F). 
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Figure 5.6 PD-1 is Expressed On Various Thymocyte Subsets. 
 Thymocytes from a 4-6 week old adult WT mouse were stained for CD4, CD8, TCRβ 
and PD-1.  Different thymocyte subsets are defined by the differential expression of CD4 and 
CD8 (A).  Mature thymocytes expressing high levels of TCRβ are also shown (F).  
Histograms show expression of PD-1 on the various gated thymocyte subsets (B-E and G and 
H).   
Shaded grey areas represent the negative control.  Percentages of cells within gated 
areas are indicated.  Data representative of 2 experiments.  DN, double negative, DP, double 
positive, SP4, single positive CD4, SP8, single positive CD8. 
 
 220 
 
 221 
 
 
 
 
 
Figure 5.7 PD-1 is Expressed On Activated Thymocytes and Tregs. 
Thymocytes from a 4-6 week old adult WT mouse were stained for CD4, CD8, CD69 
and PD-1.  Activated thymocyte subsets defined by the expression of CD4 and CD8 on 
CD69high cells are shown (A).  Histograms show PD-1 expression on the different thymocyte 
subsets (B-D).  Thymocytes were also stained for CD25 with CD4 (E).  Expression of PD-1 
on gated populations is shown (F and G).   
Shaded grey areas represent the negative control.  Percentages of cells within gated 
areas are indicated.  Data representative of 2 experiments.   
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To summarise, data in this chapter so far highlights the heterogeneity of mTEC subsets with 
particular regard to expression of co-stimulatory molecules and moreover shows the essential 
role of thymic crosstalk in the development of these subsets.   
 
5.3.5 Phenotypic Characterisation of the Thymic Mesenchyme. 
 In the final part of this chapter we aimed to further define the phenotype of 
mesenchymal cells in the thymus.  Stromal cells obtained from 7 day FTOC lobes were 
stained for CD45, EpCAM-1 and a panel of stromal cell markers (figure 5.8).  Mesenchymal 
cells were identified as CD45- EpCAM-1- (figure 5.8A).  Analysis of CD80, AIRE, MHC II, 
PD-L1 and PD-L2 expression revealed an absence or a low proportion of mesenchymal cells 
expressing these molecules (figure 5.8B-F).  Analysis of VCAM-1, ICAM-1 and PDGFRα 
indicated heterogeneous expression within the mesenchyme (figure 5.8H-J).  Interestingly, in 
contrast to the above named markers, gp38 was expressed on a majority of mesenchymal cells 
with the presence of cells expressing high levels of gp38 (figure 5.8G).  The table in figure 
5.9 summarises the proportion of mesenchymal cells expressing the indicated stromal cell 
markers.   
 
5.3.6 Defining Heterogeneity Within the Thymic Mesenchyme.  
Having analysed the phenotypic profile of the mesenchyme, we then sought to define 
this population further by focusing on the expression of gp38 and PDGFRα (figure 5.10).  
CD45 depleted stromal cells obtained from 7 day FTOCs were stained for EpCAM-1, Ly51, 
gp38 and PDGFRα (figure 5.10A).  Analysis of PDGFRα, gp38 and Ly51 expression on 
CD45- EpCAM-1- cells revealed distinct populations of mesenchyme including a gp38+ 
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Figure 5.8 Phenotypic Characterisation of the Thymic Mesenchyme. 
Thymus lobes dissected at day 15 of gestation from wildtype (WT) mouse embryos 
were placed in fetal thymus organ culture (FTOC) for 7 days.  Following culture, lobes were 
enzymatically digested to obtain suspensions of thymic stromal cells.  Cells were stained for 
flow cytometry for CD45, EpCAM-1 and the indicated stromal cell markers.  Expression 
profile of CD45 and EpCAM-1 cells is shown (A).  Histograms show expression of the 
indicated stromal cell markers on thymic mesenchymal cells defined as CD45- EpCAM-1- (B-
J).   
Shaded grey areas represent the negative control.  Percentages of cells within gated 
areas are indicated.  Data representative of at least 2 experiments.   
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Figure 5.9 Summary of the Phenotype of the Thymic Mesenchyme. 
Table summarises data from figure 5.8.  Proportion (% of gated cells) of thymic 
mesenchymal cells expressing the indicated stromal cell markers is shown.  
Key: -, 0-5%, +, 6-20%, ++, 21-70%, +++, 71-100%. 
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PDGFRα+ population of cells, mostly expressing Ly51 (figure 5.10B), a gp38low PDGFRα- 
population, with some cells expressing Ly51 (figure 5.10C) and finally a gp38high PDGFRα- 
population not expressing Ly51 (5.10D).    
 
5.3.7 Genotypic Characterisation of the Thymic Mesenchyme. 
 Following our identification of different sub-populations of mesenchyme, we then 
aimed to determine gene expression profile of these mesenchymal cells (Note: suitable cDNA 
yields were obtained only from the gp38+ PDGFRα+ subset).  Stromal cell suspensions from 7 
day FTOC lobes were cell sorted for CD45- EpCAM-1- gp38+ PDGFRα+ cells.  Gene 
expression in these cells was compared to cells sorted for total epithelium (CD45- EpCAM-1+) 
and total mesenchyme (CD45- EpCAM-1-) (figure 5.11).  Quantitative RT-PCR was carried 
out for a panel of stromal cell associated genes.  As expected, FoxN1 was specifically 
expressed by the epithelium and not in the mesenchyme populations demonstrating the purity 
of the sort (figure 5.11A).  Expression of the chemokines CCL21 and CCL19 was mostly 
restricted to the epithelium (figure 5.11B and C).  By contrast, fibroblast growth factors 
(FGF) 7 and 10, were restricted to the mesenchyme populations (figure 5.11E and F) whereas 
the receptor for FGF7 and 10, FGFR2 was predominantly expressed in the epithelium (figure 
5.11D). 
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Figure 5.10 Defining Heterogeneity Within the Thymic Mesenchyme. 
CD45 depleted stromal cell suspensions from E15 lobes placed in fetal thymus organ 
culture (FTOC) for 7 days were stained for EpCAM-1, Ly51, gp38 and PDGFRα.  Gp38 and 
PDGFRα profile on CD45- EpCAM-1- cells is shown (A).  Histograms show Ly51 expression 
on gated populations.   
Shaded grey areas represent the negative control.  Percentages of cells within gated 
areas are indicated.  Data representative of 3 experiments.   
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Figure 5.11  Genotypic Characterisation of the Thymic Mesenchyme. 
 E15 lobes placed in fetal thymus organ culture (FTOC) for 7 days were cell sorted for 
total epithelial cells defined as CD45- EpCAM-1+ and total mesenchymal cells defined as 
CD45- EpCAM-1-.  7 day FTOC lobes were also sorted for a sub-population of mesenchymal 
cells defined as CD45- EpCAM-1- gp38+ PDGFRα+.  Quantitative RT-PCR was carried out 
for the indicated genes on the three populations of cells.  Relative mRNA expression of the 
indicated genes normalised to β-actin is shown (A-F).   
PCRs were carried out in triplicate and error bars indicate standard error of the mean.  
Data representative of two distinct sorting experiments.  
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5.4 Discussion. 
5.4.1 Defining Medullary Epithelial Cell Subsets. 
 The identification of heterogeneous subsets within the mTEC lineage has advanced 
the understanding of the mechanisms and developmental pathways leading to the 
differentiation of mature mTECs.  However, the extent of mTEC heterogeneity and the 
lineage relationships between mTEC subsets are yet to be fully defined.  Clearly, a further 
understanding of how mTECs differentiate and the signalling pathways directing this will 
help to determine the basis for such mTEC heterogeneity.  In view of this, experiments in this 
chapter aimed to phenotypically define the diversity of mTEC subsets. 
Data in this chapter emphasizes some of the differences between epithelial cells in the 
cortex and medulla with particular regard to the variable expression of CD80 and the 
autoimmune regulator AIRE.  Such differences between the cortex and the medulla are likely 
to be a reflection of the tolerogenic capacity of mTECs.  However, the expression of CD80, 
PD-L1 and PD-L2 (and CD40 as shown in chapter 3) on both mTECs and cTECs (albeit at 
varying levels) reflects the ability of both lineages to deliver co-stimulatory signals to 
developing thymocytes.  This data is in line with Gray et al (2006) who demonstrate that 
cTEC and mTEC subsets have the capacity to stimulate T cells in vitro at levels comparable to 
that of DCs.  PD-L1 and PD-L2 are known to deliver inhibitory signals through their receptor 
PD-1 to regulate peripheral T cell activation and tolerance (Keir et al., 2008).  These 
inhibitory signals delivered by PD-1 have been demonstrated in PD-1-/- mice, which display 
autoimmune symptoms implicating this pathway in regulating peripheral tolerance 
(Nishimura et al., 1999).  Thus, our findings that cTECs broadly express both of these ligands 
may add support to the notion that the cortex has the capacity to support negative selection in 
the thymus (Goldman et al., 2005; McCaughtry et al., 2008). 
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Our findings of broad PD-L1 expression across the thymus are in accordance with 
previous studies (Brown et al., 2003; Liang et al., 2003).  However, whilst both these studies 
suggest that PD-L2 expression is restricted to the medulla, data in this chapter shows that PD-
L2 is actually expressed by both mTECs and cTECs.  A possible explanation for this 
discrepancy maybe explained by the fact that Liang et al (2003) and Brown et al (2003) 
analysed PD-L2 expression by histology and not flow cytometry, which may be a more 
sensitive technique to detect PD-L2 expression in the cortex.  Interestingly, in contrast to PD-
L1, not all mTECs expressed PD-L2 possibly suggesting separate roles for these two ligands 
in the thymus. 
As expected, data in this study shows that expression of CD80 and AIRE are restricted 
to the mTEChigh lineage and this is in line with data that suggests this particular subset is more 
responsible for TEC-mediated tolerance (Gray et al., 2006).  However, such expression 
patterns did not extend to the PD-1 ligands as in our study both PD-L1 and PD-L2 did not 
distinguish between mTEClow and mTEChigh subsets.  It is important to note that not all 
mTEChigh cells express CD80 and AIRE and it has previously been shown that PD-L1 is 
expressed on both AIRE- and AIRE+ mTEChigh subsets (Gray et al., 2007a).  It is currently 
unclear if PD-L2 shares a similar pattern and certainly future experiments that determine if 
PD-L2 is expressed on AIRE+ mTECs would help to further define these subsets. 
A role for thymic crosstalk in the development of the medulla has been well 
established (Shores et al., 1991; van Ewijk et al., 1994).  Potential mediators of thymic cross-
talk induced differentiation of TECs have focused on components of NF-κB signalling 
pathway (e.g. RelB, TRAF6 and LTβ), activation of which is required for the development of 
mTECs (Akiyama et al., 2005; Boehm et al., 2003; Burkly et al., 1995; Gray et al., 2006).  A 
role for receptor activator of NF-κB (RANK) signalling has been well defined as essential for 
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the development of CD80+ AIRE+ mTECs (Akiyama et al., 2008; Rossi et al., 2007b).  In the 
present study we confirm these findings by showing that stimulation of RANK induces the 
development of the mTEChigh subset as evidenced by the induction of mTECs expressing 
CD80, AIRE and high levels of MHC II, which are typically missing in the absence of RANK 
signalling.  However, data in this study shows that RANK signalling is also important for the 
development of mTECs expressing PD-L2 and to a lesser extent PD-L1.  Our findings that 
RANK signalling mediates development of the mTEClow subset, which expresses PD-L2 but 
not AIRE or CD80, suggests that RANK signalling is not just restricted to the development of 
AIRE+ mTECs but may also be required for overall normal development and organisation of 
the medulla.  Our findings are consistent with studies showing that NF-κB signalling induces 
PD-L2 but not PD-L1 expression on peripheral DCs (Liang et al., 2003).  It is important to 
note that overall, lack of thymic cross-talk and stimulation of RANK signalling did not appear 
to have a large effect on expression of PD-L1, PD-L2 or MHC II on cTECs (data not shown), 
which is in line with the knowledge that cTECs lack expression of RANK and consequently 
are unresponsive to RANKL.   
LTi cells deliver RANKL signals and the important contribution of these cells to 
mTEC development has been highlighted in studies on mice deficient for retinoic acid 
receptor-related orphan receptor (ROR)γ, a regulator of LTi development (Eberl et al., 2004; 
Sun et al., 2000).  These RORγ-/- mice show reduced numbers of AIRE+ mTECs.  In the 
context of this study, it would be of future interest to determine if development of PD-L2+ 
mTECs in these mice is perturbed.   
Findings from a recent study demonstrate that the common γ chain cytokines 
(including IL-2, IL-7, IL-15 and IL-21), which are important for T cell proliferation and 
survival, directly induce PD-1 and its ligands on peripheral T cells (Kinter et al., 2008).  
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Future experiments could involve analysing common γ chain knockout mice to determine if 
expression of the PD-1 ligands is abnormal in TECs.  
The broad expression of PD-L1 and PD-L2 in the thymus suggests an important role 
during T cell development. Thus, we aimed to determine the expression of their receptor PD-1 
on thymocytes. Studies suggest a role for PD-1 as a negative regulator of TCR signalling in 
the thymus (Keir et al., 2005).  In this study, they suggest that ligation of PD-1 with PD-L1 
inhibits TCR-mediated signalling, thereby reducing the number of DP thymocytes that receive 
a TCR signal to induce maturation to the SP stage.  Furthermore, this study also shows that 
PD-L1-/- mice have higher numbers of DP and SP4 thymocytes compared to WT.  However, 
PD-L2-/- did not show any similar defects and did not appear to be required during positive 
selection, suggesting distinct roles for PD-L1 and PD-L2 in the thymus.  Whilst such studies 
support our findings that PD-L1 is expressed in the cortex where positive selection occurs, it 
remains unclear what the precise role both PD-L1 and PD-L2 have in the medulla during T 
cell development.  
Clearly, further studies that identify TEC subsets and reveal the molecular mechanism 
of TEC development and thymic microenvironment formation are essential to improve our 
understanding of the events mediating the generation of a self-tolerant T cell repertoire. 
 
5.4.2 Defining Mesenchyme Heterogeneity.  
 In the final part of this chapter we turned our focus onto defining heterogeneity within 
the non-epithelial stromal cell compartment of the thymus, which mostly comprise of 
mesenchymal cells that constitute the capsule, septae, perivascular cells, and a network of 
fibroblasts.  The thymic mesenchyme, particularly a subset expressing PDGFRα, is known to 
play an important role during early TEC development through the provision of fibroblast 
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growth factors (FGFs) (Jenkinson et al., 2003; Jenkinson et al., 2007b).  However, these cells 
are not well characterised.  Preliminary data in this study provides further evidence that the 
mesenchyme is heterogeneous.  Data identifies three populations of mesenchyme based on the 
differential expression of PDGFRα and gp38.  The most predominant population were the 
PDGFRα+ gp38+ cells, in which a high proportion of these cells expressed Ly51.  Genotypic 
analysis of these cells revealed they lacked expression of genes associated with thymic 
epithelium but did express the mesenchyme associated growth factors FGF7 and 10.  These 
cells are likely to represent the ‘cortical mesenchyme’ as reported by Muller et al (2005) who 
identified a subset of CD45- EpCAM- cells expressing Ly51 and FGF10.  It would be of 
interest to determine if the PDGFRα+ gp38+ cells also express the fibroblast marker MTS15.  
A study identified a unique MTS15+ population of fibroblasts in which a majority of these 
cells also co-expressed PDGFRα (Gray et al., 2007b).  This study also found that MTS15+ 
cells expressed FGF7 and FGF10, which corresponds to our data on the PDGFRα+ gp38+ 
cells.  To determine if this gene expression is unique to the PDGFRα+ gp38+ population of 
mesenchyme then certainly further cell sorts of all identified mesenchyme populations in this 
study will need to be carried out.  Clearly, other growth factors important for T cell 
development and TEC development should also be investigated, such as SCF, which is 
important for proliferation of early thymocytes (Rodewald et al., 1995) and IL-6, which has 
previously been identified as important for TEC proliferation (Meilin et al., 1995).  Indeed 
data by Gray et al (2007b) have shown that MTS15+ fibroblasts express both SCF and IL-6.  
 Our observation of a novel PDGFRα- gp38high population that lacked Ly51 expression 
was interesting and clearly these cells require further characterisation to determine their 
function in the thymus.  The precise origin of all identified populations in this study are 
unknown and ontogeny experiments which trace the lineage of these cells are likely to yield 
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useful information regarding these cell types.  Furthermore, identifying the location of these 
cells within the thymic microenvironment would be useful in determining their functional 
roles during T cell development. Indeed there is evidence to suggest that MTS15+ fibroblasts, 
which were found to be located in SCZ, produce CXCL12 and so may be important in 
directing migration of DN cells toward the SCZ (Gray et al., 2007b). 
 Fibroblasts are known to support the differentiation of thymocytes beyond the DN2 
stage through the provision of extracellular matrix molecules (Anderson et al., 1997; 
Anderson et al., 1993).  Thus, future functional experiments could involve cell sorting the 
identified populations of mesenchyme and reaggregating them with DN2/3 thymocytes to 
determine if they can support the differentiation of these cells to the next stage of T cell 
development.   
Whilst the LTβR pathway is known to be important for mTEC development, studies 
implicate a role for this pathway for development of the mesenchyme (Seach et al., 2008).  
Preliminary data in this study suggests that non-TECs have high levels of LTβR (data not 
shown) suggesting an important role for lymphotoxin signalling in the mesenchyme.  
Interestingly, Seach et al (2008) found reduced numbers of MTS15+ fibroblasts in LTα-/- and 
LTβ-/- mice.  This prompts further investigation where future experiments could involve 
comparing cell sorted populations of PDGFRα+ gp38+ from WT and LTβR-/- mice to 
determine if LTβR-/- mesenchyme expresses abnormal levels of growth factors important for 
TEC or T cell development. 
To conclude, whilst we have potentially identified novel populations of mesenchyme 
in the thymus, clearly further studies are warranted.  Defining such heterogeneity will allow 
for further evaluation of the precise role the mesenchyme has alongside TECs and thymocytes 
in the thymus. 
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CHAPTER 6   
GENERAL DISCUSSION 
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6.1 Background and Overall Aims of Study. 
The development of a diverse and self-tolerant T cell repertoire is dependent on the 
unique structure of the thymus.  The thymic stromal cell compartment is organised into 
distinct microenvironments with each mediating defined stages in T cell development.  The 
thymic epithelial cells (TECs) represent the major stromal cell type of the various thymic 
regions and are essential during multiple stages of T cell development.  Whilst epithelial cells 
of the cortical lineage impose self-MHC restriction on immature thymocytes via positive 
selection, epithelial cells of the medullary lineage aid in the deletion of autoreactive 
thymocytes via negative selection (Anderson et al., 2009).  Thus, the complex trafficking of 
thymocytes through these different regions of the thymus enables developing thymocytes to 
receive essential signals from both cortical and medullary epithelial cells to induce their 
maturation.  In turn, lymphostromal interactions are also thought to mediate the establishment 
and maintenance of mature thymic microenvironments via a process of thymic crosstalk (van 
Ewijk et al., 1994).  Such bidirectional interactions between the various thymic stromal cells 
and haematopoietic cells are indispensable for thymus organogenesis.  In contrast to the well-
defined stages of T cell development, developmental steps and the signals that govern the 
establishment of thymic microenvironments remain largely undefined.  In view of this, the 
overall aims of this study were to phenotypically characterise stages of thymic stromal cell 
development, with particular emphasis on the development of cortical thymic epithelial cells 
(cTECs), which prior to the start of this study was undefined.  Furthermore, this study also set 
out to define molecular and cellular regulators of thymic stromal cell development.  In 
addition, understanding the signals that induce the migration of thymocytes to appropriate 
intra-thymic niches for their further development was of equal importance in this study.  With 
recent data suggesting a role for stromal cell-derived chemokines (Takahama, 2006), this 
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study also aimed to investigate the effect of chemokine-induced migration in the 
establishment of thymic microenvironments, with a particular focus on the poorly defined 
region of the subcapsular zone (SCZ).  Thus, data within this thesis falls into two major 
themes, where chapters 3 and 5 deal with defining TEC development and chapter 5 focusing 
on the role of chemokine-mediated establishment of thymic microenvironments.  
 
6.2 A Revised Model of Thymic Epithelial Cell Development. 
 Whilst stages in TEC development have yet to be fully elucidated, recent studies have 
begun to fill in gaps in our understanding of this process.  Studies have discovered that cTECs 
and mTECs derive from a common bipotent TEC (bTEC) progenitor or stem cell (Bleul et al., 
2006; Rossi et al., 2006).  Moreover, the discovery of mTEC progenitors downstream of 
bTECs and the identification of a precursor-product relationship within this lineage have 
helped to delineate mechanisms of mTEC development (Hamazaki et al., 2007; Rodewald et 
al., 2001; Rossi et al., 2007b).  However, due to a paucity of cTEC specific markers, events 
occurring downstream of bTECs leading to the differentiation of the cortical lineage have 
remained elusive and so attempts to isolate and study cTECs present an important challenge 
within the field.  Thus, this prompted an ontogenetic approach to investigate steps and 
mechanisms regulating cTEC development downstream of bTECs.  Using the endocytic 
receptor CD205, which is expressed within the cortex and not the medulla, we were able to 
track the development of cTECs from the earliest stage of thymus development through 
ontogeny in both WT mice and also transgenic mice to determine the signals involved in the 
development of the cortex.  Furthermore, this approach allowed for the isolation of cTEC 
populations at various points in development to carry out a genotypic analysis.  In addition, 
this study also set out to assess mTEC development with the aim of extending current 
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understanding of the development of this lineage.  Data presented in chapters 3 and 5 
regarding cTEC and mTEC development are summarised in figure 6.1 as a revised model of 
overall TEC development. 
 
6.2.1 Development of the Cortex and a Role During Positive Selection. 
This study identified a previously unreported cTEC population, defined as EpCAM-1+ 
CD205+ CD40- MHC II-/low, expressing the cTEC specific proteasome subunit β5T, during 
early thymus development.  Importantly, emergence of these cells along with an mTEC 
population defined as EpCAM-1+ CD205- CD40+, expressing mTEC associated genes such as 
AIRE and RANK, were dependent on the cell autonomous transcription factor FoxN1.  This 
data confirms the notion that whilst FoxN1 is not required for initial establishment of the 
thymus rudiment, it is essential for specification of the cortical and medullary lineages 
(Blackburn et al., 1996; Bleul et al., 2006).  Thus, FoxN1 deficient TECs are likely to 
represent bTEC progenitors arrested in their ability to differentiate into cortex and medulla.  
Consequently, FoxN1 deficient thymi remain in the adult as a cystic structure, unable to 
recruit lymphocyte progenitors (Itoi et al., 2001).  It is currently unclear what signals regulate 
FoxN1 expression and activity, with some studies implicating a role for Wnt proteins, which 
belong to a family of secreted glycoproteins with diverse functions (Balciunaite et al., 2002; 
Hollander et al., 2006). Importantly, our data contradicts previous reports that TECs are 
homogenous in the early embryo, acquiring a specific cTEC or mTEC phenotype later in 
development (Bennett et al., 2002; Klug et al., 2002; Rossi et al., 2006).  Instead, we 
demonstrate heterogeneity of TECs with an emergence of a defined cortical lineage as early 
as day 12 of gestation.  Moreover, this study also identified a previously unreported stage  
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Figure 6.1 A Revised Model of Thymic Epithelial Cell Development. 
 Figure summarises data presented in chapters 3 and 5 to provide a revised model of 
thymic epithelial cell (TEC) development where a bipotent TEC progenitor develops into 
mature cortical epithelium and mature medullary epithelium via progenitor populations 
expressing the indicated markers.  Red arrow indicates the requirement for FoxN1 and the 
orange arrow indicates the requirement for haematopoietic cells. 
 ?, indicates unknown expression profile, imm, immature, mat, mature, bTEC, bipotent 
thymic epithelial cell, cTEC, cortical thymic epithelial cell, mTEC, medullary thymic 
epithelial cell.  
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specific requirement for thymocytes during the development of the cortical lineage (discussed 
in section 6.2.3). 
The unique ability of cTECs to support positive selection is poorly defined.  However, 
the cortical epithelium is likely to possess unique cell surface molecules and antigen 
processing capabilities that promote positive selection rather than negative selection and these 
may be distinct from mTECs and APCs, which support negative selection.  CD205 is also 
known to be expressed on a subset of peripheral DCs (Kraal et al., 1986) and it was 
previously reported that this endocytic receptor is associated with the capture and endocytosis 
of diverse carbohydrate bearing antigens to direct them to appropriate compartments for 
antigen processing and presentation to CD4+ T cells (Jiang et al., 1995; Mahnke et al., 2000). 
The precise role that CD205 has in the thymic cortex is yet to be determined.  A study shows 
an involvement of CD205 in the clearance of apoptotic thymocytes by cTECs in vitro (Small 
and Kraal, 2003).  This data suggests a role for CD205 in the apoptosis of developing 
thymocytes that have failed to receive a positive selection signal.  Thus, expression of CD205 
on cTECs may reflect their functional capacity to support positive selection.  However, the 
use of CD205 knockout mice has shown that DCs still have the capacity to endocytose dying 
cells, suggesting that CD205 may not be essential for this process (Iyoda et al., 2002).  
Certainly, investigating intra-thymic T cell development in such CD205-/- mice will help to 
understand the role of this receptor in the thymus.  
This study has formally shown the existence of a cTEC progenitor downstream of 
bTEC progenitors and has identified novel checkpoints in the development of the cortical 
lineage.  Further advances in the field have also emerged with the recent identification of 
β5T, which is expressed specifically by cTECs and is associated with the positive selection of 
CD8+ T cells (Murata et al., 2007).  Additionally, Gommeaux et al (2009) report that the 
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serine protease Prss16 is specifically expressed by cTECs and is important for the positive 
selection of CD4+ T cells.  These studies along with our findings will greatly advance the field 
of cTEC development and will help to begin to understand how cTECs become specialised in 
their ability to support positive selection.  Moreover, the recently described antibody against 
the cTEC expressed Notch ligand delta-like 4 (Fiorini et al., 2008) should provide an 
important tool to study cTECs and to understand the pathways that underlie their 
development.  
 
6.2.2 Development of the Medulla and a Role During Central Tolerance. 
Medullary epithelium is indispensable for the induction of self-tolerance via the 
deletion of potentially autoreactive thymocytes by a process of negative selection.  mTECs 
transcribe a wide spectrum of tissue restricted antigens under the control of the autoimmune 
regulator AIRE (Kyewski and Klein, 2006).  Thus, elucidating the development of mTECs 
and in particular the subset expressing AIRE, is central to our understanding of how mTECs 
become specialised in their capacity to support negative selection and prevent autoimmune 
disease.  This study extends current knowledge in the field by employing a phenotypic 
approach to analyse the heterogeneity of mTEC subsets.  This study demonstrates further 
heterogeneity within the mTEC lineage based on the expression of co-stimulatory molecules 
such as the PD-1 ligands PD-L1 and PD-L2 and also CD80.  Moreover, we further 
corroborate the requirement for thymic crosstalk for the development of these subsets 
(discussed in section 6.2.3).  In particular, we demonstrate that not only is RANK-RANKL 
signalling important for development of the AIRE+ CD80+ mTEChigh subset, as previously 
reported (Akiyama et al., 2008; Hikosaka et al., 2008; Irla et al., 2008; Rossi et al., 2007b), 
but this pathway is also involved in the development of the mTEClow subset, which does not 
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express AIRE or CD80 but does express PD-L2.  Mice deficient for RANK show a marked 
absence of AIRE+ mTECs and RANK deficiency in thymic stroma resulted in profound 
symptoms of autoimmunity such as inflammatory infiltrates in the liver and the presence of 
autoantibodies in the serum (Rossi et al., 2007b).  Collectively, our data along with others 
emphasizes the central role of RANK signalling for the development and organisation of the 
thymic medulla to ensure establishment of self-tolerance. 
Complex arrays of co-stimulatory signals are reported to be essential for negative 
selection of thymocytes.  In particular, a study predicts that CD40 signalling induces other co-
stimulatory molecules (including CD80 and CD86) to cooperatively regulate MHC II 
mediated negative selection (Li and Page, 2001).  Furthermore, functional heterogeneity, such 
as varying levels of co-stimulatory molecules, within the mTEC subset has been reported to 
influence the outcome of deletion versus Treg cell fate specification (Aschenbrenner et al., 
2007).  In particular, reports suggest the B7/CD28 pathway is important for the development 
and homeostasis of Tregs, which are so important in the maintenance of peripheral tolerance 
(Salomon et al., 2000; Tai et al., 2005).  To summarise, data in this thesis demonstrates the 
complexity of mTEC heterogeneity and this, together with previous reports, is likely to reflect 
the specialisation of the medullary microenvironment to impose self-tolerance.  Indeed, 
findings from a recent study further highlight the unique nature of this region by showing that 
self-antigens can be transferred between DCs in the medulla and mTECs, thus widening the 
cellular basis for the induction of tolerance towards self-antigens (Koble and Kyewski, 2009). 
 
6.2.3 A Role for Thymic Crosstalk. 
In accordance with previous studies, data in this thesis highlights key similarities in 
the requirement for thymic crosstalk for the development of the cortex and medulla (Klug et 
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al., 1998; Naquet et al., 1999; Shores et al., 1991; van Ewijk et al., 2000).  Our data suggests 
that the initial specification of bTEC progenitors into the cortical and medullary lineages is 
thymocyte independent; consistent with the notion that thymic crosstalk is not required for 
initial patterning and differentiation of fetal thymic epithelium (Jenkinson et al., 2005; Klug et 
al., 2002).  However, whilst thymocytes are clearly not required for the initial establishment 
of these microenvironments, a developmental switch occurs where thymocyte derived signals 
are required for the further maturation and/or maintenance of epithelial regions.  Our data 
shows that with regard to the cTEC lineage, further differentiation and acquisition of markers 
associated with functional maturation of cTECs (i.e. MHC II and CD40 expression) was 
dependent on the presence of thymocytes, suggesting a stage-specific requirement for thymic 
crosstalk during cTEC development.  Furthermore, this study also extends current 
understanding on the development of mTEClow and mTEChigh subsets by demonstrating a role 
for thymic crosstalk through the provision of RANK-RANKL signalling.  Whilst thymic LTi 
cells provide RANKL during the fetal periods, both LTi and SP4 cells provide RANKL 
during the post-natal and adult stages (White et al., 2008).  LTi cells providing TNFR ligands 
such as RANKL and LTα are also known to influence the maturation of microenvironments 
within secondary lymphoid organs via NF-κB mediated signalling (Cupedo et al., 2002).  This 
common requirement for LTi derived signals is an example of the remarkable similarities 
between the thymic medulla and certain regions of the secondary lymphoid tissues such as the 
T cell zone of the spleen (Anderson et al., 2007; Derbinski and Kyewski, 2005). 
Given the importance of thymic crosstalk for development of the cortex as described 
in this study, this raises the question of whether the ability to form the cortex is temporally 
restricted.  Whilst mTEC development is plastic and can be restored by reconstituting adult T 
cell deficient mice with normal bone marrow derived precursors or peripheral T cells (Shores 
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et al., 1991; Surh et al., 1992); it was previously proposed that cortex development in 
CD3εtg26 mice, displaying a block at the earliest stage of T cell development, could be 
restored in fetal or early postnatal stages but not adult (Hollander et al., 1995).  This 
suggested the thymic epithelium is rendered unreceptive to thymic crosstalk signals resulting 
in a developmental ‘window’ for cTEC differentiation.  However, a recent study has found 
that TECs retain their receptivity to thymic crosstalk even after long periods of thymocyte 
absence (Roberts et al., 2009).  In the context of this thesis, this has implications for current 
models of thymic crosstalk and also strategies aimed at restoring thymic function in patients 
following thymic involution or ablative therapy (as discussed in section 6.2.5).   
Whilst it is difficult to distinguish the role of thymocytes for either maturation or 
maintenance of TECs, observations in this study shows that in contrast to CD3εtg26 mice, 
cTECs obtained from FTOCs depleted of all haematopoietic cells had normal levels of MHC 
II expression (data not shown).  This indicates that thymic crosstalk is involved in the initial 
induction of MHC II expression on cTECs but is not required for maintenance of expression.  
The requirement for thymocytes during TEC development reflects the ability of T cells to 
influence the microenvironment they develop in by providing a feedback mechanism.  
However, the precise signals thymocytes provide to TECs remains speculative, with some 
studies reporting that DP and SP thymocytes generated in late fetal stages are able to provide 
growth factors akin to those provided by the mesenchyme during early fetal TEC 
development (Jenkinson et al., 2003), which may influence proliferation of TEC populations 
(Erickson et al., 2002).  This could possibly explain why in the present study, levels of cTEC 
proliferation were slightly lower in thymocyte deficient mice compared to WT.   
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To summarise, the stage specific requirement for haematopoietic cells during cTEC 
and mTEC development highlights the essential role for thymic crosstalk at multiple stages of 
thymus development.  
 
6.2.4 Future Directions.  
Despite recent advancements in the field, many questions regarding TEC development 
remain unanswered.  Whilst our model of TEC development suggests that bTECs undergo 
bifurcation into the cTEC and mTEC lineage, it is currently unclear what the precise sequence 
of development is.  Indeed, our data may suggest that cortex develops before medulla as 
evidenced by the fact that appearance of CD205+ cTECs preceded the emergence of CD205- 
CD40+ mTECs.  Additionally, studies have shown that development of the cortex is a 
prerequisite for medulla formation (Klug et al., 2002).  It also remains unclear what signalling 
pathways cause bTECs to develop into either the cortical or medullary lineage.  In other 
words, is it stochastic or regulated extrinsically?  Such extrinsic signals are unlikely to be 
mesenchyme or thymocyte in origin as TECs at E12 of development can undergo cortical and 
medullary differentiation in the absence of mesenchyme (Jenkinson et al., 2003) or a normal 
programme of T cell development as demonstrated in our study and others (Jenkinson et al., 
2003; Jenkinson et al., 2005). 
It is currently unclear to what extent the CD205+ cTEC progenitors identified in this 
study are committed to the cortical lineage.  In other words, can CD205+ cells in the early 
embryo give rise to mTECs?  Future experiments could involve isolating these cells and 
reaggregating them with mismatched stromal cells to determine their fate.  Additionally, 
whilst we propose that CD205+ cTECs in the embryo are putative progenitors of more mature 
CD205+ cTECs, we are yet to formally prove the existence of a precursor-product 
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relationship.  Similar to experiments carried out on mTEC subsets (Rossi et al., 2007b), future 
experiments could involve purifying CD205+ cTECs from an embryo and reaggregating them 
with mismatched stroma.  Following culture, CD205+ cells could be analysed for their 
expression of CD40 and MHC II.  Furthermore, studies on mTECs have yielded interesting 
data on their lifespan and turnover capacity, with data suggesting that the turnover of AIRE+ 
mTECs is two weeks (Gray et al., 2007a).  Certainly future experiments should focus on 
employing similar strategies to determine the turnover capacity of cells at different stages of 
cTEC development. 
Precise mechanisms regulating overall TEC development remain undefined.  Current 
work in the lab aims to elucidate signals required for differentiation of TECs through the 
identification and manipulation of signalling pathways via a lentiviral gene delivery system.  
For example, such a tool could help target TEC associated genes such as AIRE and RANK to 
understand their development.  Other target genes could include members of the Wnt family, 
which have been implicated in the cell fate of keratinocytes in the skin (Huelsken et al., 
2001).  
Whilst an understanding of TEC development contributes to the scientific 
understanding of thymus development, it may also have implications in a wider context, 
particularly in the development of strategies for thymic regeneration.   
 
6.2.5 The importance of TEC Development in the Context of Developing Strategies For 
Thymic Regeneration.  
The immune system undergoes an age-dependent deterioration in its ability to respond 
to infection and vaccination (Aw et al., 2009).  Central to this is the gradual process of thymus 
involution, which correlates with a decline in thymic output (Berzins et al., 2002).  The 
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thymus achieves its maximum size within the first year after birth and this is followed by a 
progressive decrease in functional epithelial microenvironments, which in humans is replaced 
by fatty tissue (George and Ritter, 1996).  Hence, an ability to restore thymic 
microenvironments would aid in increasing thymic output with a view to combat the age-
associated decline in the immune system.  Studies have shown an age-dependent decline in 
cortical and medullary markers, accompanied by disorganised regions, thus affecting the 
signals given to thymocytes from the thymic microenvironments (Aw et al., 2009).  
The potential to activate TEC progenitors in an adult thymus presents an attractive 
strategy to restore declining thymus function in the elderly or patients receiving therapy. 
Whether a bipotent or lineage restricted TEC progenitor exists within the post-natal and adult 
thymus, which acts as a stem cell pool with self-renewal capacity is currently unknown. The 
fact that the thymus undergoes atrophy would suggest an absence of a stem cell pool fitting 
with the notion that a functional thymus is only required during postnatal periods and early 
adulthood.  However, studies have shown the ability to regenerate thymic microenvironments 
in mice through castration, implying that a stem cell population may exist in an adult thymus 
(Blackburn et al., 2002).  Thus, in light of recent advances in TEC development, one could 
envisage a scenario where knowing the signals required to stimulate TEC stem cell expansion 
and differentiation in situ would further promote strategies aimed at thymic regeneration and 
subsequent peripheral T cell reconstitution in the elderly or immunocompromised patients 
(Blackburn et al., 2002). 
 
6.3 Chemokine Mediated Establishment of Thymic Microenvironments.  
T cell development is defined by the ordered migration of thymocytes through distinct 
regions of the thymus in order to receive essential signals for their differentiation and 
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selection.  In the vascularised thymus, thymocyte progenitors enter at the CMJ before 
migrating towards the SCZ.  This correlates with differentiation through the DN stage of T 
cell development where cells undergo β-selection, pre-TCR signalling and extensive 
proliferation (Prockop and Petrie, 2000).  Following these events, emerging DP cells reverse 
their migration polarity moving outwards deeper into the cortex to undergo positive selection.  
Differentiation to the SP stage correlates with migration to the medulla where thymocytes 
undergo the final stages of maturation.  Such microenvironments provide specialised and 
unique signals to support the multiple stages of T cell development.  However, establishment 
of these microenvironments remain undefined.  Defining the specialised conditions of these 
thymic microenvironments and in particular the signals that allow thymocytes to reach these 
regions is central to understanding T cell development.  
Thus, this study aimed to characterise the role of chemokine-mediated establishment 
of thymic microenvironments, with a particular emphasis on the SCZ.  Additionally, T cell 
development in DOCK2 deficient mice, where chemokine (namely CCR7 and CXCR4) 
signalling may be disrupted, was also investigated.  This study demonstrates that the anatomic 
compartmentalisation of the thymus is established during ontogeny and remains relatively 
conserved through to the adult stages.  Furthermore, by employing laser capture 
microdissection (LCM) this allowed for the isolation of cells defined by their specified 
locations. To characterise signals generated by stromal cells that cannot be identified 
phenotypically, but by their location in the thymus remains a challenge.  Therefore, LCM was 
particularly useful for isolating the SCZ as there is currently no phenotypic marker that allows 
for the isolation and analysis of stromal cells in this region by flow cytometry.  We were thus 
able to analyse the anatomical compartmentalisation of chemokines in different regions of the 
thymus.  However, the technique of LCM has some limitations especially as isolated regions 
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will be ‘contaminated’ by haematopoietic cells that may ‘dilute’ the stromal cell derived 
signals.  Gosink et al (2007) have optimised a method to electronically subtract gene 
expression in one or more components of a mixed cell population to reveal expression 
patterns of minor or difficult to isolate populations.  Whether such a technique could be 
successfully applied to study stromal cell derived signals from microdissected regions of 
thymus remains to be determined.  However, despite this limitation, LCM is a reliable 
technique to study populations of cells that can only be defined by their anatomical location.  
Indeed, LCM has been successfully applied in our lab to study if replication of murine CMV, 
which is known to cause severe destruction of the splenic T cell zone, occurs in the red pulp 
or white pulp stroma (Bekiaris et al., 2008).  Furthermore, a recent study has employed LCM 
to isolate the 3rd pharyngeal pouch from mouse embryos and have identified a role for the 
transcription factor MafB in embryonic thymus development (Sultana et al., 2009).  In the 
context of the present study, LCM could also be employed to study the establishment of 
thymic microenvironments throughout ontogeny.  More specifically, establishment of the 
SCZ was observed to occur at E18.  It would thus be of future interest to elucidate if a specific 
chemokine expression pattern already exists at this point of development.  Furthermore, data 
in this thesis show that thymocyte migration to the SCZ is perturbed in CCR9-/- neonatal and 
adult mice and so it would be of equal interest to investigate if a similar scenario is present at 
E18.   
Certainly any attempts to optimise LCM to isolate cells and/or regions from 
fluorescently labelled tissues will pave the way to study more specific areas of interest.  
Whilst this study primarily focused on chemokine related expression patterns within the intra-
thymic niches and it would certainly be of future interest to employ LCM to study other genes 
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that may be important during T cell development such as members of the Wnt or Notch 
family. 
Chemokine signalling is complex and so it is difficult to assess the precise roles of 
chemokines during thymocyte migration based solely on expression patterns.  Nevertheless, 
by identifying the compartmentalisation of chemokines within the thymus and the expression 
of their receptors on thymocytes and the effect of knocked out chemokines is an important 
step in understanding this process.  Data in this study supports current notion that intra-thymic 
regions can be characterised by differential expression patterns of chemokines (Petrie, 2003; 
Takahama, 2006).  By paying particular attention to the poorly defined region of the SCZ we 
addressed what chemokines may be important in the establishment of this region.  
Importantly, by studying T cell development in DOCK2-/- mice, we can predict that in the 
absence of certain chemokines or signalling pathways, the thymus appears to have the 
capacity to initiate compensatory mechanisms that achieve normal T cell development.  
This study, along with others clearly shows the importance of chemokines in directing 
thymocytes to specific niches.  However, this poses the important question of how 
chemokines influence the migration of thymocytes.  A long existing paradigm suggests that 
chemokines diffuse away from secreting cells to establish a chemokine gradient, where 
receptive cells away from the source detect the chemokine and move up the gradient (Vicker, 
1989).  However, whether this is the mechanism in place in the thymus is unclear.  Studies 
suggest that rather than the presence of a chemokine gradient, T cells can respond to 
chemokines such as CXCL12 in the absence of a soluble chemokine gradient via the 
induction of cell polarisation and spatial re-orientation of the cell (Pelletier et al., 2000).  
However, the role of other factors that act in concert with chemokines in inducing thymocyte 
migration cannot be overlooked.  Certainly the role of adhesion molecules such as integrins 
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have been implicated in cortex to SCZ migration (Petrie, 2003).  For example, DN2 cells that 
are actively migrating towards the SCZ are known to express a variety of integrins that are 
thought to bind to certain ECM ligands.  More specifically, laminin 5 is an extracellular 
matrix (ECM) molecule secreted by subcapsular epithelial cells and its receptors (e.g. α6β4 
integrin) are specifically up-regulated on DN3 cells (Kim et al., 2000).  Such stromal 
elements present in the SCZ suggest that they may function during the DN stage of thymocyte 
development by providing a temporary anchorage site for these thymocytes, thereby 
maintaining the cells in the right environment for their survival and differentiation (Kim et al., 
2000).  Downregulation of this receptor on DP cells may explain the reversion of migration 
polarity. Chemokines interacting with ECM highlights the need to analyse migration in the 
context of the microenvironments in which they occur.  Studies have shown that the stromal 
microenvironment of the SCZ tends to differ from the cortex and instead shares similar 
characteristics as the medulla (Farr et al., 1992).   
The apparent requirement for specific niches for T cell development may not be 
absolute and this raises the longstanding question of whether thymocytes require specific 
niches to undergo T cell development, which is yet to be fully addressed.  In the context of 
cortex to medulla migration, T cell maturation and export can occur in the absence of CCR7 
mediated migration to the medulla (Kurobe et al., 2006).  Certainly, recent data suggests that 
not only can the cortex support the clonal deletion of thymocytes self-reactive to ubiquitous 
self-antigens (McCaughtry et al., 2008) but the finding that thymocytes interact with DCs 
located in the cortex help to reinforce the view that thymocytes can undergo a significant 
amount of screening for self-reactivity prior to exposure to the medullary microenvironment  
(Ladi et al., 2008).  However, the autoimmune symptoms observed in the study by Kurobe et 
al (2006), suggests that interaction of developing T cells with AIRE+ mTECs is still required 
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to establish central tolerance to tissue restricted antigens.  In the context of this study it would 
be of future interest to graft cortical epithelial cells (i.e. sorted on the basis of a CD205+ 
phenotype) into an athymic host.  Not only would such an experiment provide clues as to 
whether the medulla is derived from cortex, but also if this were not the case then would we 
see autoimmunity as result of failed negative selection? 
Aberrations in chemokine or non-chemokine mediated migration of thymocytes may 
alter the maturation/migration processes of developing T cells, which may consequently alter 
the repertoire of the peripheral T cell pool.  Indeed migratory disturbances have been 
observed in a disease context in mice infected with the protozoan parasite Trypanosoma cruzi, 
the causative agent of Chagas disease (Mendes-da-Cruz et al., 2006; Savino, 2006).  Infected 
mice displayed increased deposition of ECM ligands (namely fibronectin and laminin) and 
chemokines (namely CXCL12) in the thymus.  Such alterations correlated with the 
appearance of potentially auto-reactive thymus derived DP T cells in the peripheral organs of 
infected mice.  Consequently, such reports provide further clues for understanding intra-
thymic T cell development and for designing therapeutic strategies to target developing T 
cells in a disease context. 
 
 
6.4 Concluding remarks 
 This thesis attempted to define the development and function of thymic 
microenvironments, with particular emphasis on characterising stages in cTEC development 
and the role of chemokine-mediated establishment of the SCZ.  A major outcome of this work 
has been the definition of checkpoints in the development of the cortex, which is providing 
new insights into how the cortex acquires the ability to mediate positive selection.  These 
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findings should provide the basis for developing future novel strategies for rejuvenating the 
thymus in immunocompromised patients.  This will no doubt bring closer the prospect of 
exploiting the identified progenitor cells for increasing the longevity of the T cell repertoire. 
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